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Visual spokespersons and the localisation vs. globalisation of visual elements in 
communication through images online: An analysis of global and localised websites 
of multinational pharmaceutical companies 
 
Objective of the study 
The objective of the study was to examine the visual communication of multinational 
pharmaceutical companies through images on their global corporate website as well as 
two localised websites: their home country and China. The study focused on human 
roles depicted in the images and examined the transferability of the source credibility 
effect from marketing communications into visual communication. In addition, by the 
means of comparing and contrasting, the study investigated whether pharmaceutical 
companies globalised visual elements across the three websites or whether the elements 
were all localised to the target audience. 
 
Methodology and the analytical framework  
The study consisted of a semiotic analysis, which examined the meaning conveyed 
through images on the websites, as well as a content analysis, which produced counts of 
frequency of the visual elements. Data consisted of 257 images including narrative 
themes found on the websites of four companies: Novartis, Orion, Pfizer and Sanofi. A 
total of 503 figures in the images were analysed. The analytical framework for the study 
was comprised of the visual grammars of Kress and van Leeuwen (2006) and O’Toole 
(1994), and looked at the data through three metafunctions of meaning-making 
(interpersonal, representational and compositional) and two units of rank (work and 
figure). 
 
Findings and conclusions 
The study found that pharmaceutical companies use visual communication through 
images not only to inform website visitors about their operations but also to demonstrate 
the impact of medicinal products in the lives of consumers in a more informal setting. 
Illnesses and old age are topics, which are, however, neglected in the images. Four 
groups of visual spokespersons could be recognised in the images: consumers, business 
professionals, employees and experts. The key signifiers of the groups were their 
clothing and the image setting. Each group was deemed to enable the source credibility 
effect to take place, although in different contexts and with varying credentials. 
Localisation was the strategy most commonly adopted by the pharmaceutical companies 
in the images across their global, home country and Chinese websites. Interestingly, 
however, globalisation was utilised to a great extent at the rank of figure. Future 
research into the topic could for example incorporate a comparison between the 
intended and actual message through company and website visitor interviews. 
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Visuaaliset puolestapuhujat ja visuaalisten elementtien lokalisointi vs. globalisointi 
viestinnässä kuvien kautta verkossa: Kansainvälisten lääkeyritysten globaalin ja 
lokalisoitujen verkkosivujen analyysi 
 
Tutkimuksen tavoitteet 
Tutkimuksen tavoitteena oli selvittää miten kansainväliset lääkeyritykset viestivät 
kuvien kautta globaalilla verkkosivuillaan sekä kahdella lokalisoiduilla 
verkkosivuillaan, kotimarkkinansa sekä Kiinan. Tutkimus keskittyi ihmisrooleihin 
kuvissa ja tutki lähdeuskottavuuden vaikutusta visuaalisessa viestinnässä. Vertailemalla 
sivustoja tutkimus lisäksi selvitti mitä visuaalisia elementtejä lääkeyritykset käyttivät 
globaalisti läpi tutkittujen verkkosivustojensa, ja mitkä elementit he lokalisoivat 
kohdeyleisöille.  
 
Tutkimusmenetelmät ja analyyttinen viitekehys 
Tutkimuksessa hyödynnettiin semioottista analyysiä, jolla tutkittiin verkkosivuilta 
löydettyjen kuvien välittämät viestit, sekä sisällön analyysiä, jonka avulla visuaaliset 
elementit kvantifioitiin. Tutkimusaineisto koostui 257 juonellisesta kuvasta, jotka 
kerättiin neljän eri lääkeyrityksen verkkosivuilta: Novartiksen, Orionin, Pfizerin ja 
Sanofin. Yhteensä 503 kuvissa ollutta ihmishahmoa analysoitiin. Tutkimuksen 
analyyttinen viitekehys koostui Kressin ja van Leeuwenin (2006) sekä O’Toolen (1994) 
visuaalisista kieliopeista, joiden pohjalta aineistoa tutkittiin kolmen viestinnän tehtävän 
(interpersonaalinen, representationaalinen ja kompositionaalinen) sekä kahden 
visuaalisen tason (työ ja hahmo) kautta. 
 
Tutkimustulokset ja johtopäätökset 
Tutkimus osoitti, että lääkeyritykset käyttävät visuaalista viestintää kuvien kautta sekä 
kommunikoimaan verkkosivuilla vierailijoille liiketoiminnastaan että demonstroimaan 
tuotteidensa vaikutuksia kuluttajien elämiin epävirallisemmassa yhteydessä. Yritykset 
eivät kuitenkaan sisällyttäneet viitteitä sairauksiin tai vanhuuteen verkkosivujensa 
kuvissa. Neljä visuaalisten puolestapuhujien ryhmää tunnistettiin: kuluttajat, 
bisneshenkilöt, työntekijät ja ekspertit. Tunnistus perustui etenkin hahmojen 
vaatetuksen ja kuvan ympäristöön. Jokaisen ryhmän todettiin mahdollistavan 
lähdeuskottavuuden siirtymisen hahmosta kuvaan vaikkakin eri konteksteissa ja eri 
ominaisuuksilla. Lääkeyritykset käyttivät yleisesti lokalisointistrategiaa visuaalisessa 
viestinnässä kuvien kautta globaalilla sekä kotimarkkinoillensa että Kiinan markkinoille 
lokalisoiduilla sivustoillaan. Hahmojen osalta lääkeyritykset kuitenkin käyttivät 
globalisointia. Tulevissa aiheen tutkimuksissa voitaisiin esimerkiksi vertailla kuvien 
haluttua ja toteutunutta viestiä yritys- ja verkkosivuvierailijahaastattelujen kautta.  
 
 
Avainsanat: visuaalinen viestintä, lähdeuskottavuus, globalisointi, lokalisointi, 
lääketeollisuus, verkkosivut 
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 1. Introduction 
 
 
 
Websites are an important communication channel for companies to reach their target 
audiences (Maynard & Tian, 2004, p. 285). The internet, and websites as a result, is 
global by nature, which makes it the medium of choice for companies that want to 
communicate internationally (Zahedi & Bansal, 2011, p. 148). As international trade has 
become easier and companies have turned multinational (Hopearuoho & Ventola, 2009, 
p. 185), so has international communication also become common practice in 
companies.  
 Research has shown that corporate websites have a significant impact on a 
company’s image and performance (Maynard & Tian, 2004; Chun & Davies, 2001; 
Sullivan, 1999), which highlights the importance of how a company presents itself 
online. In addition, Lindgaard et al. (2006, p. 125) found that website visitors form an 
opinion on the website in as short a time as 50 milliseconds. The importance of websites 
as a channel for intercultural communication makes it a topic of interest for both 
academic researchers and corporate practitioners alike. 
 The use of images and pictures on company websites has become a norm 
in today’s business world. According to the findings of Lindgaard et al (2006) website 
visitors rate the pleasantness of their visit based on its visual appeal. Research also 
shows that visitors often scan images before reading textual information on a website 
(e.g. Faraday, 2000, cited in Djamasbi et al., 2011). These factors highlight the 
importance of images as tools of communication online (Zahedi & Bansal, 2011). 
Images are used online to add informational value to websites, to engage the viewer, or 
to balance the textual content on the website (Baratis et al., 2008, p. 1195). Furthermore, 
Zahedi and Bansal (2011, p. 147) found that companies use pictures and animation on 
their websites to convey subtle messages that are communicated more effectively 
through nonverbal means. In an environment where it is easy for audiences to tune out 
or avoid messages altogether, the effectiveness of messages is crucial for the success of 
companies (Singh et al., 2005, p. 72).   
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  Kress and van Leeuwen (2006, pp. 4 & 35) point out that visual messages 
are always in a coded form and only those who are aware of the code can interpret the 
messages correctly. This creates an increased risk for multinational companies (MNCs) 
to “visualise out of turn”. As company websites can be accessed globally, companies 
need to make sure that the images they use on their website communicate harmoniously 
in a global tone (Halliburton & Ziegfeld, 2009). Although multinational companies 
prefer to build a consistent international brand through the use of a global tone to 
maximize the amount of potential customers reached (Hopearuoho & Ventola, 2009, p. 
185) there is an increasing number of studies suggesting that the localisation of 
communication messages yields better returns for companies despite the higher initial 
investment needed (e.g. Zahedi & Bansal, 2011; Cyr et al., 2009; An, 2007; Taylor et 
al., 2007; Luna et al., 2002). As a result, a balance needs to be achieved between the 
elements that can be globalised for consistency and cost-effectiveness, and those that 
should be localised for better adaptation to target markets. 
 
 
1.1 Research problems 
 
Currently research on visual communication on websites has focused on its impact on 
usability (e.g. Djamasbi et al., 2011) and on creating trust and loyalty (e.g. Cyr, 2008) 
but the content of global visual messages has received little attention so far. A common 
characteristic in previous studies is also that they tend to concentrate on e-commerce 
websites instead of corporate websites in general. Furthermore, although some studies 
have purely concentrated on the images on websites (e.g. Cyr et al., 2009) many studies 
look at websites as whole entities, where all the various elements of a website are 
studied simultaneously (e.g. Djamasbi et al., 2011). 
 The purpose of this thesis is to study the visual communication that global 
pharmaceutical companies use on their corporate website as well as localized websites 
in their home market as well as a foreign one. The study will focus on the human roles 
that are depicted in the images found on corporate websites of four global 
pharmaceutical companies (Novartis, Orion, Pfizer and Sanofi). The roles will be 
2
 reflected upon spokespersons commonly used in marketing communications, thus the 
thesis combines elements of both visual and marketing communications. Furthermore, 
by the means of comparing and contrasting the study investigates which elements the 
case companies standardize across their different websites and which ones they feel 
need to be localized to communicate visually to target markets effectively. In an era of 
“glocalization” (Singh et al., 2005, p. 72. The concept is discussed in more detail in 
Section 2.3.1) this study sheds light into whether visual communication is seen by 
global pharmaceutical companies as something that needs to be localised for greater 
adaptation to the target market or something that can be standardised in order to save 
resources. 
 
Table 1: The topic, focus and context of the study 
TOPIC  
    
 
Visual communication 
FOCUS     
 
Source credibility effect Localised vs. globalised 
elements 
CONTEXT 
    
4 companies 
   
 
 
 
 
 
3 websites each 
   
 Global Home country Chinese 
5 websites each 
   
 Homepage About us R&D 
 Products & Services Sustainability 
 
1.2 Research objectives and questions 
 
As already established, communication through images is something that has generally 
been undervalued within societies (Kress & van Leeuwen, 2006, p. 35). Meaning 
making is therefore not as intuitive through images as it is through writing. This applies 
as much to companies as to individuals. MNCs face the added difficulty of operating in 
3
 a multicultural environment. When the cultural background of the viewer is different to 
that of the company there is an increased risk of the image being interpreted in a way 
that was not intended by the company, if the company does not consider these factors in 
advance. 
 This thesis will study the visual communication in the context of 
pharmaceutical companies’ websites. The focus will be on the roles that are presented in 
the images because the study aims to find out if the concept of source credibility effect 
widely researched in the field of marketing communication can also be adapted into 
visual communication. Furthermore, the thesis will evaluate the extent of globalisation 
and localisation of visual elements in the images on the websites of multinational 
pharmaceutical companies. As mentioned earlier, messages communicated visually 
through images and pictures are always coded (Kress & van Leeuwen, 2006, p. 4). This 
research examines whether the pharmaceutical MNCs feel the need to localise their 
images to target markets in order to gain better adaptation or whether they opt for a 
standardised global visual language throughout their various websites. The localised 
website for China for each company is used for the comparison together with their 
global and home country websites. The research questions for the study are as follows: 
 
1. How is the pharmaceutical industry presented in images on the websites of 
multinational pharmaceutical companies? 
2. What kinds of visual spokespersons do multinational pharmaceutical companies 
use in images on their websites? 
3. How do the visual spokespersons used on the websites of multinational 
pharmaceutical companies enable the source credibility effect to take place? 
4. Which visual elements are globalised and which ones localised in the images of 
multinational pharmaceutical companies that are found on their corporate, home 
country and Chinese localised website? 
 
The Chinese localised website was chosen for the study not only because of its 
importance to global companies as a target market but also because China is commonly 
considered as a birthplace of the Eastern medicine. Blackett and Harrison (2001, p. 48) 
distinguish two medical orientations from the development of healthcare: the Eastern 
4
 and the Western medicine. Both orientations aim to preserve health although their 
principles are profoundly different. The Eastern medicine focuses on prevention and the 
maintaining of wellness. The Western medicine, on the other hand, concentrates on 
treatment and the curing of illnesses. (Blackett & Harrison, 2001, p. 48) This distinction 
brings an additional element of interest into the study, which examines whether or not 
the distinction impacts the standardization or localization of visual elements in the 
images. 
 
  
1.3 New knowledge to be gained to the field of IBC 
 
International business communication (IBC) can be defined as the use of semiotic 
resources for formal or informal communication in an international business context. 
This definition is drawn from the definitions of business discourse and business 
communication by Bargiela-Chiappini et al. (2007) and Louhiala-Salminen (2009) 
respectively. Semiotic resources refer to the means of meaning-making, such as verbal, 
written and visual, which function within the semiotic modes of, for example, speech, 
writing and images. From the semiotic modes, or sign systems, communicators can 
choose the necessary signs to accomplish their communication purposes (Stöckl, 2004, 
p.11).  
 Following this definition, the present study fits into the field of IBC for 
three reasons. Firstly, the study examines the business-to-consumer online 
communication of four multinational pharmaceutical companies, which justifies the 
notion of a business context in the definition. In addition to studying multinational 
companies, the thesis evaluates online communication on three websites: global, home 
country and Chinese. This fulfils the requirement for an international context. Finally, 
the study investigates images found on the websites. It therefore focuses on the semiotic 
mode of images and in particular the semiotic resource of visual meaning-making. The 
thesis, therefore, studies the use of a semiotic resource for formal business-to-consumer 
communication in an international business context, as required by the definition of 
IBC. 
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  As mentioned in Section 1.1, prior research on online visual 
communication has focused on technical aspects (e.g. Djamasbi et al., 2011) and on its 
effect on customer behaviour (e.g. Cyr, 2008). Furthermore, previous studies have 
mainly concentrated on e-commerce websites instead of corporate websites in general. 
Furthermore, although some studies have purely concentrated on the images on websites 
(e.g. Cyr et al., 2009) many studies look at websites as whole entities, where all the 
various elements of a website are studied simultaneously (e.g. Djamasbi et al., 2011). 
 Within the context of the pharmaceutical industry, there have been 
numerous studies on direct-to-consumer (DTC) communication on websites (e.g. Davis 
et al., 2007; Macias & Stavchansky Lewis, 2003-4), television (e.g. Frosch et al., 2007) 
and in print (e.g. Mehta & Purvis, 2003). These have mainly concentrated on 
advertising, and on the advertising of prescription based medicinal products in 
particular. The studies tend to either investigate the content of the adverts (e.g. Frosch et 
al., 2007; Macias & Stavchansky Lewis, 2003-4), the response they evoke in consumers 
(e.g. Kim & Lee, 2012; Chen & Carroll, 2007; Singh & Smith, 2005; Mehta & Purvis, 
2003) or their impact on consumer behaviour (e.g. Polen et al., 2009; Singh & Smith, 
2005; Deshpande et al., 2004). The impact of source credibility in pharmaceutical 
advertising has also been the point of interest in some recent studies (e.g. Kim & Lee, 
2012; Limbu et al., 2012; Kim, 2011). The majority of the studies have, however, 
investigated the U.S. pharmaceutical industry (e.g. Kim & Lee, 2012; Polen et al., 2009; 
Chen & Carroll, 2007; Frosch et al., 2007; Singh & Smith, 2005; Deshpande et al., 
2004; Macias & Stavchansky Lewis, 2003-4; Mehta & Purvis, 2003) instead of the 
global pharmaceutical industry (e.g. Mackey & Liang, 2012; Auton, 2004). 
 The localisation and globalisation of website content has increased in 
popularity as a topic of debate within academic research as the globalisation of business 
operations has progressed. In 2012 approximately 34 % of the population of the world 
were regular users of the Internet, a figure that is estimated to increase up to nearly 50 
% by 2017 (Miglani, 2012). With its global reach, the internet provides a perfect 
medium for globalisation of communication (Maynard & Tian, 2004, p. 287) but the 
meaningfulness of standardising messages is questioned by many researchers (e.g. 
Shneor, 2012; Tixier, 2005; Singh et al., 2003; Simeon, 2001; Barber & Badre, 1998). 
Prior research also specifies that localisation is not just a process of translating content 
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 to a target language but one that adapts to the culture, visual and design preferences as 
well as administrative specificities of the target market (Shneor, 2012, p. 354; Tixier, 
2005, p. 16, Cyr & Trevor-Smith, 2004, p. 1199; Barber & Badre, 2001). Little 
evidence, however, is available on the effect of localisation or globalisation of visual 
elements on websites within the pharmaceutical industry despite the growing 
importance and prominence of the Internet as a source of health and medical 
information (Kim, 2011, pp. 57-58).  
 The present study will contribute to the field of IBC in that it combines the 
study of corporate websites with communication through images within the 
pharmaceutical industry, which to the author’s best knowledge has not been done in 
previous studies. Furthermore, the source credibility effect has not previously been 
researched in the context of visual communication in images other than advertisements 
within the pharmaceutical industry. The thesis will increase understanding of how visual 
spokespersons influence the credibility of visual messages and will thus be able to give 
recommendations to pharmaceutical companies on how to communicate more 
effectively through images on their websites. Finally, the study will contribute to the 
debate on the localisation vs. globalisation of visual elements by examining an industry, 
which has not so far been given much attention to in terms of the debate. 
 
 
1.4 Structure of the thesis 
 
The current chapter has introduced the topic of the thesis project as well as discussed its 
importance as a focus of study within the field of international business communication. 
Furthermore, the research problem, objectives and questions were presented and 
discussed.  
Chapter 2 provides an overview of prior research related to the present 
study. Section 1 discusses the pharmaceutical industry and its characteristics, and 
introduces the four case companies. The following sections will go on to examine key 
concepts of the thesis in three contexts: firstly, the concept will be looked at in terms of 
communication in general, secondly, it will be discussed in terms of communication in 
7
 an international setting, and finally the concept will be examined in the context of the 
pharmaceutical industry. The key concepts that will be discussed are in the order of 
appearance visual communication, websites as communication channels, and the source 
credibility effect. In addition, the analytical framework for the study will be presented 
based on the reviewed literature. 
Chapter 3 will introduce the research methods that will be used to execute 
the study in question. The data collection process will also be discussed and the 
trustworthiness of the study evaluated. Chapter 4 will present the findings of the study 
in relation to the research questions outlined in Section 1.2. This is followed by the 
discussion in Chapter 5. Finally, the last chapter will present a conclusion of the study 
and make suggestions for future research. 
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 2. Literature review 
 
 
 
In this chapter, the key concepts relating to the thesis will be discussed with an 
emphasis on prior literature. First, the pharmaceutical industry and its development will 
be briefly investigated as far as is relevant in terms of this research. The case companies 
will also be introduced with an emphasis on the markets in which they operate. Then the 
three major concepts of the thesis – visual communication, websites and source 
credibility effect – will be described following a similar pattern. The term will be first 
defined based on prior research, which is then followed by a discussion on the topic in 
three different contexts: communicative, global and pharmaceutical. The final section 
presents the analytical framework for the study based on the literature. 
 
 
2.1 Pharmaceutical industry and the case companies 
 
This section will describe key developments in the pharmaceutical industry based on 
prior research and reflect on their relevance for the current study. In addition, it will 
briefly present the four case companies of the study. The section forms an important 
basis for the study by examining the industry specific subtleties that multinational 
companies face within the pharmaceutical industry. 
 
2.1.1 A brief look at the pharmaceutical industry 
 
The pharmaceutical industry is currently facing multiple challenges due to economic 
and demographic changes in the market. According to Javalgi and Wright (2003), the 
research and development costs for pharmaceutical companies had more than doubled 
in seven years by 2003. It has been forecast that global pharmaceutical companies will 
need to bring between 24 and 36 new medicinal products that earn between 1 and 1.4 
9
 billion US Dollars each into the market within the seven years to reach their forecast 
revenues (Javalgi & Wright, 2003). While doing this, pharmaceutical companies that 
invest heavily in the development of new medicine are facing fierce competition from 
companies manufacturing generic drugs based on expired patents. New medicines that 
are developed and brought into the market only get a relatively short period of time of 
brand exclusivity until the patent protection expires and other companies are allowed to 
replicate the product with less R&D expenditure. For example, according to Javalgi and 
Wright (2003), in China a pharmaceutical company that receives a Class I drug 
certificate is granted 12 years of exclusive manufacturing rights, pricing freedom, and 
priority considerations for reimbursement (p.275). Blackett and Harrison (2001, p. 45) 
suspect that the rate of the market changes is driven by the Internet and direct-to-
consumer advertising. 
 For global communication, the internet is an unparalleled channel and also 
an increasingly important source of healthcare related information for consumers 
(Blackett & Harrison, 2001, p. 45). Blackett and Harrison (2001) conclude that, through 
the internet, patients have reinstated some of the power of deciding for their own 
medication that once was fully in the hands of the doctors who treat them. Now patients 
search the internet for illnesses that match their symptoms as well as for potential cures 
for them, and request for these cures from their doctors. This further highlights the 
importance of the internet as a means of communication for pharmaceutical companies.  
 Direct-to-consumer (DTC) advertising in the context of pharmaceutical 
advertising refers to any promotional campaign by a pharmaceutical company that aims 
to communicate to the general public through consumer-oriented media (Limbu et al., 
2012, p. 23). The popularity of DTC advertising in the pharmaceutical industry has 
skyrocketed in the last twenty years, having increased an impressive 467 percent 
between 1996 and 2005 (Limbu et al., 2012, p. 23). It is currently a strictly regulated 
field in the pharmaceutical markets but there are major differences between countries. 
In many Asian countries as well as within the European Union, the DTC advertising of 
medicines is restricted to over-the-counter (OTC) products such as cold remedies, 
painkillers and hay fever tablets, whereas the advertising of prescription based 
medicinal products to consumers is banned altogether (Geyer, 2011; Blackett & 
Harrison, 2001).  The two most notable exceptions to this policy in the world are New 
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 Zealand and the United States, both of which allowed the advertising of prescription 
drugs in mass media in the late 1990’s (Geyer, 2011). In the USA, the DTC advertising 
of pharmaceutical companies is closely monitored by the Food and Drug Administration 
(FDA), which maintains that the DTC advertisements must have a fair balance between 
the benefits and risk information that is provided to the consumers (Jambulingam & 
Sharma, 2010, p. 333; Calfee, 2002, p. 183). However, adverts that seek to raise 
awareness of the advertised illness or to simply remind patients of the product without 
providing any detailed information of it are exempt from the fair balance requirement 
(Jambulingam & Sharma, 2010, p. 333). This difference in policies provides the 
opportunity for multinational pharmaceutical companies to differentiate their visual 
messages to their US target groups on their website, which would suggest that there will 
be clear differences in the visual messages in North America compared to the other 
continents. 
 Due to the restrictions on the pharmaceutical industry, the buyers and the 
consumers of medicinal products have remained separate, as companies are not allowed 
to communicate directly to the end-user of the product (Blackett & Harrison, 2001). 
This is a much-debated issue not only in political circles but also in the field of 
academic research as well. The proponents of DTC advertising assure that its purpose is 
to inform patients, help them become more knowledgeable on medicinal issues and 
allow them to be more involved in their own healthcare (Limbu et al, 2012, p. 24). 
Furthermore, DTC adverts are said to result in earlier screenings for illnesses and 
encourage patient-doctor discussions on issues depicted in the adverts (Polen et al., 
2009, p. 43; Calfee, 2002, p. 184). The opponents of DTC advertising in the 
pharmaceutical industry maintain, however, that the use of DTC advertising increases 
inappropriate or excessive prescriptions, increases healthcare costs, interferes with the 
doctor-patient relationship and fails to provide the required level of risk information 
(Limbu et al., 2012; Polen et al., 2009; Lexchin & Mintzes, 2002; Wilkes et al., 1992). 
Furthermore, Polen et al. (2012) found in their study that half of the research 
respondents felt that DTC advertising caused unnecessary concerns over side effects. 
With 17.8 % of those surveyed, these concerns raised by DTC pharmaceutical adverts 
led to them to stop taking their medication (p. 50). These potential risks are considered 
to be the reasons why DTC advertising of prescription medicine was not allowed in the 
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 US until the 1990’s and why it still remains banned in most other countries in the world 
(Calfee, 2002). 
 There is, however, another entrance to DTC marketing for prescription 
based drugs. The growth of the over-the-counter (OTC) sector has turned this into an 
attractive opportunity to pharmaceutical companies and many medicinal brands have 
been able to make the transition from prescription-based into OTC products (Blackett & 
Harrison, 2001, p. 40). Examples of such products include well-known brands such as 
Zyrtec, Diflucan, Canesten and Zovirax. The lure of the OTC sector for pharmaceutical 
companies is obvious: as the patients have become more knowledgeable, they have a 
greater tendency to purchase OTC products instead of going to a doctor’s for a 
prescription. Furthermore, with fewer restrictions on communication, it is easier to 
make target consumers aware of your product and build a favourable brand.  
 Looking further back at the development of the pharmaceutical industries, 
there are two clearly distinguishable paths to be observed. The Eastern strategy for 
healthcare aims to preserve good health and wellness (Blackett & Harrison, 2001, p. 
47). This is often achieved through preventive practices such as eating food products 
that have reported health benefits or medical properties. According to Blackett and 
Harrison (2001, p. 48) the Western medical orientation aims to treat established 
illnesses and cure infected patients. Even though both orientations focus on maintaining 
health, the starting point is significantly different with Eastern medicine focusing on 
maintaining wellness whereas the Western medicine seeks to cure illness. Despite both 
orientations having now spread all over the world, this distinction may have a 
significant impact on the communication requirements in Eastern and Western 
pharmaceutical markets. 
 
2.1.2 Case companies 
 
Four pharmaceutical companies were chosen into the present study of visual 
communication through images on their corporate websites. Three of the companies 
were chosen from the listing of biggest public companies in the world (Forbes, 2012): 
Pfizer, Novartis and Sanofi. The companies are respectively the three largest 
pharmaceutical companies in the world according to Forbes’ weighting of their sales, 
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 profits, assets and market value. Orion was chosen as the fourth case company, and it 
represents the largest pharmaceutical company in Finland, the author’s home country. 
The companies will next be briefly introduced individually. 
 Pfizer is the largest public pharmaceutical company in the world. The US-
based company was founded in 1849 and holds an estimated market value of 165.4 
billion US dollars (Forbes, 2012). The company has throughout its history grown 
remarkably through mergers and acquisitions. Pfizer is commonly known for its 
research and development of medicinal products, having accumulated R&D costs of 
over 9 billion US dollars in 2011 (Pfizer, 2011, p. 16). The company does, however, 
also produce generic products. The company operates a global website as well as 43 
linguistically localized websites for markets all over the world. It does not, however, 
have a separate home country website for the United States, which implies a degree of 
globalisation in the company’s online communication. For this study, the images for 
Pfizer were collected from two websites: www.pfizer.com and the Chinese localised 
www.pfizer.com.cn. The images found on the Pfizer.com website will be considered in 
both the category of global websites as well as that of home country websites. This is 
done for the fact that it is not possible to distinguish whether Pfizer.com is actually used 
as a global website or a US localised website. If this decision was made without better 
knowledge this would compromise the comparisons made between the three websites. 
The fact will, however, be taken into account when investigating the level of 
localisation and globalisation in the images. (Pfizer, 2012) 
 Novartis is the second largest public pharmaceutical company in the world 
with an estimated market value of 150.4 billion US dollars (Forbes, 2012). The Swiss 
company was formed in 1996 through the merger of two companies, Ciba-Geigy and 
Sandoz. The company spent 9.1 billion US dollars on research and development in 2012 
but also offers low cost generic products. The company has a global website as well as 
39 localised websites for different markets around the world. The images for this study 
were collected from Novartis’ global (www.novartis.com), Swiss (www.novartis.ch) 
and Chinese website (www.novartis.com.cn). (Novartis, 2012) 
 French company Sanofi is listed as the third largest pharmaceutical 
company by Forbes (2012) with an estimated market value of 103.3 billion US dollars. 
The company was founded in 1973 and it has grown significantly through acquisitions 
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 throughout its existence. In 2011 Sanofi spent 4.8 million Euros (6.5 million US dollars) 
on research and development (Sanofi, 2011, p. F6). In addition to its global corporate 
website, the company has 78 additional websites with localised content. For the purpose 
of this study the images found on the global (www.sanofi.com), French (www.sanofi.fr) 
and Chinese website (www.sanofi.cn) were analysed. (Sanofi, 2012) 
 The fourth company for the analysis was chosen from the author’s home 
country. Orion is the largest pharmaceutical company in Finland with a market value of 
around 3.2 billion Euros (4.3 billion US dollars) according to Kauppalehti (2012). No 
evaluation by Forbes (2012) was available. In the year 2011 Orion accumulated 
research and development expenses of 87.5 million Euros (118.4 million US dollars). 
Orion has 16 localised websites on top of the Finnish corporate website and its English 
language version. As the content of the English corporate website differed from the 
Finnish corporate website, the former was deemed as equivalent of a global corporate 
website, whereas the latter was analysed as the Finnish localised website. The websites 
analysed from Orion were, therefore, the global (www.orion.fi/en), the Finnish 
(www.orion.fi) and the Chinese website (www.orionpharma.cn). (Orion, 2012) 
 The case companies, therefore, included one US and three European 
pharmaceutical companies. Three of the companies (Pfizer, Novartis and Sanofi) were 
listed among the 2000 largest public companies in the world (Forbes, 2012) to which 
the largest pharmaceutical company of the author’s home country was added. Due to the 
small number of case companies the size of the company cannot, however, in the 
present study be used as a variable from which to draw any conclusions. This will 
therefore be left for future research to investigate. 
 
 
14
 2.2 Visual communication 
 
This section discusses the field of visual communication, which forms the overall topic 
of the thesis. The section will first define the concept of visual communication, then 
discuss its origins within the systemic functional linguistics before presenting two visual 
grammars, which are commonly used in the study of visual communication. Finally, the 
section will discuss prior research on visual communication that is relevant to the study, 
visual communication in a global context and visuals within the pharmaceutical 
industry. This section forms the majority of the theoretical basis of the study, and is 
therefore crucial for the achievement of the research objectives. 
Visual communication can be defined as communication through visual 
aids and cues that can be read or viewed. Indeed, Kress and van Leeuwen (2006, p. 17) 
state that written communication is in fact a sub-category of visual communication; one 
that has so far, however, been given much more attention than other forms of visual 
communication. Based on their research on children’s books, Kress and van Leeuwen 
(2006) conclude that there is an ever-increasing prominence to written communication 
and the so-called old visual literacy related to it. Other forms of visual communication 
are either seen as the domain of a very small elite of specialists or as a form of self-
expression rather than communication. The latter viewpoint suggests that visual 
communication (apart from writing) is something that everyone can do spontaneously 
and that there is no need for teaching it. (Kress and van Leeuwen, 2006, p. 16). In this 
study visual communication will be used separately from written communication as the 
term to discuss communication with images and pictures.  
 Despite the tendency towards written communication there has been 
numerous studies highlighting the importance of visual elements of communication and 
the visual appeal. An (2007, p. 304) underlines several studies of visual messages in 
advertising, which showed that these are more easily processed by target audiences, and 
also more effective in getting their attention compared to pure verbal messages. The 
visual appeal of messages is thus deemed as an integral part of the communication 
process, as it has the power to command attention and stimulate curiosity (An, 2007; 
Moriarty, 1997). The findings of the study by Cyr et al. (2009), however, state that the 
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 elements of visual communication used in images on websites can have a negative as 
well as a positive impact on the visitor’s perceptions of the website. The effect, 
according to the authors, depends on the manner in which the elements are used in the 
images (Cyr et al., 2009, p. 556-557). The visual elements according to Kress and van 
Leeuwen (2006) and O’Toole (1994) are discussed in Section 2.2.2 on visual grammar. 
First it is, however, worth looking into the origins of the visual grammar, the Hallidayan 
systemic functional linguistics. 
 
2.2.1 Systemic functional linguistics 
 
As the grammar of visual communication is based on the field of systemic functional 
linguistics (SFL) this topic will be covered as an introduction into the theme. SFL is a 
social semiotic approach to linguistics developed by Michael Halliday (e.g. Halliday & 
Matthiessen, 2004), and though it was originally created for the purpose of analysing 
the semiotic resource of language, its application to other semiotic resources has proven 
productive (Lim, 2004, p. 220). Djonov (2007, p. 150) points out that SFL’s 
applicability rises from its focus on 
semiosis, which means the making 
and understanding of meaning. This 
is what the term ‘functional’ refers to 
in its title: the analysis of how 
grammar creates and expresses 
meaning. Furthermore, it is systemic 
because it sees grammar in the form 
of system networks instead of plain 
structures (Halliday & Matthiesen, 
2004, p. 23).  Meaning, therefore, is 
inbuilt in systemic patterns of choice 
(Halliday & Matthiesen, 2004, p. 23) 
and choices are realised as structure. 
The focus on meaning and meaning-
Figure 1: The stratification of written language. 
Adapted from Halliday & Matthiesen (2004, p. 
25) 
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 making is what enables SFL’s principles to be extended from studying language to the 
study of, for example, images (Kress & van Leeuwen, 2006; O’Toole, 1994).  
 Another aspect of SFL, which makes it easily applicable to semiotic 
resources other than language is the idea that language forms and is formed by the 
socio-cultural context in which it occurs (Djonov, 2007, p. 150). Halliday and 
Matthiesen (2004) point out that one of the purposes of language is to make sense of our 
experiences, and that way it comes into contact with the context in which it is used, the 
experiences that go on outside language itself (p. 24). In order to express our 
experiences, Halliday & Matthiesen propose two levels, or strata: firstly the experience 
is transformed into meaning, and secondly the meaning is put into words. The former 
level is referred to as the stratum of semantics, whereas the latter is the stratum of 
lexicogrammar. These strata are represented in Figure 1, which is adapted from Halliday 
and Matthiesen’s stratification of language (2004, p. 25).  
 The interdependency that exists between language and its socio-cultural 
context is reflected by three metafunctions developed by Halliday (Halliday & 
Matthiessen, 2004, p. 29), which guide our linguistic choices: the ideational, the 
interpersonal and the textual. The ideational metafunction is used to reflect on our 
experiences of the world around us and to build logical relationships between the 
experiences (Halliday & Matthiessen, 2004, p. 29). The interpersonal metafunction 
enables the forming of a relationship between the author of the text as well as its reader 
through the communication of, for example, attitudes and feelings (Halliday & 
Matthiesen, 2004, p. 106). Finally, the textual metafunction fills the role of the enabler 
or facilitator of language. Its function is to construct the text that entails ideational and 
interpersonal meanings (Halliday & Matthiesen, 2004, p. 30). (Djonov, 2007, p. 150) 
 Halliday and Matthiessen (2004, p. 9) present a lexicogrammatical rank 
scale that represents the units for studying language. A clause consists of phrases, which 
in turn consist of words. Words, on the other hand, can be broken down into 
morphemes. This goes on so that each of the four ranks consists of one or more units of 
the rank that is next below them (Halliday & Matthiesen, 2004, p. 9).  
 As mentioned earlier, Halliday’s systemic functional theory of linguistics 
is adaptable to semiotic resources beyond language. The next section will discuss the 
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 adoption of these SFL concepts in visual communication through the works of Kress 
and van Leeuwen (2006) and O’Toole (1994). 
 
2.2.2 Visual grammar 
 
Like in SFL, the frameworks of visual analysis by Kress and van Leeuwen (2006) and 
O’Toole (1994) both recognise three metafunctions that are included in all acts of 
communication. Whereas Kress and van Leeuwen (2006) have opted to use the same 
terminology as Halliday, O’Toole (1994) edited them to better suit the analysis of 
paintings. He refers to the modal function as one that engages our attention and interest, 
similarly as the interpersonal function in SFL. The ideational metafunction in SFL is 
replaced by the representational function in the analysis of visual language. The aim of 
the function, however, remains the same: to convey information about the reality. 
Finally, the compositional function in visual language is used to structure the other two 
functions into a coherent message, like the textual function in SFL is used to construct 
and facilitate text. (O’Toole, 1994, p.5) In the present study the metafunctions will be 
referred to as the interpersonal, the representational and the compositional function, as 
this has become the most common terminology to be used in the study of visual 
communication. 
 The linguistic rank scale of clause, phrase, word and morpheme is 
replaced in O’Toole’s (1994) visual language with the units of work, episode, figure and 
member. As with their SFL counterparts, each of the units of visual language consists of 
one or more components of the unit next below. Therefore works consist of episodes, 
which consist of figures, which in turn consist of members. The unit of work refers to 
the image as a whole. An episode is a part of the work, which acts as its own sequence 
in the image, for example by depicting a separate action or a separate theme from other 
actions or themes represented in the image. The unit of figure refers to the participants 
in the image. Finally, a member refers to a part of the figure, for example a body part.  
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 Table 2: A map of visual grammar. Adapted from O'Toole (1994, p. 24) 
 
Table 2 presents the elements in O’Toole’s (1994) framework for visual analysis 
according to the metafunctions and units of language discussed in this subsection. The 
elements of visual grammar, which are relevant to the present study, will be looked into 
in more detail in Section 2.5, which introduces the analytical framework used in the 
study. 
 
2.2.3 Prior research on visual elements 
 
The use of images has become a rule rather than an exception in today’s business world. 
Research of images in general terms has, however, found conflicting evidence on the 
use of images on websites (Cyr et al., 2009, p. 543). On the one hand, images have been 
found to irritate the visitors of interactive websites by cluttering up the site, slowing it 
down, and disrupting its functionality (Riegelsberger, 2002; Riegelsberger et al., 2002). 
But on the other hand, however, research shows that images attract visitor’s attention 
(Riegelsberger, 2002) and increase the credibility of the website content in the eyes of 
the visitor (Fogg et al., 2002). 
 INTERPERSONAL REPRESENTATIONAL COMPOSITIONAL 
WORK Rhythm           
Modality 
Gaze 
Frame 
Light 
Perspective 
Narrative themes 
Scenes 
Portrayals 
Interplay of episodes 
Framing 
Positioning 
Proportion 
EPISODE Relative prominence 
Interplay of modalities 
Actions 
Actor – goal 
Focal/side sequence 
Interplay of actions 
Relative position in 
work 
Alignment 
Interplay 
FIGURE Gaze               
Contrast 
Stance 
Characterization 
Character 
Act/Stance/Gesture 
Clothing components 
 
Relative position in 
episode 
MEMBER Stylization Part of body/object 
Natural form 
Cohesion 
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  A major advantage of the use of images compared to textual information is 
the difference in how visitors interpret the messages. Riegelsberger et al. (2002, p. 2) 
argue that when reading text consumers are more able to utilise critical thinking 
compared to looking at a visual message in an image. Investigating advertising the 
authors conclude that as a viewer’s interpretation of an image is derived from his/her 
real-life experiences of similar situations, images are more able to stimulate affective 
responses than pure textual information. This has been utilised especially in advertising 
where images showing attractive people using the product are commonplace (p. 2). This 
effect has also been found to be true in online environments (Riegelsberger et al., 2003). 
 In terms of the interpersonal function, research has found that the use of 
unnatural or unexpected images may have undesired emotional effects on viewers (Cyr 
et al., 2009). This relates to the element of modality, which can be defined as the extent 
to which the image represents reality in the viewer’s opinion (Kress & van Leeuwen, 
2006, p. 155). Cyr et al. (2009) thus advise companies and web designers to avoid the 
use of unrealistic images.  
 To further the study of the interpersonal fuction, Meyers-Levy and 
Peracchio (1992; Peracchio & Meyers-Levy, 1994) examined the impact of image 
cropping and camera angle on image perception in advertising. Image cropping, referred 
to as frame in the map of visual grammar, determines elements of the image that are 
shown to the viewer and those that are hidden or merely implied. Peracchio and 
Meyers-Levy (1994) found that a visually cropped or incomplete figure generated a 
positive response in the viewers, as they felt the need to relieve the ambiguity and 
complete the image in their head. The positive response, the authors argue, is a result of 
the pleasure of resolving the incomplete image (p. 190). The processing of a visually 
cropped image requires, however, a relatively higher level of motivation from the 
viewer  compared to an image that is presented to the viewer as a whole. Furthermore, 
as Peracchio and Meyers-Levy (1994, p. 910) point out, the positive response may be 
dependent on the viewer being able to resolve the cropped image successfully. The 
impact of an unsuccessful resolution has, as to the best knowledge of the author, not yet 
been researched.   
 In their study of camera angles in advertising, Meyers-Levy and Peracchio 
(1992) found that if the person or product was photographed from a low angle, which 
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 showed the target as if the viewer was looking up at it, the advert received a more 
positive reaction than adverts portraying a high camera angle, where the viewer was 
looking down on the person or product portrayed. When a person or product was shown 
at eye level, the viewers’ perceptions of it were between these two extremes (p. 454). 
 In terms of the compositional function, the website viewing patterns that 
visitors use have a significant impact in terms of the positioning of images on a web 
page. Shrestha and Owens (2008) found evidence in their eye-tracking study of people’s 
website reading patters of the F-shaped pattern commonly accepted by practitioners. 
The F-shaped pattern indicates that website visitors scan content on the top, in the 
middle and on the left-hand side of the page (Shrestha & Owens, 2008). This would 
imply that images positioned in those areas of a web page would gain the most attention 
and thus have the greatest potential of successfully communicating a visual message. 
There are, however, drawbacks to this assumption. Drèze and Hussherr (2003) found in 
their research on online advertising that consumers have learnt to avoid looking at 
banner adverts, which are positioned at the top of the page. This would suggest that 
placing an image, which a website visitor could mistake for an advert, above other 
content on top of the web page is not a successful strategy in terms of visual 
communication. Furthermore, as noted by Hopearuoho and Ventola (2009), the reading 
paths utilised by website visitors are of significance. With printed text the traditional 
reading pattern in Western countries goes from left to right, top to bottom (Hopearuoho 
& Ventola, 2009, p. 188). The authors, however, highlight that the reading path of a 
website is significantly different. Furthermore, as the reading pattern in non-Western 
countries differs already in terms of printed textual material, the website reading pattern 
may again be very different from that of the Western one. With a lack of academic 
research in this topic, this study will compare the positioning of images on the websites 
of multinational pharmaceutical companies to the F-shaped pattern suggested by 
Shrestha and Owens (2008) and discuss its potential implications in the field of online 
visual communication. 
 In terms of the representational function academic research has given the 
most attention to characters and their gender as well as roles in images. The presence of 
people in images on websites has been linked to higher levels of perceived social 
presence, which in turn is related to a higher degree of online trust (Cyr et al., 2009, p. 
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 540; Cyr et al., 2007, p. 52; Hassanein & Head, 2007, p. 689). Investigating the 
portraying of female figures in online advertisements Plakoyiannaki et al. (2008) found 
that women are mainly portrayed in traditional or decorative roles, thus playing by the 
existing sexist stereotypes. The authors, however, note that the number of adverts 
portraying non-traditional and egalitarian women had still been increasing (p. 109). 
Shoop et al. (2008) also found evidence of the prevalence of sexist stereotypes in their 
study examining images of men and women in US and Japanese fashion magazines. The 
authors concluded that despite observed gender-related cultural differences between the 
two nations the magazines all showed a trend towards portraying men as serious and 
women as cheerful and breezy, thus lacking seriousness. Furthermore, Martin (2012) 
investigated the portraying of ageing characters in images targeted at elderly people 
finding that men were more often portrayed as active and independent, whereas women 
were shown as dependent, at risk and passive. The discussion on characters will be 
continued in Section 2.4 when the topic is related to source credibility effect and 
spokespersons commonly used in the field of marketing communications. 
  
2.2.4 Global visual communication 
 
Opportunities to globalise visual communication across various target markets has 
raised interest among practitioners and academics alike. Zahedi and Bansal (2011, p. 
148) argue that the prominence of the internet as a channel for visual communication 
has ignited the creation of a global visual language. As visual material and meaning are 
shared globally over the internet, this would lead to the messages being universal and 
that anyone anywhere could decode them.   
 If visual communication was, in fact, something that is universal to people 
then how come the meaning of images often remains unclear? Kress and van Leeuwen 
(2006, pp. 4 & 35) emphasize that visual communication is always in a coded form. The 
reason why the message seems clear to the viewer is because s/he is already familiar 
with the meaning of the code. This indicates that the viewer has already been socialized 
into the cultural context in which the visual communication takes place. When we come 
face-to-face with images and visuals that originate from cultures that are foreign to us 
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 we may be able to appreciate them as forms of art, but not as forms of communication. 
To do the latter we would need to become members of these cultures. (Kress & van 
Leeuwen, 2006, p. 4) 
 Research on advertising supports the latter viewpoint. For example An 
(2007, p. 303) found out that employing advertising visuals that reflect the 
communication styles of a particular national market is an effective way of 
communicating with consumers around the world. Multinational advertisers might, 
therefore, prefer to use differentiated ad visual strategies in web advertising for different 
markets (An, 2007, p. 303). The debate on differentiation and standardization of visual 
messages will be returned to in the discussion about culture in Section 2.3.  
 
2.2.5 Visual communication in the pharmaceutical industry 
 
Although several studies have been conducted to examine the direct-to-consumer 
communication and advertising of pharmaceutical companies on websites (e.g. Davis et 
al., 2007; Macias & Stavchansky Lewis, 2003-4), television (e.g. Frosch et al., 2007) 
and in print (e.g. Mehta & Purvis, 2003) the visual elements used in communication in 
the pharmaceutical industry have often been left uncovered.  
Macias and Stavchansky Lewis (2003-4) found in their content analysis 
study of 90 direct-to-consumer drug websites that 89 % of the websites included at least 
one image, whereas 80 % of them included images of either people or animals in 
particular. The most common characters were women (81%), men (70%), children 
(38%) and doctors (29%). Macias and Stavchansky Lewis (2003-4) argue that the 
women, men and children used in the images represent consumers who would use the 
product advertised on the website. Furthermore, the authors argue that the companies 
aim to lend medical credibility through the use of doctors in the images on the websites. 
The implications of the use of consumers and experts in images will be discussed in 
more detail in Section 2.4, which introduces the source credibility effect. 
Many studies have found evidence of the use of emotional appeals in 
online and print advertisements of pharmaceutical companies (e.g. Limbu et al., 2012; 
Frosch et al., 2007; Main et al., 2004). According to Liu and Pearson (2008, p. 141) the 
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 most common positive emotional cues used in direct-to-consumer adverts are warmth, 
empowerment and assurance. The most common negative emotional appeal according 
to the authors is fear. Main et al. (2004) studied the functions of headlines and visuals in 
direct-to-consumer print advertisements of medicinal products of three product 
categories – prescription-based, over-the-counter and dietary supplements. The findings 
suggested that visuals were more commonly used to create positive emotional appeals 
such as warmth, happiness and humour, in the adverts of prescription-based drugs as 
well as dietary supplements compared to headlines. However, headlines were more 
often used to communicate rational or negative emotional appeals such as fear, guilt and 
shame in all of the three product categories. 
 The impact of source credibility and the use of spokespersons in 
pharmaceutical advertising has also recently been the focus of a small number of studies 
(e.g. Kim & Lee, 2012; Limbu et al., 2012; Kim, 2011). These will be discussed in more 
detail in Subsection 2.4.3, which covers the use of spokespersons and stereotyping 
within the pharmaceutical industry. 
 Despite limited research on visual communication in the pharmaceutical 
industry, its importance and relevance is commonly understood. For example Martin 
(2012) emphasizes the ways how visual images not only reflect but also reproduce 
social differences. This, according to the author, can influence consumers’ bodily 
conduct and their perceptions of health risks in everyday life. 
 
2.3 Websites as communication channels 
 
This section discusses the internet and websites in particular as channels for corporate 
communication. The importance of these channels is first discussed in general before 
relating them to visual communication and the global pharmaceutical context of the 
study.  
Internet users tend to visit web pages in search for relevant information 
(Yoshida et al., 2006, p. 201). As a result, websites have become an important channel 
for communication for companies (Song & Zahedi, 2005, p. 1219; Maynard & Tian, 
2004, p. 285) or even one of the main channels (Chun & Davies, 2001, p. 315). In 2012, 
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 the amount of people who use the Internet at least once a month reached 2.4 billion 
(Miglani, 2012). This equates to approximately 34 % of the actual population 
worldwide. Forrester, a global research and advisory firm, estimates that by 2017 nearly 
half of the world population will be using the internet regularly. These figures highlight 
the commonly accepted importance of the internet for global businesses.  
 Corporate websites serve various functions for communication providing 
benefits to both companies and consumers. Through Web technologies, companies can 
reach out to target audiences (Halliburton & Ziegfeld, 2009, p. 910; Tung et al., 2009, p. 
97), communicate about their brand and corporate identity (Halliburton & Ziegfeld, 
2009, p. 910; Kim et al., 2003, p. 17), provide detailed information of their products, 
services and processes to various stakeholder groups (Schaupp, 2010, p. 43; Tung et al., 
2009, p. 97; Maynard & Tian, 2004, p. 285; Kim et al., 2003, p. 17; Chun & Davies, 
2001, p. 330), interact with target audiences (Schaupp, 2010, p. 43; Tung et al., 2009, p. 
97; Kim et al., 2003, p. 17) as well as conduct e-commerce (Schaupp, 2010, p. 43; Tung 
et al., 2009, p. 97; Maynard & Tian, 2004, p. 285). Furthermore, Maynard & Tian 
(2004, p. 286) point out that corporate web sites have been identified as suitable 
channels for corporate reputation building.  
 The use of websites for communication has been proven to have several 
benefits. On top of the benefit of reaching vast numbers of potential customers anytime 
and anywhere, websites allow companies, for example, to control the flow of 
information (Maynard & Tian, 2004, p. 285; Sullivan, 1999, p. 197), to reduce the costs 
of communication (Sullivan, 1999, p. 199) as well as improve their image and 
performance (Kim et al., 2003, p. 17; Chun & Davies, 2001, p. 316; Sullivan, 1999, p. 
207). The above benefits highlight the importance for companies to establish a presence 
on the Internet as well as to present themselves online in an appropriate way (Maynard 
& Tian, 2004, p. 285; Kim et al., 2003, p. 17). 
 Schaupp (2010) points out that not only has the Internet had a significant 
effect on the way businesses operate and the way consumers access information but it 
has redefined the public’s expectations on the accessibility of information. Whereas 
previously it was a norm that consumers had to wait on hold or in a queue to get hold of 
a piece of information, in today’s world consumers expect to find the required 
information in a matter of seconds online. Schaupp (2010) suggests that this change in 
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 consumer attitudes is not specific to a particular culture, market or group but one that is 
global breaking all these traditional borders. (Schaupp, 2010, p. 43) 
 Halliburton and Ziegfeld (2009, p. 910) note that in addition to the vast 
opportunities and benefits provided by the Internet it also possesses a significant 
challenge for companies. This challenge, according to the authors, stems from the 
worldwide access provided by the Internet and the need to globalise or localise websites 
accordingly. This challenge will be discussed in more detail in Subsection 2.3.1, which 
discusses websites as a channel of global communication. 
 
2.3.1 Websites in global communication 
 
As mentioned in the previous Subsection, the current global online population is 
approximately 2.4 billion, and it has been estimated to increase up to 3.5 billion by 2017 
(Miglani, 2012). As a global medium, the Internet is accessible to people worldwide 
independent of their residence and time zone (Singh et al., 2005b, p. 129). The Internet 
therefore presents companies with a possibility to expand globally quickly even 
regardless of the company’s size, origin or financial power (Halliburton & Ziegfeld, 
2009, p. 911).  
 The use of websites in global communication calls for an evaluation of the 
meaningfulness of communicating to a global audience at the same time with the same 
message. Halliburton & Ziegfeld (2009, p. 910) highlight this as a major challenge of 
the Internet as a medium for communication and call for a consideration of the extent to 
which website content should be adapted to different target audiences. This has been 
actively debated in the field of academic research. The proponents of adaptation of 
website content argue that different preferences and legislature in terms of culture, 
language, graphics, design, consumer protection and operations between markets 
require the adaptation of websites to their particular contexts (e.g. Tixier, 2005; Simeon, 
2001; Barber and Badre, 1998). Furthermore, research shows that the Internet is not a 
culturally neutral medium (Shneor, 2012; Singh et al., 2003) and that culture, in turn, 
has an impact on the format, layout, and design of e-commerce websites (Lo and Gong, 
2005; Cyr and Trevor-Smith, 2004; Cyr et al., 2005; Simon, 2001), as well as content 
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 depictions (Singh et al., 2005a, Okazaki, 2004; Singh et al., 2005b; Singh et al., 2003; 
Singh and Baack, 2004; Singer et al., 2008). 
 Despite the vast amount of support for adapting website content, a group 
of academics and practitioners recognise the potential of the Internet as a channel for 
standardization. The greatest benefit of this approach for companies is the lower cost of 
designing a website which communicates harmoniously in a global tone, compared to 
creating websites for each target market (Shneor, 2012, p. 352; Tixier, 2005, p. 29). 
Furthermore, Maynard and Tian (2004) question the impact of culture in the need for 
adaptation of website content. The authors argue (p. 286) that the Internet overshadows 
the more traditional media with its capacity to bring different cultures together. This 
creates a potential for cultural homogenization (Maynard & Tian, 2004, p. 287), which 
could lead to the creation of a global standard of online communication. 
 These two logics of communicating to audiences in markets around the 
world are identified in academic research as the localisation strategy and the 
globalisation strategy (e.g. Cyr et al., 2009; An, 2007; Tixier, 2005).  Furthermore, a 
third approach, which draws elements from both of the aforementioned logics, is 
introduced in the literature, namely glocalisation (e.g. Okazaki & Skapa, 2008). These 
will be looked into more deeply in the following subsection. 
 
2.3.2 Localisation, globalisation and glocalisation of communication on websites 
 
As the previous subsection outlined, there are two strategies for companies to adopt for 
communicating to audiences in different cultures and markets: localisation and 
globalisation. Localisation, also referred to as adaptation and differentiation in academic 
literature, is a process through which a product or a service is adapted to local language, 
culture, design preferences and administrative specificities (Shneor, 2012, p. 354; 
Tixier, 2005, p. 16; Cyr & Trevor-Smith, 2004, p. 1199; Barber and Badre, 2001). Cyr 
and Trevor-Smith (2004, p. 1199) argue that idiomatic language translation is not 
sufficient when localising a product or a service but such details as time zones, 
currency, brand names and geographic examples must also be considered. Furthermore, 
a number of design features may be localised on websites, such as colours, icons, 
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 animations and images (Cyr et al., 2009, p. 557). Cyr and Trevor-Smith (2004, p. 1199) 
conclude that a successfully localised product or a service is such that it appears to have 
been developed within the particular target market and culture.  
 A company that does not adapt its products and services to preferences 
and specificities of target markets opts for the globalisation strategy (Tixier, 2005, p. 
43). The Internet has been identified as an ideal medium for globalisation (Maynard & 
Tian, 2004, p. 287) with its capacity to expand across territorial borders and its 
capability to bring different cultures together (Maynard & Tian, 2004, pp. 286, 287). 
These interconnections between societies and cultures could potentially lead to global 
standards in communication. Prior research has, however, so far supported the use of 
localisation and adaptation, as will be discussed next. It should, however, be noted that 
the Internet influences the globalisation potential of different industries at different rates 
(Yip, 2000, p. 1), and one should therefore take care when drawing universal 
conclusions. 
 Singh et al. (2005, p. 73) discuss previous research done to investigate the 
need to localize versus standardize website content in global markets, and conclude that 
it has been unanimously for the localization of content. Zahedi and Bansal (2011) found 
that making a website culturally congruent could improve its usability and as a result 
increase customer satisfaction, trust and loyalty. According to Luna et al. (2002) 
adapting websites to local cultures reduces the cognitive efforts to process website 
content from the visitors, which results in easier navigation and creates favourable 
attitudes towards the website. Cultural localisation also has the potential for users to 
remain longer at the website (Cyr et al., 2009, p. 557).  
 According to An (2007) many global companies opt for a compromise 
between the localisation and globalisation strategies, the so-called ‘glocalisation’ 
approach.  Glocalisation refers to combining elements of globalisation with the 
constraints of the local environment to fulfil the requirements by the target audience 
(Tixier, 2005, p. 16). Okazaki and Skapa (2008, p. 1225) adopt glocalisation strategy 
and argue that instead of being merely a medium for globalisation as suggested by 
Maynard and Tian (2004, p. 287), the Internet is, in fact, a glocal medium allowing 
companies to create localised content with global access. Perhaps a more accurate 
definition for the term is provided by Blackett and Harrison (2001), who refer to 
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 glocalisation as “globalisation that recognises and embraces local subtleties” (p. 49). 
This is, for example, evident in the development and maintenance of localised websites 
within global corporate websites to allow companies to communicate with local 
consumers (An, 2007, p. 304).   
 
2.3.3 Visual communication on websites  
 
Prior research within the field of e-commerce has shown that the inclusion of images of 
people on websites can achieve higher levels of perceived social presence and as a result 
a higher degree of online trust (Cyr et al., 2009, p. 540; Hassanein & Head, 2007, p. 
704). In accordance with the studies supporting localisation of website content (e.g. 
Zahedi and Bansal, 2011; Singh et al., 2005; Luna et al., 2002) Cyr et al. (2009) found 
that adapting websites to the image preferences of users from different backgrounds also 
appears to be of importance, especially taking into account the continuous expansion of 
the Internet into new locations. Research suggests that the visual appeal of websites as 
well as of the separate elements on it, such as information, graphics and web tools, is a 
strong determinant of the visitors’ perception of the website and the satisfaction they 
experience for the visit (Lavie & Tractinsky, 2004, p. 269; Simeon, 2001, p. 420) 
 Zahedi and Bansal (2011, p. 148) argue that the Internet has globalised 
visual communication. The authors reason that as images of various types are used as 
communication tools across the Web, their role as effective modes of asynchronous 
mass communication has increased (Zahedi & Bansal, 2011, p. 148). There are, 
however, studies, which question the global nature of visuals. An (2007), who focused 
on global advertising, and Quiye, who examined communication through graphs, both 
maintain that there are cultural differences in terms of preferences for visual 
communication. Furthermore, Taylor et al. (2007) found that localised advertising 
campaigns on the Internet are more effective than standardised advertising campaigns. 
The findings of the study by An (2007), however, suggest that despite the localisation of 
visual messages proving successful in reaching consumers around the world, the 
perceived similarities between target markets allow global advertisers to group similar 
markets together and create standardised messages to these groups. This approach will, 
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 according to An (2007), combine the high level of reach of a localised advertising 
message with the advantages of a standardised global approach, such as cost savings, 
consistency and enhanced brand identity building (An, 2007, p. 326). 
 
2.3.4 Websites as communication channels in the pharmaceutical industry  
 
The Internet is an indispensible source of health and medical information for 
consumers. Among various sources of health information, such as doctors, friends and 
family as well as mass media, the Internet has been identified in prior research as the 
most accessible and frequently used source. Furthermore, prior research shows that 
compared to other media, for example TV, radio and print, the Internet is rated the most 
important and satisfactory source of health information. Consumers, for example, feel 
that online health information improves their decision-making abilities and encourages 
them to talk with their doctor. It also improves their understanding of health conditions 
as well as makes them more comfortable about following their doctor’s advice (Ybarra 
& Suman, 2006, p. 29). The growing demand for and consumption of online healthcare 
information has led to pharmaceutical companies establishing a prominent presence on 
the Internet. (Kim, 2011, pp. 57-58) 
Blackett and Harrison (2001, p. 49) argue that the trend within the 
pharmaceutical industry is towards global brands and globally consistent 
communication. Relating back to the discussion on the two communication strategies 
this would then imply that a globalisation strategy was deemed appropriate to be used in 
global pharmaceutical communication. Blackett and Harrison (2001, p. 49), however, 
maintain that it is still important to recognise local sensitivities and subtleties in the 
foreign market, and take these into account in the communication. Based on prior 
research it could therefore be expected that differences would exist between the global 
and localised pharmaceutical websites in terms of their visual elements.  
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 2.4 Source credibility effect 
 
 
This section introduces the concept of source credibility, which is highly important for 
providing answers to research questions 2 and 3. The concept has not previously been 
researched within the field of visual communication, and as a result the section will first 
discuss it in terms of its heritage within marketing communication. The section will then 
link relevant research in source credibility effect to visual communication and to the 
pharmaceutical industry. 
A key determinant of the success of communication messages is the 
credibility that the audience attributes to the source of the message (Fill, 2009, p. 507). 
Research indicates that source credibility is a factor of three dimensions: expertise, 
trustworthiness, and attractiveness (e.g. Ohanian, 1991; Clow et al., 2006). Furthermore, 
Fill (2009, p. 507) highlights the perceived personal motives of the source as a key 
component of credibility. Expertise refers to the level of which the source is perceived 
to possess better knowledge and experience of the advertised matter compared to the 
consumer. Trustworthiness is the extent to which the source can be regarded as 
objective and honest. Source credibility can be established by either the initiator of the 
marketing communication’s message or by a specifically selected spokesperson (Fill, 
2009, p. 507) 
 
2.4.1 Spokespersons 
 
Despite the use of spokespersons having been widely researched in the field of 
marketing communication (e.g. Limbu et al., 2012; Wang & Doong, 2010; Clow et al., 
2006; Lafferty et al., 2002; Stafford et al., 2002; Agrawal & Kamakura, 1995; Ohanian, 
1991) the topic has yet to be adopted into visual communication through images other 
than advertisements. Companies use spokespersons in order to increase the credibility of 
their communication activities (Fill, 2009). As with the case of organisation’s delivering 
their own messages, consumers will weigh up the validity of the message and the 
perceived credibility of the spokesperson delivering the message to decide whether to 
accept the message or not (Fill, 2009, p. 508). There are six groups of spokespeople 
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 commonly discussed in the literature: experts, celebrities, consumers, spokescharacters, 
company chief executive officers (CEOs) and company employees (Limbu et al. 2012, 
p. 25; Fill, 2009, p. 509; Stafford et al., 2002, p. 18; Friedman & Friedman, 1979, p. 
63).  
 Expert spokespersons are individuals who have superior product 
knowledge compared to the target group that is gained through experience, study or 
training (Limbu et al., 2012 p. 25; Fill, 2009, p. 509; Friedman & Friedman, 1979, p. 
63). In the context of medicinal products, expert spokespersons generally include 
doctors and pharmacists. According to prior research, expert spokespersons should be 
used in marketing communications if the advertised product could cause a financial or 
physical risk to the consumer or if the performance of the product needs verification 
(Friedman & Friedman, 1979, p. 71). 
 A celebrity spokesperson is a well-known public figure such as an actor, 
athlete or a musician, who has gained this status by achievements in an area that is 
unrelated to the product class of the advertised product (Friedman & Friedman, 1979, p. 
63). Research has shown that in terms of brand recall the celebrity spokesperson seems 
to be the most effective type of spokespersons in marketing communications (Friedman 
& Friedman, 1979, p. 70). There are, however, risks involved with using a celebrity 
spokesperson as a brand advocate. Care needs to be taken into the selection of the 
celebrity spokesperson, as their traits need to match the brand and its current or desired 
traits (Tom et al., 1992, p. 48). With the other spokesperson groups, the company has 
more control over the spokesperson, as they are either fictional characters (human or 
animated) or employed by the company. Even though marketing communication using 
celebrity spokespersons has been shown to result in greater levels of ad recall, there is a 
risk that consumers receiving the message remember the celebrity but not the brand that 
is being advertised (Fill, 2009, p. 511). Furthermore, celebrities may be advocates of 
several brands at the same time (Tom et al., 1992, p. 48), which may create unwanted 
associations with other brands or make the validity of the company’s message 
questionable.  
 A consumer spokesperson’s effect in marketing communications is based 
on his/her similarity with the target consumer. The role is normally filled by an ordinary 
person, who has no special knowledge or expertise regarding the advertised product 
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 other than what s/he has gained through normal use of the product (Friedman & 
Friedman, 1979, p. 63). Fill (2009, p. 511) states that similar lifestyles, interests and 
opinions between the consumer spokesperson and the target consumer make the latter 
more receptive of the message, make the message more credible, and increase the 
consumer’s understanding of the message. 
 Animated characters are sometimes referred to as safe options to be 
appointed as brand spokespersons. This statement is based on the fact that they are 
fictional characters that can be fully controlled by the company, which is never entirely 
possible with human spokespersons (Stafford et al., 2002, p. 18). As such, the match 
between the brand and the animated spokescharacter can be optimized to a greater 
extent than that of the match between the brand and for example a celebrity 
spokesperson. Whereas a human spokesperson’s public image may change for the worse 
and by doing so create negative associations for the brand, a spokescharacter’s public 
persona can be influenced so that the spokescharacter portrays the exact qualities and 
attributes that the company wants consumers to associate with the brand (Stafford et al., 
2002, p.17; Tom et al., 1992, p. 48). 
 In certain cases, the CEO of a company makes a good spokesperson for its 
products and brands. A CEO spokesperson can be effective when the public image of 
the CEO is positive and his/her character creates positive associations with and 
increases credibility of the brand (Fill, 2009, p. 511). Furthermore, the CEO is often 
perceived as knowledgeable about the brand, which draws from the expertise dimension 
of the source credibility effect (Stephens & Faranda, 1993). The CEO can therefore be 
placed between the expert and the celebrity, but the personal motives that a CEO has 
might be perceived as high. Most obvious examples of such CEOs include Sir Richard 
Branson for Virgin Group and the late Steve Jobs for Apple.  
 Employees are frequently used as spokespersons in marketing 
communication materials for service companies, as customer satisfaction is often 
directly related to the performance of an employee (Stephens & Faranda, 1993, p. 36). 
Stephens and Faranda (1993) differentiate between the use of front-office and back-
office employees as spokespersons. Front-office employees refer to company personnel, 
who are directly in contact with the consumer, such as pharmacists, which makes them 
an evident choice for brand spokespersons (Stephens & Faranda, 1993, p. 37).  Back-
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 office employees’ work, on the other hand, does not involve regular customer 
interaction (Stephens & Faranda, 1993, p. 36). An example of such is a laboratory 
worker. Although back-office employees are not uncommon in marketing 
communication, Stephens and Faranda (1993, p. 38) note that they are less common 
than front-office workers.  
 
2.4.2 Visual spokespersons 
 
It is a known fact that the visual appearance of other people is a key component in 
guiding our attitudes and behaviour in social interaction. Visual appearance can be 
divided into dynamic visual aspects, which include gestures, facial expressions and 
gaze, as well as static visual aspects such as body shape, gender, clothes and hair. These 
attributes initiate a set of expectations in human beings regarding, for example, the 
personality, character, likely behaviour, attitudes and opinions of the other person 
independent of whether the attributes are witnessed face-to-face, on a paper or through a 
screen. (Haake & Gulz, 2008, p. 1-2)  
 This process of categorization by visual cues relies heavily upon 
stereotypes. A stereotype can be defined as a culturally shared socio-cognitive 
representation of a typical member of, for example, a human, a professional or a social 
group (Haake & Gulz, 2008, p. 2). A stereotype incorporates the beliefs that members of 
the culture share on a group of people.  These are activated by visual cues and may 
include various non-visual attributes that are then projected onto the person: how the 
person is expected to behave or not to behave, what is s/he expected to say or not to say. 
Haake & Gulz (2008, p. 2) refer to this as “visual cues carrying social baggage”.  
 In the literature, there exists a distinction between a stereotype and a 
prototype, which requires further clarification in terms of the topic of this thesis. 
Whereas a prototype is used to represent a portrayal of a typical example of a concept 
based on the actual frequency of occurrences, a stereotype is seen as something that is 
constructed out of elements that actually do not exist by an outlet such as culture or 
media. As such stereotypes are said to bring along negative associations, while 
prototypes remain neutral. (Haake & Gulz, 2008, p. 3) As this study examines visual 
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 spokespersons that may carry negative, neutral or positive associations meanings in 
them the term visual stereotype will be used. However, an important division needs to 
be made, as the thesis will use the term ‘stereotype’ as a carrier of associations on a 
continuum between negative and positive. As stereotypes themselves are culture-
specific, so will the continuum of associations be as well. 
 
2.4.3 Spokespersons and stereotyping in the pharmaceutical industry 
 
This subsection focuses on the emotional aspect of using influential spokespersons. 
Limbu et al. (2012, p. 24) note that there is a trend in pharmaceutical advertising away 
from rationality and towards emotional messages. This has been criticised for 
persuading consumers and attempting to influence their healthcare decision-making 
instead of providing a fair balance of benefits and risk information about the medicinal 
product (Kim & Lee, 2012, p. 254).  
 The use of spokespersons has been widely researched within the 
pharmaceutical industry especially in terms of direct-to-consumer advertising. The 
research has, however, focused on just three of the groups of spokespersons: celebrities 
(e.g. Limbu et al., 2012; Polen et al., 2009), experts (e.g. Kim & Lee, 2012; Limbu et 
al., 2012) and consumers (e.g. Kim & Lee, 2012). The findings of these studies will 
next be briefly looked into. 
 Prior research suggests that the use of celebrity spokespersons in 
pharmaceutical advertising does not necessarily provide positive results. Polen et al. 
(2009, p. 50) found that 90 % of research respondents felt that the use of celebrity 
spokespersons in pharmaceutical advertising had a negative impact on trust in the 
advertised product. The same study showed that fewer than 10 % of respondents were 
encouraged by the celebrity spokesperson used to visit their doctor to inquire about a 
medicinal product they saw being advertised (Polen et al., 2009, p.49). Limbu et al. 
(2012) studied the use of celebrity and expert spokespersons in the advertising of 
prescription-based medicinal products within high- and low-involvement target 
audiences, high-involvement referring to consumers with a medical condition treatable 
by the advertised product and low-involvement to those who do not have such a 
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 condition. The research findings showed that the use of a celebrity spokesperson helped 
in brand and ad recall for low-involvement consumers but was ineffective among the 
high-involvement consumers.    
Comparing the celebrity and expert spokespersons, prior research has 
shown that consumers prefer the use of experts in adverts for over-the-counter products 
to celebrities (Limbu et al., 2012). This could suggest that expert spokespersons would 
also be preferred in the advertising of prescription-based pharmaceutical products due to 
the higher risk associated with the drugs compared to over-the-counter products (Limbu 
et al., 2012, p. 26). This was to some extent supported by the study by Limbu et al. 
(2012) as they found out that the use of expert spokespersons increased ad credibility. 
This effect was, however, stronger within the low-involvement consumer group than the 
high-involvement group.  Limbu et al. (2012, p. 33) concluded that public policy 
makers should be alert that the use of spokespersons and other peripheral cues in 
advertising have a more persuasive effect on consumers, who do not actually need the 
advertised medication, compared to those who do.  
 Kim and Lee (2012) studied the impact that the presence of an expert or a 
consumer (referred to as a peer in the study) spokesperson, as well as no spokesperson 
at all, in advertisements had on the consumer response to the ad. The study showed that 
the use of a spokesperson, whether an expert or a consumer, had a more favourable 
impact on the attitudes of the respondents compared to no spokesperson being used in 
the advert at all (Kim & Lee, 2012, p. 255).  The effectiveness of doctors as expert 
spokespersons for pharmaceutical companies is based on their specialised knowledge 
and product-relevant expertise that can exert significant persuasive influence on 
consumers. Kim and Lee (2012, p. 248) argue that this influence is especially powerful 
because the consumer integrates the expert’s opinions to their own belief system, which 
is sustained for a longer period of time than the advertising campaign runs.  
 The use of typical consumers as spokespersons in pharmaceutical adverts 
is, according to Kim and Lee (2012, p. 248), based on their perceived similarity with the 
consumer that is exposed to the advert. The consumer spokesperson may be seen to 
evaluate the medicinal product from the same standing point as the consumer 
him/herself. The better the consumer can relate to the consumer spokesperson, the 
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 greater the perceived relevance and acceptance of the ad message. (Kim & Lee, 2012, p. 
248) 
 Comparing the expert and the consumer spokesperson Kim and Lee (2012, 
p. 254) found out that the expert spokesperson in the form of a doctor produced 
perceptions of drug efficacy that were significantly greater than those of the consumer 
spokesperson. The authors also found, however, that both types of spokespersons were 
seen as trustworthy by the consumers (p. 256), a trait which was not associated with the 
celebrity spokesperson in the study by Polen et al. (2009, p. 50).  
  
Chapter 2 has so far introduced the economic context of the pharmaceutical industry, in 
which the case companies operate. Furthermore, systemic functional linguistics was 
discussed in order to understand the theoretical basis of visual communication, and as a 
result this study. Relevant research into the key concepts of the thesis, source credibility 
effect and websites as communication channels, were then discussed both on a general 
level and in the context of international businesses. This key literature leads to the 
development of the analytical framework for the study, which will next be described in 
Section 2.5. 
 
 
2.5 Analytical framework 
 
The analytical framework combines elements from the frameworks by Kress and van 
Leeuwen (2006) and O’Toole (1994), both of which are based on the field of functional 
semiotics. The images will be considered through the three functions of analysis 
introduced in Section 2.2.2: interpersonal, representational and compositional. These 
directly relate to Halliday’s (Halliday & Matthiesen, 2004) interpersonal, ideational and 
textual metafunctions used to analyse texts in the field of systemic functional 
linguistics.  
 O’Toole (1994) introduced the rank scale for analysing paintings, which 
includes work, episode, figure and member. As the main focus of this study is on 
spokespersons and the human roles portrayed in the images, the rank of member will 
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 not be included in the analysis for two reasons. Firstly, it is deemed challenging to 
categorize a spokesperson just by a part of their body. Secondly, as a result of the first 
reason, by excluding the rank of member from the analysis the trustworthiness of the 
study will be retained at a high level, as the results of the study remain to a higher extent 
replicable. Furthermore, the rank of episode was also excluded from the analysis as the 
study will focus on images with only one actor, as will be explained in more detail in 
Section 3.2. 
 
2.5.1 Interpersonal function 
 
The interpersonal function considers the tools and devices that are used in the image to 
engage the viewer’s attention as well as evoke thoughts and emotions (O’Toole, 1994). 
At the rank of work the interpersonal function analyses the modality, setting, social 
distance and appraisal used in the image.  
Modality is a term adopted from linguistics into visual communication and 
it means the extent to which the viewer considers the image to portray reality and truth 
(Kress & van Leeuwen, 2006, p. 155). O’Toole (1994, p. 9) refers to this as slant and 
defines it as the uncertainty or ambiguity that a painter includes in a painting. For the 
study, colour has been chosen as the signifier of modality. Kress and van Leeuwen 
(2006, p. 160) talk about three scales of colour, which are used to define modality in an 
image. Colour saturation refers to the scale running from a full colour to a black and 
white image. Colour differentiation is a scale where the other extreme is maximally 
diversified range of colour, whereas the other being monochrome colours. Finally, 
colour modulation refers to the extent to which the colours are modulated, where fully 
modulated means an image that uses many different shades of red, and unmodulated 
means an image with realistic colours. The element of modality will be coded in the 
present study into either high or low, high referring to realistic colours whereas low 
being images with any modified colours. 
 In addition the interpersonal function includes information about the 
characters, their actions, as well as the image setting. At the rank of work, the study 
includes an analysis of the setting portrayed in the image as well as the social distance. 
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 This will be coded in terms of a two-by-two matrix: the images are either formal or 
informal and either pharmaceutical or non-pharmaceutical by their setting. 
The social distance refers to the distance of intimacy in the images and 
will be coded according to Edward Hall’s dimensions of distance suggested by Kress & 
van Leeuwen (2006, p. 125). This includes six levels of distance. Images with intimate 
distance only show a person’s face or head. A close personal distance includes a 
person’s head and shoulders. At far personal distance the person is visible from the 
waist up. A close social distance shows the whole figure, where as a far social distance 
shows the figure and some of its surroundings. Finally, at public distance the torso of at 
least four people are visible in the image. (Kress & van Leeuwen, 2006, p. 125) 
 Furthermore, at the rank of work appraisal theory (Martin & White, 2005) 
will be used to evaluate the feel of the images. The appraisal theory is a framework for 
mapping feelings, which involves three semantic regions that cover the concepts that are 
traditionally known as emotion, ethics and aesthetics (Martin & White, 2005, p. 42). 
The appraisal theory is often used to analyse written communication but its application 
into visual resources has been limited, even though there appears to be no barriers to its 
adoption into the field of visual communication.  
 Emotion is referred to by the term ‘affect’, which is concerned with 
registering feelings, both positive and negative (White, 2008, p. 8). In written language 
this is often done through the use of verbs or adjectives of emotion, such as to love/to 
hate or happy/sad. In visual language the evaluation will be based on visual cues. 
Judgement refers to the evaluation of human behaviour in terms of a system of ethics or 
social norms. It therefore deals with admiration, critique, praise and condemnation 
within a cultural context. Appreciation focuses on the evaluation of objects, texts, 
artefacts and other materials other than human behaviour. The most obvious expression 
of appreciation is concerned with aesthetics of form and appearance. (White, 2008, p. 8-
11)  
 In the present study, appraisal will be categorised under one of the three 
headings: affect, judgement or appreciation. Furthermore, the nature of the appraisal 
will be coded into either positive or negative emotional appeals. Main et al. (2004, p. 
125) defines positive emotional appeals in advertising as a way of influencing the 
attitude and decision-making of consumers by evoking favourable affective responses. 
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 Positive emotional appeals include, for example, warmth, joy, humour and nostalgia 
(Main et al., 2004, p. 124). Negative appeals use threatening or disturbing images to 
evoke, for example, fear, guilt, shame, regret, sadness or anger (Main et al., 2004, p. 
126). These are used in order to evoke anxiety in consumers, which has been shown to 
have links to greater degree of attitude change and higher rates of compliance with a 
message compared to positive appeals.  
 The visual elements on the interpersonal metafunction at the rank of work 
and the coding used for them in the study are summarized in Image 1.  
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Image 1: Coding on the interpersonal metafunction at the rank of work 
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 The interpersonal characteristics chosen for the analysis of figures include the gaze of 
the figures, focal point of the images, and the potential highlighting of figures. The gaze 
will be categorized into three categories: towards the camera, towards another figure or 
into the distance. Referring back to Section 2.2.2 and the discussion on visual grammar 
these three have been derived from Kress and van Leeuwen’s (2006) division between 
images that demand and those that offer. With a direct gaze towards the camera the 
figure demands something from the viewer, such as attention or interaction. On the 
other hand the figure can offer interaction or information to the viewer by looking away 
from the camera towards the other figures or into the distance without addressing the 
viewer directly with their gaze.  
 
 
 
Image 2: Coding on the interpersonal metafunction at the rank of figure 
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  The other elements of the interpersonal function adopted into the study 
will focus on whether or not the figures are raised above the rest in the images. The 
analysis here concentrates on focal points and highlighting. A focal point in an image is 
the element depicted that the eyes of the viewer are drawn to. It is what raises the 
viewer’s interest in the image and makes the viewer focus his/her attention in the image. 
Highlighting investigates whether colour saturation or light are used to highlight some 
of the figures. 
 
2.5.2 Representational function 
 
The representational function conveys information about the reality created in the image 
(O’Toole, 1994). The representational function at the rank of work consists of the 
analysis of the image in terms of its communicative purpose. If the image aims to tell a 
story it is categorised as a narrative theme (O’Toole, 1994, p. 19). Depending on the 
units used in the image this can either be a story or a complex of interwoven or separate 
stories. In line with O’Toole’s (1994) definition, Kress and van Leeuwen (2006, p. 59) 
establish the term ‘narrative pattern’ to represent images that depict ongoing or 
unfolding actions. For their purpose of storytelling, narrative themes are quite distinct 
from scenes and portrayals, the purpose of which is only to portray or represent. The 
difference lies in the fact that scenes portray objects and scenery, whereas portrayals 
depict persons or groups of people (O’Toole, 1994, p. 19). 
At the rank of figure for the representational function the element of 
character used by O’Toole (1994) will be broken down into three components: gender, 
age and spokesperson. Gender will be coded in terms of female and male figures, 
whereas age will be coded into four categories: child, young adult, adult and elderly. 
Finally the spokespersons used in marketing communications introduced in Section 2.4 
will be used as a basis for coding of the figures. This list of spokesperson groups will, 
however, not be seen as exhaustive and the emergence of potential new groups is not 
ruled out.  
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Image 3: Coding on the representational metafunction at the rank of figure 
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Furthermore, the figures will be analysed in terms of their clothing and 
their role in the action or event that is being depicted in the narrative theme. The 
clothing is important for the present study, as the categorisation of the figures into 
spokespersons will highly be based upon visual stereotypes, which often are represented 
through clothing. An expert spokesperson, for example, in this study could be a figure 
wearing a white doctor’s coat and/or a stethoscope.  
 The role that the figures have in the action or event that is being depicted 
in the narrative theme will be coded in terms of Kress and van Leeuwen’s (2006, p. 63) 
analysis of action processes. According to the researchers, an action process involves 
two main characters: an actor and a goal. An actor in an image is the figure, which 
initiates the action. A goal, on the other hand, is the figure that the action is directed to. 
(Kress & van Leeuwen, 2006, p. 63) 
 
2.5.3 Compositional function 
 
The compositional function focuses on the arrangements of forms in the image, the 
relation between the image elements, as well as the axes and the positioning of 
characters in the image. At the rank of work, this will be analysed in terms of the 
positioning of the image on the section of the website it is in. This will be coded as top, 
middle or bottom, where top refers to the top banner, middle to the images found in the 
middle of the page, often placed within text, and bottom to the bottom of the page. The 
placing of the images is significant because, as mentioned in Subsection 2.2.3 in the 
discussion on prior research on the compositional function in a visual context, website 
visitors tend to follow in line of particular reading paths (Hopearuoho & Ventola, 2009; 
Shrestha & Owens, 2008). Therefore, an image placed at the top of a page should 
receive more attention from the website visitors and thus have a higher rate of recall 
than an image placed on the bottom. Furthermore, a division between ideal and real is 
suggested in the literature (Hopearuoho & Ventola, 2009, p. 188; Kress & van 
Leeuwen, 2006, p. 186). This implies that the division of information on a web page 
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 varies according to the different areas. Kress and van Leeuwen argue (2006, p. 187) that 
if images occupy mostly the top part of a web page with textual information below it, 
this implies that the idealised or generalised essence of the information is communicated 
visually whereas the text merely elaborates on it. However, if the text occupies the top 
of the page with images below it, this acts as evidence of pharmaceutical companies 
considering images as subservient to textual communication (Kress & van Leeuwen, 
2006, p. 187). In addition to the placing of the images, the number of figures will also 
be included in the compositional function.  
 
 
 
 
Image 4: Coding on the compositional metafunction at the rank of work 
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 At the rank of figure the compositional function will be evaluated based on the figures’ 
positioning within the image (left/centre/right) and their alignment in relation to the 
vertical and diagonal axes (straight/diagonally). The positioning within the image has 
been considered parallel by visual communication researchers to the linguistic system of 
theme and rheme (Hopearuoho & Ventola, 2009, p. 188; Kress & van Leeuwen, 2006, 
p. 181). This means that what is placed on the left-hand side of the image is presented as 
a given element, one that the viewer is already familiar with. This may not be the case 
in reality, but it is what the image composition suggests (Hopearuoho & Ventola, 2009, 
p. 188; Kress & van Leeuwen, 2006, p. 181). The element placed on the right-hand side 
of the image is then presented as something new to the viewer, something that was not 
known to him/her beforehand (Kress & van Leeuwen, 2006, p. 181).  
The alignment of the figures to the vertical and diagonal axes contributes 
to the stability or energy within the image. Figures that are depicted as being straight in 
relation to the whole image, i.e. in alignment with the vertical axis, are said to bring 
stability and harmony into the image. Figures, which are diagonally in relation to the 
whole image and thus aligned with a diagonal axis, tend to create dynamism and energy. 
(O’Toole, 1994, p. 23) 
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Image 5: Coding on the compositional metafunction at the rank of figure 
 
This section described the analytical framework, which will be used to analyse the 
image material in order to answer the research questions outlined in Section 1.2. The 
framework utilises the frameworks for visual analysis by both Kress and van Leeuwen 
(2006) and O’Toole (1994). Furthermore, the appraisal theory will be adopted into the 
analysis of visual communication to determine the feelings and emotions embedded 
within the images. Table 3 summarizes the analytical framework in terms of the two 
ranks selected (work and figure) and the three functions of visual communication 
(interpersonal, representational and compositional). 
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 Table 3: The analytical framework of the study 
 INTERPERSONAL REPRESENTATIONAL COMPOSITIONAL 
WORK • Modality 
• Setting  
• Social distance 
• Appraisal 
• Narrative theme • Positioning  
• Number of figures 
FIGURE • Gaze  
• Focal point 
• Highlighting 
• Gender 
• Age 
• Spokesperson 
• Clothing 
• Role in the action 
• Positioning of figures 
(left/centre/ right) 
• Alignment of figures 
(straight/ diagonally) 
 
 
In order to utilize the analytical framework shown in Table 3 and answer the research 
questions presented in Section 1.2, suitable research methods were examined. Next, 
Chapter 3 will present the combination of research methods chosen for the study as well 
as discusses the data collection process. 
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 3. Data and methods 
 
 
 
The following sections will discuss the methods that have been chosen to study the 
topic laid out in Chapters 1 and 2. Chapter 3 includes short introductions to the methods 
as well as justifications for their suitability for studying the particular topic. Finally, the 
collection of the data and trustworthiness of the study will be discussed. 
 
 
3.1 Research methods 
 
This study will utilize mixed methods research by combining qualitative and 
quantitative methods in a sequential manner. Semiotic analysis will be used to analyse 
the images and find cultural references in them. Furthermore, content analysis will be 
used to provide a quantitative means of comparing the websites.  
Jogulu and Pansiri (2011) note that as management research is becoming 
more complex it requires new techniques for investigating research problems. In fact, 
Onwuegbuzie and Leech (2005) go as far as to argue that the existing division between 
quantitative or qualitative research methods is the biggest threat to the advancement of 
the social sciences, as the two are not used as a unified, holistic and interactive process. 
An increasing group of researchers use mixed methods approach in order to tackle these 
issues (Jogulu and Pansiri, 2011; Molina Azorín and Cameron, 2010).  Mixed methods 
research can be defined as the use of a combination of quantitative and qualitative 
research methods within the same study (Molina Azorín and Cameron, 2010). The aim 
is not to replace quantitative or qualitative approaches, but to use the strengths and 
weaknesses of the two in order to create a method that is better adapted to examining 
some research problems (Truscott et al., 2010). The research methods will next be 
discussed in more detail. 
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3.1.1 Semiotic analysis 
 
Semiotic analysis is “the study of the signs or systems of signs [and it] concerns the 
principles by which signification occurs. Signification refers both to the processes by 
which events, words, behaviours and objects carry meaning from the members of a 
given community, and to the content they convey” (Barley, 1983, p. 394). The aim of 
the semiotic analysis in this study is to examine the meaning that is conveyed in the 
images chosen from the pharmaceutical companies’ websites. The method fits the 
research in question because it allows for a structured and systematic analysis of the 
images based on the framework of analysing images by Kress and van Leeuwen (2006) 
and O’Toole’s (1994) framework for analysing paintings as well as other semiotic 
artefacts and architecture.   
 Central to semiotic analysis is the notion of the sign. Barthes (1967) 
defines a sign as the relationship between or the union of the outlet and the content of 
the sign. The outlet can for example be a word or a sound. Barley (1983, p. 399) argues 
that by this definition the semiotic theory presumes that anything can function as a sign. 
This highlights the role of the researcher in semiotic analysis. Barley (1983, p. 394) 
concludes that semiotics is ultimately the study of how communication is possible, as 
the same sign systems are presumed in all communication. The study would therefore 
benefit from the verification of the findings by one or more other researchers, as is 
discussed in Section 6.3 outlining the limitations of the study.   
 
3.1.2 Content analysis 
 
Content analysis is a systematic and quantitative method of describing the content of 
semiotic resources (Kenney, 2009, p. 228). Duriau et al. (2007, p. 5) note that it has 
been widely used for academic research purposes to study topics in business and 
management. It has also been a method of choice for many academics studying 
communication on websites through either textual or visual elements (e.g. Shneor, 2012; 
Singh et al., 2009; Singh et al., 2005; Maynard & Tian, 2004; Macias & Stavchansky 
Lewis, 2003-4).  
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 Martin (2012) and Rose (2001), among other researchers, highlight the 
importance of visual images as not only reflections of social contexts but also as 
reproducers of them. As such, content analysis will provide a meaningful method of 
examining today’s social contexts and realities depicted in the images. For the purpose 
of this study content analysis will be used to produce counts of frequency of visual 
elements outlined in the analytical framework in Section 2.5. The defining of the 
categories for coding is of upmost importance in content analyses, as the trustworthiness 
of the study increases if it could be repeated by another researcher with the same 
findings and results. For this reason the coding system was developed for the study with 
the slightest of details in mind. This was discussed in Section 2.5. 
 
 
3.2 Data collection 
 
For the study the three world’s biggest pharmaceutical companies (Pfizer, Novartis and 
Sanofi respectively) were chosen from the Forbes Global 2000 listing of the world’s 
biggest public companies in 2012.  The companies represent the three largest 
pharmaceutical companies in the world according to Forbes’ weighting of their sales, 
profits, assets and market value. In addition, Orion, the largest Finnish pharmaceutical 
company was added as the fourth case company.  
 The data was collected from the websites of the companies in January 
2013. The images were collected by moving along the top navigation bar and the 
subpages listed on the left navigation bar. Any images that were behind links on the 
page that led away from the website were disregarded. Furthermore, as the focus of this 
study is on communication through pure images, adverts were excluded from the study. 
However, images that include a textual element other than a promotion were accepted 
into the study. The textual element was, however, not analysed as part of the image. 
 Three criteria were used when choosing the images for the analysis from 
the companies’ websites:  
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 1. The images needed to be in one of the following sections of the website: 
Homepage, About us, Research & Development, Products & Services or 
Sustainability.  
 
2. Only images that include human characters were selected as one of the main 
characteristics to be analysed is the spokespersons portrayed in the images.  
 
3. Only images that have a narrative theme were chosen. 
 
In his framework for analysing paintings O’Toole (1994, p.19) establishes the term 
‘narrative theme’. By this term he distinguishes paintings that include a story or 
complex of stories from ‘scenes’, which do not depict any action such as landscape 
paintings or still-lifes, and ‘portrayals’, which he defines as scenes that portray a person 
or a group of people. Accordingly, Kress and van Leeuwen (2006, p. 59) use the term 
‘narrative pattern’ to distinguish images that present “unfolding actions and events, 
processes of change, transitory spatial arrangements”. Image 6 provides example of a 
narrative theme, where a boy is handing over a piece of paper to a pharmacist. Only 
such images that have a narrative theme were chosen for the semiotic analysis so that 
the actions that the different spokespersons take in the images could be taken into 
account in the analysis. 
The result of the analysis will be 
an understanding of the visual messages that the 
case companies communicate through the 
images on their website. The analysis will also 
reveal potential contextual differences arising 
from the cultural background of the companies. 
 
 
  Image 6: An example of a narrative 
theme 
(http://www.orion.fi/en/Products-and-
Services/) 
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 3.3 Trustworthiness of the study 
 
The trustworthiness of the study refers to the extent to which the study can be deemed to 
meet the expected quality standards of an academic research project. According to 
Kenney this is done in quantitative projects through analysing the reliability and validity 
of the research. In a qualitative research project the trustworthiness can be seen as a sum 
of three components: credibility, transferability and dependability. Furthermore, it is 
important to evaluate the potential for researcher’s bias. As the present study utilised 
both quantitative and qualitative research methods, it will be evaluated based on all five 
characters suggested by Kenney as well as the potential for researcher’s bias. (Kenney, 
2009, p. 14) 
 The reliability of a research project refers to the consistency, stability, and 
dependability of the quantitative data gathering (Kenney, 2009, p. 14). To achieve 
reliability the images were all collected from the websites of the case companies on the 
same day. Furthermore, in addition to saving the images also print screens of the whole 
web pages were saved to maintain future reference to the positioning of the images even 
in an event where the websites were changed. Validity of a study means that the 
measures selected to analyse the phenomenon actually measure the elements intended 
(Kenney, 2009, p. 14). The validity of the present study was ensured by the use of a 
combination of two widely accepted frameworks for analysing visual communication, 
one by Kress and van Leeuwen (2006) and one by O’Toole (1994).  
 The credibility of a qualitative study refers to the accuracy and 
faithfulness of the researcher’s descriptions of the gathered data (Kenney, 2009, p. 14). 
In the present study this was achieved through an extensive use of example images to 
further elaborate the coding behind visual elements. The coding sheets were also 
included into this document as appendices for future evaluation (please see appendices 
1-3). Furthermore, the coding elements were thoroughly described with even the 
smallest of details, as is required by the method of content analysis, to show the 
reasoning behind the coding and allow for potential future replication of the study. 
These factors also add to the dependability of the study, which Kenney (2009, p. 14) 
defines as a clear path of reasoning behind a research study, which other researchers can 
follow and replicate if necessary with the same findings and conclusions. Finally, the 
transferability concerns the potential of the research findings to be adapted to a context 
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 beyond that of the research project (Kenney, 2009, p. 14). Although care should be 
taken when considering the relevancy of any research findings in a context other than 
that of the study, as will be seen in Section 6.4, the present study gives an extensive list 
of recommendations for further study, which are relevant topics not only within the 
pharmaceutical industry but in other business contexts as well.  
 Despite the aforementioned steps to ensure the trustworthiness of the 
study, an element of bias is always present in qualitative analyses. As discussed, visual 
communication is dependent upon shared systems of signs (Haake & Gulx, 2008, p. 2; 
Barley, 1983, p. 399). The universality of the signs used in this research has not been 
studied, which suggests that there is potential for differences in the coding of these 
elements of researchers from different demographic, social and cultural backgrounds. 
The researcher has not, however, been influenced by any personal values or 
experiences, and has striven for as objective an analysis as is possible in a study by only 
one researcher. 
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 4. Findings 
 
 
 
This chapter presents the findings of the study. The first section will present the general 
findings in terms of images per company, website and website section as well as 
spokesperson groups. These four categories will then be used in the following section as 
background variables to discuss the findings of the study. These sections have been 
labelled according to the three metafunctions of visual communication: interpersonal, 
representational and compositional (Kress & van Leeuwen, 2006; O’Toole, 1994). 
 
 
4.1 General findings 
 
A total of 257 images qualified for the analysis from the websites of the four case 
companies, as are presented in Table 4. Whereas Orion, Pfizer and Sanofi had a similar 
number of narrative images that fulfilled the prerequisites of this study (51, 54 and 46 
respectively), Novartis had double the amount of narrative images (106), which 
equalled to 41.2 % of the total number of images.  
 
 Table 4: Unique narrative images by case company 
Company Frequency 
Novartis 106 41.2 % 
Orion 51 19.8 % 
Pfizer 54 21.0 % 
Sanofi 46 17.9 % 
Total 257 100.0 % 
 
Pfizer was the only company not to have a separate global website and home country 
website. Being the only company in the analysis to originate from an English-speaking 
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 nation, the reason behind this strategy may be related to meaning-making through the 
semiotic resource of language. It, however, implies either that the company considers 
visual messages globally understandable or that the company is currently using the 
images only for the purpose of appeal, not as tools for communication. As Pfizer.com 
acts as both the global and the home country website, it was considered in both 
categories also in the analysis for this study when investigating the findings by the three 
websites.  
Table 5 presents the number of narrative images per website analysed for 
the study. Whereas the global and the home country websites had a similar share of the 
images (44.3 % and 42.9 % respectively), the number for the Chinese localised websites 
was significantly lower (12.8 %). The discrepancy in the total number of images for the 
websites compared to the actual number of narrative images analysed arises from the 
fact that some images were re-used on another website. On average an image was used 
1.34 times throughout the 11 websites analysed. The duplicate images were included in 
the analysis of the findings by website but the analyses by company, section and 
spokesperson group only included unique images. This was done because it was 
impossible to tell which website the image originally belonged to. However, the 
inclusion of duplicate images would have compromised the relevancy of the findings by 
the other variables. 
 
 Table 5: Narrative images by website 
Website Frequency 
Global 153 44.3 % 
Home country 148 42.9 % 
China 44 12.8 % 
Total 345 100.0 % 
 
 
As per Table 6, the most images with narrative themes were found on the Sustainability 
(34.2 %) and About us (29.2 %) -sections of the websites. The least images were found 
on the homepages (6.2 %) and the Products & Services -section (10.9 %). There are, 
57
 however, notable differences between the case companies, as can be seen in Table 7. On 
the Products & Services section, for example, Novartis has a share of 3.8 % of their 
images, where the same share for Sanofi equals 30.4 %. This implies that the 
importance of different topics for visual communication is not standard across the 
industry but depends on other variables. 
 
 Table 6: Unique narrative images by website section 
Section Frequency 
Homepage 16 
6.2 % 
About us 75 
29.2 % 
Research & Development 50 
19.5 % 
Products & Services 28 
10.9 % 
Sustainability 88 
34.2 % 
Total 257 
100.0 % 
 
The division of narrative images between the three websites also included differences 
between the case companies, as can be seen in Table 6. Whereas Orion and Sanofi had 
the most images on their global website, Novartis had the majority of theirs on their 
Swiss localised website. Pfizer.com’s share of 78.9 % of the images found across the 
Pfizer websites was taken into account in both the global and the home country category 
due to the lack of separate websites for the two categories. Another notable difference 
can be seen in the share of narrative images of the Chinese localised website for the case 
companies. Whereas the Chinese website has the smallest share of images for Novartis, 
Pfizer and Orion, the latter having only a share of 2.3 % of their images on the Chinese 
website, for Sanofi the Chinese localised website exceeded their French localised 
website in the number of images with a share of 32.6 %. 
 As noted earlier, the number of unique narrative images was exceeded by the 
numbers of images found in the various websites in total. The difference stems from the 
fact that some companies have used the same images again in one of the other websites. 
The average re-use rate for the images, as discussed earlier in this section, is 1.34. 
However, the differences for Sanofi, Novartis and Pfizer are not significant with images 
being used on average once, 1.04 and 1.06 times throughout the three websites 
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 respectively. However, the rate for Orion equals 1.71 meaning that the majority of 
narrative images are used on two different websites for the company. All of these 
duplicate images are on the global website and the home country website, and none of 
the images on the Chinese website were used on the other two websites. 
 
 Table 7: Website and section by company 
Website Novartis Orion Pfizer Sanofi Total 
Global 39 47 45 22 153 35.5% 54.0% 78.9% 47.8% 51.0% 
Home country 56 38 45 9 148 50.9% 43.7% 78.9% 19.6% 49.3% 
China 15 2 12 15 44 13.6% 2.3% 21.1% 32.6% 14.7% 
Total 110 87 57 46 300 / 345 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Section Novartis Orion Pfizer Sanofi Total 
Homepage 5 1 7 3 16 4.7% 2.0% 13.0% 6.5% 6.2% 
About us 33 8 25 9 75 31.1% 15.7% 46.3% 19.6% 29.2% 
Research & 
Development 
23 17 7 3 50 
21.7% 33.3% 13.0% 6.5% 19.5% 
Products & 
Services 
4 5 5 14 28 
3.8% 9.8% 9.3% 30.4% 10.9% 
Sustainability 41 20 10 17 88 38.7% 39.2% 18.5% 37.0% 34.2% 
Total 106 51 54 46 257 100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table 8 presents the number of narrative images on the various sections by website. 
Again, clear differences are visible. These suggest that different topics would be more 
important to be visually communicated to different audiences. The global website is the 
website of choice for the visual communication of research and development activities 
(25.5 %) with significant shares also on the About us- and Sustainability-sections (26.8 
% and 36.6 % respectively). The latter two figures, however, fall short of the 
corresponding shares for the home country website (35.8 % and 40.5 % respectively). 
These suggest that the companies find it important to communicate about their heritage 
and corporate citizenship on the global and especially on the home country website. The 
About us –section has also the highest share of images on the Chinese localised website, 
however, an interesting difference compared to the other two websites is the 
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 significantly higher share of images on the Products & Services –section on the Chinese 
websites. To better understand the reasons behind the discrepancies further research into 
the topic would be necessary.  
 
 Table 8: Section by website 
Section Global Home country China Total 
Homepage 5 8 6 19 3.3% 5.4% 13.6% 5.5% 
About us 41 53 14 108 26.8% 35.8% 31.8% 31.3% 
Research & 
Development 
39 18 8 65 
25.5% 12.2% 18.2% 18.8% 
Products & 
Services 
12 9 11 32 
7.8% 6.1% 25.0% 9.3% 
Sustainability 56 60 5 121 36.6% 40.5% 11.4% 35.1% 
Total 153 148 44 345 100.0% 100.0% 100.0% 100.0% 
 
The narrative images were coded into groups of human spokespersons. The basis for 
these was found in marketing communication research, which presented five commonly 
accepted groups of human spokespersons (e.g. Limbu et al., 2012; Fill, 2009; Stafford et 
al., 2002; Stephens & Faranda, 1993; Friedman & Friedman, 1979): consumer, CEO, 
employee, expert and celebrity. This list was not, however, considered as exhaustive but 
the potential emergence of new groups was examined. A total of 503 figures were 
identified in the images. This total excludes figures that were too small or unclear to be 
properly categorised and analysed for the purpose of this study. This was done to 
enhance the possibility of reiteration of the thesis findings, and thus to improve the 
validity of the study.  
 In terms of the spokesperson groups, the study found out that in a visual 
context a CEO spokesperson operates differently to one in a multimodal context, 
incorporating both visuals and language. In a visual context the CEO spokesperson 
relies on the celebrity-like status of the CEO, as without textual cues the viewer is 
reliant on his/her prior knowledge on the looks and characteristics of the CEO to be able 
to recognise him/her. As a result, no figures could be categorised into the CEO 
spokesperson group. A new group of visual spokespersons, however, emerged through 
the analysis, which was named business professionals. Figures marked as business 
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 professionals were distinguishable by smart clothing as well as a non-pharmaceutical 
setting, and many of them depicted an on-going negotiation or a speech, as can be seen 
in Image 7 retrieved from Novartis China website on novartis.com.cn. 
 
 
 
 
 
 
 
 
Image 7: Business professionals on the Novartis China website 
(http://www.novartis.com.cn/nov/channel.shtml?channel_id=27) 
 
The use of business professionals as visual spokespersons was in fact so prominent that 
the group was the second most popular among the case companies with a share of 20.7 
% of the figures, yet still far behind the most popular group: consumers with a share of 
53.3 %. No celebrities were presented in the images found on the websites. 
 
 Table 9: Spokespersons in narrative images 
Spokesperson Frequency 
Consumer 
268 
53.3 % 
Employee 
93 
18.5 % 
Expert 
38 
7.6 % 
Business professional 
104 
20.7 % 
Total 
503 
100.0 % 
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 This section has discussed the general findings of the study in terms of the shares of 
images found on the websites by company, website and section as well as spokesperson 
groups. The following sections will follow in line with the analytical framework 
discussed in Section 2.5 and presented in Table 3.  
 
 
4.2 Findings on the interpersonal metafunction 
 
The interpersonal metafunction was analysed in terms of modality, setting, social 
distance and appraisal at the rank of work, as well as by gaze, focal point and 
highlighting at the rank of figure. The following subsection will present the results for 
these elements by company, followed by the discussion of them by website as well as 
by website section. Finally, the elements will be reflected upon the figures used in the 
images through analysis in terms of spokespersons. The results for focal points will only 
be analysed in terms of the spokespersons for image technical reasons. All images 
include a focal point, which limits the usefulness of comparing the shares of focal points 
by company, website or section. Furthermore, as none of the figures in the analysed 
images were highlighted, the element will not be analysed through the background 
variables.   
 The modality of an image was defined as the extent to which the image 
portrays reality in the eyes of the viewer (Kress & van Leeuwen, 2006, p. 155). The 
study focused on the colours in images as the key determinant of the represented 
modality. The variable was coded either high, if no colour modification had taken place, 
or low, if some degree of modification was evident. This scale was deemed suitable for 
a preliminary study in the visual communication on the websites of multinational 
pharmaceutical companies. However, a continuum with a higher number of alternative 
options is recommendable for further studies, as this will add detail into the analysis. 
The settings depicted in the narrative images were coded according to two 
scales: formal-informal and pharmaceutical-non-pharmaceutical. A setting was coded as 
formal in such cases where an established event was taking place (such as a visit to the 
doctor’s or a speech) or the picture showed people at work. An informal setting was 
used as a reference for leisurely activities or a break from work. Settings that included a 
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 reference to medicine or health-care were coded as pharmaceutical, whereas settings 
with no such reference were non-pharmaceutical. The results were analysed through 
cross-tabulation that resulted in four groups of settings: formal-pharmaceutical, 
informal-pharmaceutical, formal-non-pharmaceutical, and informal-non-
pharmaceutical. The characteristics of each setting group will next be analysed in terms 
of example images. 
 
 
Image 8: An example of a formal-pharmaceutical setting 
(http://www.orion.fi/Vastuullisuus/) 
 
Image 8 shows an example of a formal-pharmaceutical setting from Orion’s home 
country website (www.orion.fi). The coding is based on both the objects and the 
depicted actions within the setting. In Image 8, the existence of chemical equipment 
indicates that the image portrays a laboratory, which is supported by the two figures 
wearing white coats and blue rubber gloves. The image portrays two related narratives 
as both figures are focused on their own action, which in this case can be categorised as 
work.  
Image 9 shows one of the few examples of 
an informal-pharmaceutical setting. According to the 
coding a formal setting shows an established event, 
such as a visit to the doctor’s, or a figure at work. In 
Image 9, however, a figure can be seen taking 
medication by him/herself. The existence of the insulin 
pen makes the setting a pharmaceutical one. As the 
image presents an intimate distance, the surrounding 
objects provide us with no clues as to whether the 
Image 9: An example of an 
informal-pharmaceutical 
setting 
((http://en.sanofi.com/our_co
mpany/highlights/highlights.a
spx) 
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 setting is formal or informal. However, the green shirt collar that is visible implies that 
the figure represents a consumer taking medication instead of a doctor giving 
medication to a figure, who is cropped out of the image apart from his/her four fingers. 
 
 
Image 10: An example of a formal-non-pharmaceutical setting 
(http://www.novartis.com.cn/nov/channel.shtml?channel_id=4) 
 
In Image 10, three figures are shown at a close personal distance exposing a chart in the 
background and the corner of a laptop screen in the bottom-left corner of the image. 
These props imply that despite the lack of pharmaceutical work clothes the setting in the 
image is a formal one. This is further supported by the smart business clothing that can 
be coded on two of the figures. Taking into account the lack of evidence of a 
pharmaceutical setting the image is therefore coded as formal-non-pharmaceutical. 
 
 
Image 11: An example of an informal-non-pharmaceutical setting 
(http://www.pfizer.com/products/#A) 
 
Image 11 shows an example of an informal-non-pharmaceutical setting. It is clear from 
both the surroundings and the clothing in the image that the setting is neither formal nor 
pharmaceutical. Furthermore, in the case of Image 11, the demographics of the figures 
also present an additional cue as the image features two children and an elderly 
gentleman. 
 The social distance refers to the distance of intimacy in the images. This 
was coded in the study according to Edward Hall’s dimensions of distance suggested by 
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 Kress & van Leeuwen (2006, p. 125). The intimate distance only shows a body part of 
the figure, such as the face. A close personal distance shows a figure’s head and 
shoulders, whereas the far personal distance presents the 
figure from the waist up. A close social distance shows the 
whole figure but very little of his/her surroundings, where as a 
far social distance includes some of the surroundings as well. 
At a public distance the torso of at least four people can be 
seen in the image. (Kress & van Leeuwen, 2006, p. 125) 
 The appraisal theory was adopted into the study 
in order to analyse the feelings depicted in the images. The 
framework involves three semantic dimensions: affect, 
judgement and appreciation (White, 2008, pp. 8-11). Affect 
refers to emotions, such as happiness or sadness, judgement to 
evaluation of human behaviour, such as right or wrong, and 
appreciation to the evaluation of objects for their material 
characteristics. (White, 2008, pp. 8-11) The dimensions were 
further coded into either positive or negative based on the 
evaluation of the feeling. 
 
 
 
 
 
 
 
 
 
Image 13: An example of a public distance in an image 
(http://www.novartis.ch/citizenship/nachbarschaft-Basel.shtml) 
 
Table 13 shows the existence of the various dimensions in the images. Only 28.4 % of 
the original set of images were analysed according to the theory, as the other images 
Image 12: An example 
of a close social distance 
(http://www.pfizer.com/
about/) 
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 could not be reliably categorised under any of the three dimensions. As seen in Table 
13, the most common category of feeling depicted in the images was that of affect (74.0 
%), followed by appreciation (21.9 %). Only three images were seen to depict 
appreciation.  
As can be seen in the total column in Table 10, the vast majority of images 
portraying feelings were evaluated as positive (95.9 %).  All of the negative emotional 
appeals were categorised as affect. Next examples of each represented dimension of 
feeling will be discussed.  
 Most images 
that were coded into the 
category of positive affect 
contained images of healthy-
looking people smiling. In 
90.0 % of these images there 
were at least two figures in 
the image, which emphasized 
the feeling of friendship and 
belongingness. Image 14 is an 
example of positive affect 
portraying the closeness of a girl and her dog. 
 The images of negative affect all showed signs 
of illnesses. The categorisation was based on the sad and 
worried expressions that the figures have on their face. 
Contrary to the images of positive affect, which portrayed 
feelings that the viewers can aspire to, the negative affect 
images act as reinforcement to what should be avoided. This 
is clearly demonstrated in Image 15.  
 The images showing judgement included 
admirable actions by depicted figures. Whereas the 
categorisation for affect relied on facial expressions, the 
coding for judgement was dependent on the act. This is a 
result of its definition as the evaluation of right or wrong. In 
Image 14: An example of positive affect 
(http://www.novartis.com/products/animal-health.shtml) 
Image 15: An example of 
negative affect 
(http://en.sanofi.com/resp
onsibility/patient/atm/the
rap_fields/ntd/leishmania
sis/leishmaniasis.aspx) 
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 Image 16 judgement is portrayed as a volunteer 
feeds a person in need. Such a noble and 
unselfish act is perceived admirable, which leads 
to its categorisation as positive. It is worth 
noting, however, that the evaluation of feelings is 
culture dependant and therefore always 
represents the values of the evaluator. 
Finally, three images were coded under the 
dimension of positive appreciation. The general 
definition of appreciation is the evaluation of 
objects, texts, artefacts and other materials other 
than human behaviour. However, as White 
(2008, p. 11) notes there are cases, where human 
figures can also be “appreciated”. This takes 
place when the evaluation of the figure does not 
concern the correctness or incorrectness of their actions, like in the dimension of 
judgement, but on the evaluation of, for example, their appearance. This was the case in 
all three images that were coded as appreciation in this study. (White, 2008, p. 11) 
Image 17 presents an example, where the depicted figure 
can be appreciated for their beauty instead of their 
behaviour.  
 
4.2.1 Findings on the interpersonal metafunction by 
company 
 
Based on the analysis, the totals for high and low modality 
in the images were relatively close, as seen on Table 10, 
with high modality taking a 54.1 % share of the images 
and low modality 45.9 %. Yet again, there were 
differences between the case companies. Pfizer was the 
only company, who had more low than high modality  
Image 16: An example of positive 
judgement 
(http://www.novartis.com/corporate-
responsibility/responsible-business-
practices/community-
engagement/index.shtml) 
Image 17: An example of positive 
appreciation 
(http://www.orion.fi/Tutkimus-
ja-tuotekehitys/Vapaaehtoiseksi-
laaketutkimukseen/Tutkimuksest
a-maksettavat-korvaukset/) 67
 Table 10: Results on the interpersonal elements at the rank of work by company 
Modality Novartis Orion Pfizer Sanofi Total 
High 62 32 21 24 139 58.5% 62.7% 38.9% 52.2% 54.1% 
Low 44 19 33 22 118 41.5% 37.3% 61.1% 47.8% 45.9% 
Total 106 51 54 46 257 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Setting Novartis Orion Pfizer Sanofi Total 
Formal-pharmaceutical 26 30 18 21 95 24.5% 58.8% 33.3% 45.7% 37.0% 
Informal-
pharmaceutical 
0 4 0 2 6 
0.0% 7.8% 0.0% 4.3% 2.3% 
Formal-non-
pharmaceutical 
33 3 12 9 57 
31.1% 5.9% 22.2% 19.6% 22.2% 
Informal-non-
pharmaceutical 
47 14 24 14 99 
44.3% 27.5% 44.4% 30.4% 38.5% 
Total 106 51 54 46 257 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Social distance Novartis Orion Pfizer Sanofi Total 
Intimate 13 10 8 11 42 12.3% 19.6% 14.8% 23.9% 16.3% 
Close personal 21 4 6 15 46 19.8% 7.8% 11.1% 32.6% 17.9% 
Far personal 26 20 22 10 78 24.5% 39.2% 40.7% 21.7% 30.4% 
Close social 6 4 1 1 12 5.7% 7.8% 1.9% 2.2% 4.7% 
Far social 4 6 3 1 14 3.8% 11.8% 5.6% 2.2% 5.4% 
Public 36 7 14 8 65 34.0% 13.7% 25.9% 17.4% 25.3% 
Total 106 51 54 46 257 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Appraisal Novartis Orion Pfizer Sanofi Total 
Affect-positive 28 11 8 4 51 75,7% 68,8% 61,5% 57,1% 69,9% 
Affect-negative 0 0 0 3 3 0,0% 0,0% 0,0% 42,9% 4,1% 
Judgement-positive 9 2 5 0 16 24,3% 12,5% 38,5% 0,0% 21,9% 
Judgement-negative 0 0 0 0 0 0.0% 0.0% 0.0% 0.0% 0.0% 
Appreciation-positive 0 3 0 0 3 0,0% 18,8% 0,0% 0,0% 4,1% 
Judgement-negative 0 0 0 0 0 0.0% 0.0% 0.0% 0.0% 0.0% 
Total 37 16 13 7 73 100,0% 100,0% 100,0% 100,0% 100,0% 
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 images on their websites, with shares of 61.1 % and 38.9 % respectively. The different 
levels of regulation between the companies’ home markets may explain some of this 
difference. As explained in Section 2.1.1, the US market is one of the few in the world 
where direct-to-consumer (DTC) advertising of prescription-based drugs is allowed. 
Even though the communication towards consumers is still regulated by the Food and 
Drug Administration (FDA) that states that the adverts cannot be misleading or 
highlight the drug’s benefits at the expense of its risks, this difference in regulations still 
suggests a lower level of control compared to the tightly regulated EU and Swiss 
markets. The basis for this assumption is, however, challenged by the respective shares 
of high modality images of the Pfizer.com website and the Pfizer China website (42.2 % 
and 25.0 % respectively).   
 The analysis showed that an informal-non-pharmaceutical setting was the 
most common by a small margin before that of the formal-pharmaceutical. This implies 
that pharmaceutical companies do not limit their visual communications to the realms of 
their own operations, but beyond that to the lives of consumers in general. A significant 
notion in terms of the settings in images is the lack of informal-pharmaceutical images 
on the websites of the case companies. This group of settings gained just a 2.3 % share 
of all the narrative images.  
 Yet again, differences appear among the case companies in terms of the 
setting variable. Orion and Sanofi’s narrative images depicted remarkably more formal-
pharmaceutical settings compared to the other types of setting with shares of 58.8 % and 
45.7 % respectively. Novartis and Pfizer, however, favour the use of informal-non-
pharmaceutical settings with almost equal shares of 44.3 % and 44.4 % respectively. 
The most notable variation exists within formal-non-pharmaceutical settings that take 
up to 31.1 % of Novartis’ images but only 5.9 % of those of Orion’s.  
Based on the research findings, the trend in social distances in the 
pharmaceutical industry seems to be towards the closer distances, where a figure is 
shown from the waist up or even closer than that, and the public distance with several 
figures depicted. Kress and van Leeuwen (2006, p. 125) explain that the social distance 
depends on the social relation that the company wants the viewer to have with the image 
figures, and is therefore an imaginary one that does not represent an actual level of 
familiarity between the viewer and the figure. Furthermore, the distance determines how 
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 much is presented to the viewer and thus functions as a frame for the visual message 
(Kress & van Leeuwen, 2006, p. 125).  
 On the basis of the framework by Kress and van Leeuwen (2006), the case 
companies are mainly interested in building close bonds between the viewer and the 
figure in the images. The viewer is brought into the image as if s/he was an additional 
member in the action or a silent observer. S/he is given the opportunity to get 
acquainted with the figures. An example of an intimate setting can be seen in Image 9, 
whereas Image 10 presents an example of a close personal distance. A far personal 
distance is presented in Image 7 on page 64. This strategy can be seen as an attempt to 
increase the dimensions of trustworthiness and attractiveness of the source credibility 
framework, and accordingly make the viewer more receptive of the visual message. The 
close social and far social distances, which depict figures from a further distance, create 
a social relation between the figure and the viewer, which corresponds to that of two 
strangers that do not have the intention of becoming better acquainted with each other. 
An example of a close social distance can be seen in Image 12, whereas a far social 
distance is represented in Image 8. 
 In terms of the appraisal element, the positive affect was the most 
common option on the websites of all of the four companies. Positive judgement was 
also relatively commonly used but the most interesting differences came in the positive 
appreciation and negative affect elements. Orion was the only company to use positive 
appreciation in images. This was done by depicting a young beautiful girl in an informal 
setting. Perhaps the most significant difference was in the use of negative emotional 
appeals, which were all depicted by Sanofi. This was, however, somewhat diminished 
by the low share of negative appeals in the narrative images in total. 
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  Table 11: Results on the interpersonal elements at the rank of figure by company 
Gaze Novartis Orion Pfizer Sanofi Total 
Camera 1 5 1 6 13 0.5% 5.3% 1.1% 6.1% 2.7% 
Figure 68 42 30 32 172 34.0% 44.2% 33.7% 32.7% 35.7% 
Distance 73 16 17 27 133 36.5% 16.8% 19.1% 27.6% 27.6% 
Object 57 32 39 31 159 28.5% 33.7% 43.8% 31.6% 33.0% 
Eyes closed 1 0 2 2 5 0.5% 0.0% 2.2% 2.0% 1.0% 
Total 200 95 89 98 482 100.0% 100.0% 100.0% 100.0% 100.0% 
 
At the rank of figure the interpersonal function was analysed in terms of the gazes of the 
figures. The differences in terms of this element turned out to be smaller compared to 
many other elements analysed. Novartis favoured figures looking into the distance (36.5 
%) just over figures looking at each other (34.0 %). Orion preferred figures looking at 
each other (44.2 %) over those looking at an inanimate object in the image (33.7 %), 
whereas Pfizer also favoured the two but the opposite way with almost the same shares 
(33.7 % looking at a figure and 43.8 % looking at an object). The gazes in Sanofi’s 
images were divided relatively evenly according to figures, objects and the distance 
(32.7 %, 31.6 % and 27.6 % respectively). 
 
4.2.2 Findings on the interpersonal metafunction by website 
 
Table 12 shows the results in terms of the interpersonal function at the rank of work by 
website. Interestingly, high modality has the highest share of narrative images for the 
home country websites with the majority of images on the Chinese localised website 
being low modality. The global website is almost evenly divided between the two 
modalities.  
 In terms of the image setting, both global and home country websites 
show a tendency towards informal-non-pharmaceutical settings (41.2 % and 42.6 % 
respectively). The Chinese websites, however, strongly favour the formal-
pharmaceutical setting (54.5 %). This could be an indication that due to an unfamiliar 
market place and culture, pharmaceutical companies opt for images on their Chinese 
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 localised website, which are universally linked to healthcare and medicinal products. 
Further research would, however, be necessary to validate this assumption. 
 From the results it is evident that the companies use a larger range of 
social distances on their global and home country websites compared to their Chinese 
localised website. In fact, no narrative images featuring a close social or a far social 
distance were found on the Chinese websites. Whereas a far personal distance was 
preferred on the global and Chinese websites (35.3 % and 40.9 %), a third of all the 
images found on the home country websites depicted a public distance (33.8 %). This 
could support the assumption that the companies find it more important to communicate 
corporate citizenship on their home country websites compared to global or other 
localised websites, as the public distance can be used to communicate belongingness to 
a community. 
 As can be seen in Table 12, a wider range of appraisals was used in the 
global website compared to the localised websites. The most common appraisals for all 
three websites were in order of frequency positive affect and positive judgement. These 
were, in fact, the only appraisals used on the Chinese websites. The home country 
websites included a third appraisal in positive appreciation, whereas the global website 
utilised the aforementioned three with the addition of positive appreciation and negative 
affect. The use of appreciation in narrative images used to communicate to a global 
audience implies that the image content is believed to be universally considered as 
something that is ethical and admirable. As most of these images showed acts of 
kindness and unselfishness, it is possible that the visual message is interpreted the same 
way universally. This, however, would provide an interesting topic for future research. 
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 Table 12: Results on the interpersonal elements at the rank of work by website 
Modality Global Home country China Total 
High 76 86 20 182 49.7% 58.1% 45.5% 52.8% 
Low 77 62 24 163 50.3% 41.9% 54.5% 47.2% 
Total 153 148 44 345 100.0% 100.0% 100.0% 100.0% 
     
Setting Global Home country China Total 
Formal-pharmaceutical 61 42 24 127 39.9% 28.4% 54.5% 36.8% 
Informal-
pharmaceutical 
3 3 2 8 
2.0% 2.0% 4.5% 2.3% 
Formal-non-
pharmaceutical 
26 40 7 73 
17.0% 27.0% 15.9% 21.2% 
Informal-non-
pharmaceutical 
63 63 11 137 
41.2% 42.6% 25.0% 39.7% 
Total 153 148 44 345 100.0% 100.0% 100.0% 100.0% 
     
Social distance Global Home country China Total 
Intimate 25 20 12 57 16.3% 13.5% 27.3% 16.5% 
Close personal 26 21 8 55 17.0% 14.2% 18.2% 15.9% 
Far personal 54 36 18 108 35.3% 24.3% 40.9% 31.3% 
Close social 7 9 0 16 4.6% 6.1% 0.0% 4.6% 
Far social 11 12 0 23 7.2% 8.1% 0.0% 6.7% 
Public 30 50 6 86 19.6% 33.8% 13.6% 24.9% 
Total 153 148 44 345 100.0% 100.0% 100.0% 100.0% 
     
Appraisal Global Home country China Total 
Affect-positive 30 23 12 65 61.2% 79.3% 85.7% 70.7% 
Affect-negative 3 0 0 3 6.1% 0.0% 0.0% 3.3% 
Judgement-positive 13 5 2 20 26.5% 17.2% 14.3% 21.7% 
Judgement-negative 0 0 0 0 0.0% 0.0% 0.0% 0.0% 
Appreciation-positive 3 1 0 4 6.1% 3.4% 0.0% 4.3% 
Appreciation-negative 0 0 0 0 0.0% 0.0% 0.0% 0.0% 
Total 49 29 14 92 100.0% 100.0% 100.0% 100.0% 
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  Table 13: Results on the interpersonal elements at the rank of work by website 
Gaze Global Home country China Total 
Camera 11 6 1 18 3.7% 2.2% 1.4% 2.8% 
Figure 99 103 24 226 33.1% 38.4% 33.8% 35.4% 
Distance 74 72 18 164 24.7% 26.9% 25.4% 25.7% 
Object 110 85 28 223 36.8% 31.7% 39.4% 35.0% 
Eyes closed 5 2 0 7 1.7% 0.7% 0.0% 1.1% 
Total 299 268 71 638 100.0% 100.0% 100.0% 100.0% 
 
In terms of the gaze of the figures, as seen on Table 13, only minor differences could be 
found between the different websites. Whereas the home country websites favoured 
figures looking at each other, the global and Chinese localised websites included more 
figures looking at objects. These two gazes were, however, the two most popular ones 
on all three websites with looking into the distance as a clear third favourite gaze before 
the rest. 
 
4.2.3 Findings on the interpersonal metafunction by section 
 
The findings suggest that there is a link between modality of narrative images and the 
section where the image is placed. This link is represented in Table 14, which shows the 
modality of images by the sections analysed in the study. Most notably the 
Sustainability section has a share of 72.7 % of high modality images. As modality is 
derived from the perceived reality depicted in the image, it could be argued that it has a 
direct relationship on the credibility of a visual message. The strategy to use high 
modality images on a section, such as Sustainability, which often receives a high level 
of scrutiny, could therefore be advised. This would provide another fascinating topic for 
future research. 
A further finding visible in Table 14 is the high proportion of low 
modality images in the About us -section. This can be partially attributed to subsections 
concerning the history of the companies. Whether it be a deliberate choice or a 
necessity, based on the availability of historical images, the majority of images used to 
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 visualise the history of the companies are black-and-
white or they use otherwise distorted colours. It may be 
that those images originate from the time before colour 
film or that companies have chosen to use distorted 
colours as cues for a long history of operations. An 
example of a low modality image is provided in Image 
18, whereas Image 13 is an example of a high modality 
image. 
 In terms of the image settings there appears 
to be a clear division between the sections. The formal-
pharmaceutical setting was rationally favoured in the 
Research & Development – and Products & Services –
sections with shares of 60.0 % and 57.1 % respectively. This is understandable as these 
sections are used to communicate about the operations of the companies, which more 
often than not are executed in formal pharmaceutical working environments. The 
informal-non-pharmaceutical setting was preferred in the Sustainability-section (46.6 
%) as well as somewhat surprisingly in the About us –section (40.0 %). This setting is a 
logical choice for visual communication on sustainability as this often involves 
reflecting on the company’s operations and activities into the wider contexts of the local 
community and environment. However, the choice of this setting for the About us –
section presents a slight mismatch, as the section is often used to communicate about 
the history, strategy and values of companies. A multimodal research study would be in 
place to study whether the mismatch is evident between the textual and visual 
information in this section. The aforementioned settings were equally popular on the 
homepages of the websites. However, another interesting result is the use of formal-
non-pharmaceutical settings. Despite its lack of use in the other sections studied, it 
gained a relatively large share of the narrative images on the About us – and 
Sustainability-sections (28.0 % and 29.5 % respectively). This could be explained by 
different expected audiences for these sections, as they could be of particular interest to 
current and potential investors.  
As seen in Table 14, the shorter social distances are utilised in particular 
on the Products & Services- and Research & Development -sections on the websites, 
Image 18: An example of a low 
modality image 
(http://www.orion.fi/Orion/Hist
oria/1940--ja-1950-lukujen-
vaiheita/) 
75
 which generally are used to communicate about the operations and accomplishments of 
the company. By using a shorter social distance in these images the company presents 
itself as well as its work and products as approachable and easy to familiarize with. The 
homepages of the companies also favour the close personal and far personal distances, 
however the number of narrative images from this section is too low for any 
generalisations to be made based on it.   
 The public distance, however, seems to be used by the case companies as 
more of an invitation for the viewer. The image presents a narrative, in which the 
company is present either through a visual representation or through an implied 
reference, and it invites the viewer to join in. Perhaps for this reason public distances 
are the most used social distance on the About us- and Sustainability -sections of the 
websites. Both of these sections include narrative images that show the company’s 
commitment to its surrounding community, an example of which can be seen in Image 
13. 
 As seen in Table 14, the shares between the sections for appraisal are 
relatively similar. A clear exception is provided by the Research & Development –
section with its relatively low share of positive affect images (52.9 %) and relatively 
high share of positive judgement images (35.3 %). In fact, the only two sections with 
images depicting other than positive affect or positive judgement were Research & 
Development and Sustainability.  
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 Table 14: Results on the interpersonal elements at the rank of work by section 
Modality Homepage About us R&D Products & Services Sustainability Total 
High 7 29 26 13 64 139 43.8% 38.7% 52.0% 46.4% 72.7% 54.1% 
Low 9 46 24 15 24 118 56.3% 61.3% 48.0% 53.6% 27.3% 45.9% 
Total 16 75 50 28 88 257 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       Setting Homepage About us R&D Products & Services Sustainability Total 
Formal-
pharmaceutical 
6 23 30 16 20 95 
37.5% 30.7% 60.0% 57.1% 22.7% 37.0% 
Informal-
pharmaceutical 
1 1 1 2 1 6 
6.3% 1.3% 2.0% 7.1% 1.1% 2.3% 
Formal-non-
pharmaceutical 
3 21 6 1 26 57 
18.8% 28.0% 12.0% 3.6% 29.5% 22.2% 
Informal-non-
pharmaceutical 
6 30 13 9 41 99 
37.5% 40.0% 26.0% 32.1% 46.6% 38.5% 
Total 16 75 50 28 88 257 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       Social distance Homepage About us R&D Products & Services Sustainability Total 
Intimate 1 9 14 13 5 42 6.3% 12.0% 28.0% 46.4% 5.7% 16.3% 
Close personal 4 11 14 7 10 46 25.0% 14.7% 28.0% 25.0% 11.4% 17.9% 
Far personal 8 22 18 6 24 78 50.0% 29.3% 36.0% 21.4% 27.3% 30.4% 
Close social 0 4 0 1 7 12 0.0% 5.3% 0.0% 3.6% 8.0% 4.7% 
Far social 0 5 1 0 8 14 0.0% 6.7% 2.0% 0.0% 9.1% 5.4% 
Public 3 24 3 1 34 65 18.8% 32.0% 6.0% 3.6% 38.6% 25.3% 
Total 16 75 50 28 88 257 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       Appraisal Homepage About us R&D Products & Services Sustainability Total 
Affect-positive 6 12 9 7 17 51 75.0% 80.0% 52.9% 87.5% 68.0% 69.9% 
Affect-negative 0 0 0 0 3 3 0.0% 0.0% 0.0% 0.0% 12.0% 4.1% 
Judgement-
positive 
2 3 6 1 4 16 
25.0% 20.0% 35.3% 12.5% 16.0% 21.9% 
Judgement-
negative 
0 0 0 0 0 0 
0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Appreciation-
positive 
0 0 2 0 1 3 
0.0% 0.0% 11.8% 0.0% 4.0% 4.1% 
Appreciation-
negative 
0 0 0 0 0 0 
0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Total 8 15 17 8 25 73 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
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 In terms of gaze, there were logical patterns to be observed in the research 
results. Both the Research & Development- and Products & Services –sections showed 
a strong preference for the use of figures looking at inanimate objects (49.3 % and 46.5 
% respectively). A significant proportion of these showed people concentrating at their 
work either in a pharmaceutical setting or an office. The narrative images in the sections 
therefore act to communicate about the operations of the companies, even though a 
typical office setting would not necessarily be associated with a pharmaceutical 
company.  
 Whereas the Research & Development- and Products & Services –sections 
preferred the gaze at objects, the About us- and Sustainability-sections had the greatest 
share of figures looking at each other. This enhances the community spirit, which 
normally is communicated through these sections. On the homepage the gaze at an 
object and a figure had equal shares (34.5 % each). 
 
Table 15: Results on the interpersonal elements at the rank of figure by section 
Gaze Homepage About us R&D 
Products & 
Services Sustainability Total 
Camera 2 2 0 0 9 13 6,9% 1,7% 0,0% 0,0% 4,1% 2,7% 
Figure 10 45 21 13 83 172 34,5% 38,5% 28,0% 30,2% 38,1% 35,7% 
Distance 7 38 17 7 64 133 24,1% 32,5% 22,7% 16,3% 29,4% 27,6% 
Object 10 32 37 20 60 159 34,5% 27,4% 49,3% 46,5% 27,5% 33,0% 
Eyes closed 0 0 0 3 2 5 0,0% 0,0% 0,0% 7,0% 0,9% 1,0% 
Total 29 117 75 43 218 482 100,0% 100,0% 100,0% 100,0% 100,0% 100,0% 
 
 
4.2.4 Findings on the interpersonal metafunction by spokesperson group 
 
The findings on the interpersonal function by spokespersons are shown in Table 16. All 
spokesperson groups have higher proportions of high rather than low modality images. 
The consumer had the lowest share of high modality images, but even that was 59.0 %. 
 In terms of the image settings discrepancies were apparent. An informal-
non-pharmaceutical setting was preferred for consumers (67.5 %), whereas employees 
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 and experts were most commonly found in formal-pharmaceutical settings (76.3 % and 
92.1 % respectively). Business professionals, on the other hand, had a strong preference 
for formal-non-pharmaceutical settings (90.4 %). The image setting turned out to be a 
key determinant in categorising the figures into the spokesperson groups along with the 
clothing. 
 In terms of the social distance two key trends emerged. Firstly, business 
professionals were mostly depicted at a public distance (64.4 %), which in turn means 
that they will have been shown in groups of four or more figures in images. This will be 
verified when examining the results for the compositional function in Subsection 4.4.4. 
Secondly, employees and experts were in most cases shown at a far personal distance 
(41.9 % and 42.1 % respectively). The far personal distance refers to images where a 
figure can be seen from the waist up. Consumers were almost drawn between these two 
distances with 38.8 % of figures being depicted at a public distance and 30.6 % at a far 
personal distance.  
 Consumers (77.4 %), employees (85.7 %) and business professionals 
(100.0 %) were all strongly linked to positive affect for the appraisal dimension. Experts 
were drawn between positive affect and positive judgement (50.0 % each). The 
relatively high share of positive judgements among experts is reasonable, as doctors in 
particular are often perceived as heroes in many cultures. No generalisation should, 
however, be drawn the sample sizes being so low for this dimension.  
At the rank of figure, the interpersonal function by spokesperson group 
included the analysis of the gaze of the figures and the focal points. The gaze of the 
consumers spread most evenly along the five alternatives with distance (36.5 %) and 
other figure (36.2 %), however, taking the largest shares. Employees concentrated 
mostly on an inanimate object (62.5 %) as most of the narrative images with employees 
depicted a typical working situation in a pharmaceutical company, an example of which 
can be seen in Image 8. The experts only looked at one of two directions: at an 
inanimate object (58.8 %) or another figure (41.2 %). This is rational as the narrative 
images of experts commonly showed a doctor either talking to a patient or nursing a 
patient with a medical instrument. The biggest share of business professionals gazed at 
other figures (42.0 %), which corresponds to the negotiations often depicted in such 
images. 
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 Table 16: Results on the interpersonal elements at the rank of work by spokesperson 
group 
Modality Consumer Employee Expert Business professional Total 
High 158 62 24 70 314 59.0% 66.7% 63.2% 67.3% 62.4% 
Low 110 31 14 34 189 41.0% 33.3% 36.8% 32.7% 37.6% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      Setting Consumer Employee Expert Business professional Total 
Formal-
pharmaceutical 
31 71 35 1 138 
11.6% 76.3% 92.1% 1.0% 27.4% 
Informal-
pharmaceutical 
4 7 0 0 11 
1.5% 7.5% 0.0% 0.0% 2.2% 
Formal-non-
pharmaceutical 
52 13 3 94 162 
19.4% 14.0% 7.9% 90.4% 32.2% 
Informal-non-
pharmaceutical 
181 2 0 9 192 
67.5% 2.2% 0.0% 8.7% 38.2% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      Social distance Consumer Employee Expert Business professional Total 
Intimate 20 9 3 0 32 7.5% 9.7% 7.9% 0.0% 6.4% 
Close personal 37 11 9 17 74 13.8% 11.8% 23.7% 16.3% 14.7% 
Far personal 82 39 16 16 153 30.6% 41.9% 42.1% 15.4% 30.4% 
Close social 19 4 1 0 24 7.1% 4.3% 2.6% 0.0% 4.8% 
Far social 6 13 0 4 23 2.2% 14.0% 0.0% 3.8% 4.6% 
Public 104 17 9 67 197 38.8% 18.3% 23.7% 64.4% 39.2% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      Appraisal Consumer Employee Expert Business professional Total 
Affect-positive 96 6 6 20 128 77.4% 85.7% 50.0% 100.0% 78.5% 
Affect-negative 4 0 0 0 4 3.2% 0.0% 0.0% 0.0% 2.5% 
Judgement-
positive 
21 1 6 0 28 
16.9% 14.3% 50.0% 0.0% 17.2% 
Judgement-
negative 
0 0 0 0 0 
0.0% 0.0% 0.0% 0.0% 0.0% 
Appreciation-
positive 
3 0 0 0 3 
2.4% 0.0% 0.0% 0.0% 1.8% 
Appreciation-
negative 
0 0 0 0 0 
0.0% 0.0% 0.0% 0.0% 0.0% 
Total 124 7 12 20 163 100.0% 100.0% 100.0% 100.0% 100.0% 
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 Table 17: Results on the interpersonal elements at the rank of figure by spokesperson 
group 
Gaze Consumer Employee Expert 
Business 
professional Total 
Camera 10 2 0 1 13 3.8% 2.3% 0.0% 1.0% 2.7% 
Figure 94 22 14 42 172 36.2% 25.0% 41.2% 42.0% 35.7% 
Distance 95 9 0 29 133 36.5% 10.2% 0.0% 29.0% 27.6% 
Object 56 55 20 28 159 21.5% 62.5% 58.8% 28.0% 33.0% 
Eyes closed 5 0 0 0 5 1.9% 0.0% 0.0% 0.0% 1.0% 
Total 260 88 34 100 482 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Focal point Consumer Employee Expert 
Business 
professional Total 
Yes 98 55 21 39 213 36.6% 59.1% 55.3% 37.5% 42.3% 
No 170 38 17 65 290 63.4% 40.9% 44.7% 62.5% 57.7% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
 
A clear distinction interestingly formed in terms of which spokespersons 
acted as the focal points in the images. Employees and experts were the centre of the 
viewer’s attention the majority of the times (59.1 % and 55.3 % respectively), whereas 
both consumers and business professionals were more often not the focal points in the 
images with shares of 63.4 % and 62.5 % respectively. This is potentially a piece of 
evidence of the perceived importance of the different spokesperson groups to the 
pharmaceutical companies. The employees and experts are given central roles in the 
narrative images perhaps for their greater involvement with the pharmaceutical industry 
and the higher level of expertise that results from it.  
 
4.3 Findings on the representational metafunction 
 
At the rank of work, the analytical framework included the analysis of the content of the 
image. Only such images that included narrative themes were selected for the study as 
explained in Section 3.2 concerning the data collection. The findings that will be 
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 discussed in this section will therefore only include elements at the rank of figure. These 
elements include consideration on the figures in terms of their gender, age and 
spokesperson group, as well as their clothing and their role in the ongoing or unfolding 
action that the narrative theme presents.  
 
4.3.1 Findings on the representational metafunction by company 
 
The representational element of character proposed by O’Toole (1994) was broken 
down into three elements: gender, age and spokesperson. An interesting finding of the 
study in terms of gender was the relative preference towards male figures in the 
companies. Orion was the only one of the case companies to feature more narrative 
images of women in the images on their websites than men (55.7 % compared to 44.3 
%). The other companies had a majority of male figures in their images, the highest 
percentage being Sanofi’s 64.8 %. 
 In terms of age there were smaller discrepancies. All four companies had a 
significant majority of adult figures. There were, however, differences in shares of 
children and young adults in the narrative images. Whereas Sanofi had a share of 30.8 
% of children in their images, only 11.0 % of figures found in images on Novartis’ 
websites featured children. The opposite was true for young adults, however, as 
Novartis represented the highest share with 16.0 % and Sanofi the lowest with 5.8 % of 
figures in their images. 
 The low shares of elderly figures can be deemed as slightly surprising, as 
old age is often related to worsening health in communities. This may, however, reflect 
the lower levels of internet use among the elderly population. As Whittler and Spira 
(2002) found, people react more favourably towards advertising, which contains 
characters that they perceive are similar to them. Furthermore, pharmaceutical 
companies may not want their website visitors to be faced with visual messages about 
the inevitable fate of growing old and becoming weaker, but rather opt for messages 
emphasizing the process of happy and healthy aging. 
As discussed, four distinct spokesperson groups were found in the images 
collected from the websites of the case companies: consumers, employees, experts and 
business professionals. The group of consumers was very prominent in all four 
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 companies’ websites, so much so that it was the most popular group of visual 
spokespersons in three out of the four companies. On Sanofi’s websites 71.0 % of all 
figures were consumers, a share that was unmatched by the other companies. Orion was 
the only company that preferred the use of employees as visual spokespersons, although 
with a very small margin to consumers (41.7 % and 39.8 % respectively), as can be seen 
in Table 18.  
The use of business professionals in images was not consistent among the 
case companies. Whereas on the Novartis and Pfizer websites the group was the second 
most popular with shares of 29.5 % and 29.0 % of the images respectively, business 
professionals were used to a much lesser extent on the Orion and Sanofi websites with 
shares of 10.7 % and 6.5 % respectively.  
What could be deemed as a surprise is the low percentage of expert 
spokespersons found in the narrative images.  Despite it being the second most popular 
group on Sanofi’s websites it only achieved a share of 7.6 % of all figures in the images. 
An expert visual spokesperson was defined in the context of the pharmaceutical industry 
as doctors and pharmacists, who could also be argued to fill the role of front-office 
employees for pharmaceutical companies as the company staff itself has limited and 
restricted opportunities for interaction with the end-users. For the close interaction with 
the consumers one could argue that the use of doctors and pharmacists in the images on 
pharmaceutical companies websites would enhance the credibility of the visual 
messages and thus enable the source credibility effect to take place. Further research 
would, however, be in order to prove this argument. 
 The clothing component reflected the proportions of different types of 
visual spokespersons in the images for the case companies. For example, the high share 
of work clothing found in Orion’s images is directly related to the high share of 
employee spokespersons in them. As the clothing was an integral part of the coding to 
the spokesperson groups, its discussion is more meaningful in that context in Subsection 
4.3.4. 
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 Table 18: Results on the representational elements at the rank of figure by company 
Gender Novartis Orion Pfizer Sanofi Total 
Female 79 54 35 32 200 39.5% 55.7% 42.2% 35.2% 42.5% 
Male 121 43 48 59 271 60.5% 44.3% 57.8% 64.8% 57.5% 
Total 200 97 83 91 471 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Age Novartis Orion Pfizer Sanofi Total 
Child 22 21 19 32 94 11.0% 20.6% 20.4% 30.8% 18.8% 
Young adult 32 9 11 6 58 16.0% 8.8% 11.8% 5.8% 11.6% 
Adult 136 68 61 63 328 68.0% 66.7% 65.6% 60.6% 65.7% 
Elderly 10 4 2 3 19 5.0% 3.9% 2.2% 2.9% 3.8% 
Total 200 102 93 104 499 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Spokesperson Novartis Orion Pfizer Sanofi Total 
Consumer 111 41 40 76 268 55.5% 39.8% 43.0% 71.0% 53.3% 
Employee 21 43 19 10 93 10.5% 41.7% 20.4% 9.3% 18.5% 
Expert 9 8 7 14 38 4.5% 7.8% 7.5% 13.1% 7.6% 
Business 
professional 
59 11 27 7 104 
29.5% 10.7% 29.0% 6.5% 20.7% 
Total 200 103 93 107 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Clothing Novartis Orion Pfizer Sanofi Total 
Casual 76 41 30 68 215 38.0% 40.2% 32.3% 63.6% 42.8% 
Smart 85 12 31 11 139 42.5% 11.8% 33.3% 10.3% 27.7% 
Work 22 49 23 22 116 11.0% 48.0% 24.7% 20.6% 23.1% 
Not in picture 17 0 9 5 31 8.5% 0.0% 9.7% 4.7% 6.2% 
No clothes 0 0 0 1 1 0.0% 0.0% 0.0% 0.9% 0.2% 
Total 200 102 93 107 502 100.0% 100.0% 100.0% 100.0% 100.0% 
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 4.3.2 Findings on the representational metafunction by website 
 
In terms of the global and localised websites, male figures were preferred in all websites 
studied. Whereas the global and home country websites showed similar shares of male 
figures (54.4 % and 55.1 % respectively), the Chinese localised websites had a share as 
high as 73.8 % of male figures. This implies that there is an extent of localisation of 
visual messages at least in terms of the figures in the narrative images. 
On all the websites, adults are the most prominent age group. The Chinese 
website shows the greatest preference for adult figures with a share of 73.3 % compared 
to 62.8 % on the global websites and 65.0 % on the home country websites. The second 
most prominent age group for all websites is children, although with significantly lower 
shares. The global websites feature a greater share of child figures compared to the 
other websites with a share of 24.4 %. The home country website features 16.6 % of 
child figures whereas the Chinese website 16.0 %. There are some discrepancies in 
terms of the use of young adults in images as well. For home country websites young 
adults gained a share of 14.8 % but the global websites only had a share of 9.0 % and 
the Chinese websites 6.7 %. The use of elderly figures was relatively similar across the 
different websites.  
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 Table 19: Results on the representational elements at the rank of figure by website 
 
Gender Global Home country China Total 
Female 136 118 17 271 45.6% 44.9% 26.2% 43.3% 
Male 162 145 48 355 54.4% 55.1% 73.8% 56.7% 
Total 298 263 65 626 100.0% 100.0% 100.0% 100.0% 
     
Age Global Home country China Total 
Child 76 46 12 134 24.4% 16.6% 16.0% 20.2% 
Young adult 28 41 5 74 9.0% 14.8% 6.7% 11.1% 
Adult 196 180 55 431 62.8% 65.0% 73.3% 64.9% 
Elderly 12 10 3 25 3.8% 3.6% 4.0% 3.8% 
Total 312 277 75 664 100.0% 100.0% 100.0% 100.0% 
     
Spokesperson Global Home country China Total 
Consumer 169 138 31 338 54.0% 49.8% 39.7% 50.6% 
Employee 62 52 23 137 19.8% 18.8% 29.5% 20.5% 
Expert 26 11 9 46 8.3% 4.0% 11.5% 6.9% 
Business 
professional 
56 76 15 147 
17.9% 27.4% 19.2% 22.0% 
Total 313 277 78 668 100.0% 100.0% 100.0% 100.0% 
     
Clothing Global Home country China Total 
Casual 151 99 23 273 48.4% 35.9% 29.5% 41.0% 
Smart 65 99 21 185 20.8% 35.9% 26.9% 27.8% 
Work 78 58 29 165 25.0% 21.0% 37.2% 24.8% 
Not in picture 17 20 5 42 5.4% 7.2% 6.4% 6.3% 
No clothes 1 0 0 1 0.3% 0.0% 0.0% 0.2% 
Total 312 276 78 666 100.0% 100.0% 100.0% 100.0% 
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 All three websites favoured the use of consumers in the narrative images, 
although to varying extents. Global websites had the highest share of consumers with 
54.0 % just surpassing home country websites with 49.8 % but the Chinese websites 
featured a much lower share of 39.7 % of consumers. The Chinese websites, however, 
featured a much greater proportion of employees in figures compared to the other 
websites. Employees were depicted in 29.5 % of figures on the Chinese websites 
compared to 19.8 % on the global and 18.8 % on the home country websites. The use of 
experts was also the most prominent on the Chinese websites (11.5 %), whereas 
business professionals gained the highest share on the home country websites (27.4 %). 
Again, the clothing component matched the shares of the different spokesperson groups. 
 
4.3.3 Findings on the representational metafunction by section 
 
Examining the results by section on Table 20 an interesting discrepancy is visible in 
terms of the gender of the figures. Only the Products & Services –section has a majority 
of female figures, although the Research & Development –section features equal shares 
of both genders. The biggest difference between the genders is found on the homepages 
of the websites, where 66.7 % of figures are male.  
 In terms of the age of the figures, adults are prominently featured in all 
sections. Interestingly, however, the Sustainability-section seems to also show a slight 
tendency towards younger figures with children gaining a share of 23.6 % and young 
adults a share of 16.4 % of figures in this section. The Products & Services –section, 
however, has the highest share of child figures (25.0 %) as well as elderly figures (6.8 
%). Interestingly, no elderly figures were presented on the homepages of the websites. 
 Consumers were the most prominent group of visual spokespersons in all 
of the sections examined. The highest shares were found on the homepages (62.5 %) 
and the Sustainability-section (63.6 %). Of the figures found on the Products & Services 
–section 50.0 % were consumers. The other two sections, however, remained below the 
50 percent mark (About us with 42.1 % and Research & Development 39.2 %). 
Employees were mostly found on the Research & Development -section (30.4 %) and 
on the homepages (28.1 %), whereas experts were preferred on the Products & Services 
– (21.7 %) and Research & Development –sections (15.2 %). The most business 
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 professionals were present in the About us – (34.7 %) and Sustainability-sections 
(20.4%). Yet again, the clothing components reflected on the shares of the different 
spokesperson groups.  
 
Table 20: Results on the representational elements at the rank of figure by section 
Gender Homepage About us R&D Products & Services Sustainability Total 
Female 9 44 36 17 94 200 33.3% 37.3% 50.0% 54.8% 42.2% 42.5% 
Male 18 74 36 14 129 271 66.7% 62.7% 50.0% 45.2% 57.8% 57.5% 
Total 27 118 72 31 223 471 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       
Age Homepage About us R&D Products & Services Sustainability Total 
Child 7 17 6 11 53 94 22.6% 14.0% 7.7% 25.0% 23.6% 18.8% 
Young adult 3 6 9 3 37 58 9.7% 5.0% 11.5% 6.8% 16.4% 11.6% 
Adult 21 96 60 27 124 328 67.7% 79.3% 76.9% 61.4% 55.1% 65.7% 
Elderly 0 2 3 3 11 19 0.0% 1.7% 3.8% 6.8% 4.9% 3.8% 
Total 31 121 78 44 225 499 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       
Spokesperson Homepage About us R&D Products & Services Sustainability Total 
Consumer 20 51 31 23 143 268 62.5% 42.1% 39.2% 50.0% 63.6% 53.3% 
Employee 9 21 24 10 29 93 28.1% 17.4% 30.4% 21.7% 12.9% 18.5% 
Expert 2 7 12 10 7 38 6.3% 5.8% 15.2% 21.7% 3.1% 7.6% 
Business 
professional 
1 42 12 3 46 104 
3.1% 34.7% 15.2% 6.5% 20.4% 20.7% 
Total 32 121 79 46 225 503 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       
Clothing Homepage About us R&D Products & Services Sustainability Total 
Casual 17 39 27 15 117 215 53.1% 32.2% 34.6% 32.6% 52.0% 42.8% 
Smart 4 47 15 4 69 139 12.5% 38.8% 19.2% 8.7% 30.7% 27.7% 
Work 11 24 30 19 32 116 34.4% 19.8% 38.5% 41.3% 14.2% 23.1% 
Not in picture 0 11 6 8 6 31 0.0% 9.1% 7.7% 17.4% 2.7% 6.2% 
No clothes 0 0 0 0 1 1 0.0% 0.0% 0.0% 0.0% 0.4% 0.2% 
Total 32 121 78 46 225 502 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
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 4.3.4 Findings on the representational metafunction by spokesperson group 
 
As presented by Table 21, which contains the results on the representational function by 
spokesperson, the majority of all spokespersons were depicted by male figures. Whereas 
the other spokespersons were within 4 percentage points of each other (between 54.9 % 
and 58.6 %), business professionals had as large a share as 65.4 % of male figures. 
 The age groups showed logical discrepancies between the spokespersons. 
Adults were the most prominent group for all spokespersons. It was also the larger of 
only two age categories for employees, experts and business professionals, the other 
being young adults. This makes sense, as to qualify for these titles in reality requires an 
extensive amount of training and education. Interestingly though, only 2.6 % of expert 
figures were young adults, which implies that the case companies rely on the 
assumption that expertise is something that is gained through life experience. No elderly 
figures were depicted as members of these spokesperson groups due to the retirement 
age. Having said that an elderly expert figure could have been visually represented 
through cues other than those related to profession, a stereotypical example of which 
could be the elderly mentor often present in representations of the Asian cultures.  
 The clothing became an important signifier of the different spokesperson 
groups. Although some exceptions were found, the majority of consumers were 
depicted in casual clothes (77.9 %), whereas employees (87.1 %) and experts (92.1 %) 
wore work clothes, and business professionals smart business clothes (98.1 %). The 
greatest variation could be found among the consumers and the employees. Of the 
consumers 12.0 % were found to wear smart clothes, whereas for 9.7 % of the figures 
the image was framed so that no clothes could be seen. Furthermore, one figure was 
also presented with no clothes at all. Of the employees 6.5 % were presented with 
casual clothing and 4.3 % with smart clothes. These figures were identified as 
employees through other elements than clothing, such as the image setting or the 
presence of the company logo. 
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 Table 21: Results on the representational elements at the rank of figure by spokesperson 
group 
Gender Consumer Employee Expert 
Business 
professional Total 
Female 116 36 12 36 200 45.1% 44.4% 41.4% 34.6% 42.5% 
Male 141 45 17 68 271 54.9% 55.6% 58.6% 65.4% 57.5% 
Total 257 81 29 104 471 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Age Consumer Employee Expert 
Business 
professional Total 
Child 94 0 0 0 94 35.1% 0.0% 0.0% 0.0% 18.8% 
Young adult 26 14 1 17 58 9.7% 15.7% 2.6% 16.3% 11.6% 
Adult 129 75 37 87 328 48.1% 84.3% 97.4% 83.7% 65.7% 
Elderly 19 0 0 0 19 7.1% 0.0% 0.0% 0.0% 3.8% 
Total 268 89 38 104 499 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Clothing Consumer Employee Expert 
Business 
professional Total 
Casual 208 6 1 0 215 77.9% 6.5% 2.6% 0.0% 42.8% 
Smart 32 4 1 102 139 12.0% 4.3% 2.6% 98.1% 27.7% 
Work 0 81 35 0 116 0.0% 87.1% 92.1% 0.0% 23.1% 
Not in picture 26 2 1 2 31 9.7% 2.2% 2.6% 1.9% 6.2% 
No clothes 1 0 0 0 1 0.4% 0.0% 0.0% 0.0% 0.2% 
Total 267 93 38 104 502 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Role in the action Consumer Employee Expert 
Business 
professional Total 
Actor 73 63 28 33 197 42.7% 84.0% 87.5% 53.2% 57.9% 
Goal 98 12 4 29 143 57.3% 16.0% 12.5% 46.8% 42.1% 
Total 171 75 32 62 340 100.0% 100.0% 100.0% 100.0% 100.0% 
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 The narrative themes depicted in the images more often than not had one actor and at 
least one goal. Some images were, however, also found, which included more than one 
actor or no figures as the goals of the actions. In the latter cases, the narrative image 
depicted an actor operating a machine or handling an inanimate object. An interesting 
finding shown in Table 21 is that consumers were mostly depicted as goals of actions 
(57.3 %) rather than as actors themselves (42.7 %). The other figures, however, were 
more often actors. The difference was especially significant among employees and 
experts, who in 84.0 % and 87.5 % of the cases respectively were the actors of the 
narratives. This may be used to communicate about the active role that employees and 
experts have in healthcare. However, as noted by Blackett and Harrison (2001) 
consumers have also actively regained power for their own healthcare decision-making, 
which, however, is not represented in the set of images studied. 
 
 
4.4 Findings on the compositional metafunction 
 
Through the compositional function, the study aimed to gain knowledge on how the 
structural choices made by the pharmaceutical companies when selecting the narrative 
images for their websites influence the message sent to the website visitors. This 
mission was embarked on through four visual elements. Firstly, at the rank of work the 
positioning of the image on a web page was coded in terms of top, middle and bottom 
depending on the relation of the image and other content on the web page. Top referred 
to banners on top of the page above the actual content of the page. Middle signified 
images that were in the middle of the page among the content. This often meant that the 
image was surrounded by textual information. The bottom of the page referred to 
images that have no content below the picture. Secondly, the number of figures in the 
images was coded. Discrepancies in terms of the total numbers were found, as some 
images did not include figures but only parts of them, members. Thirdly, at the rank of 
figure the positioning of figures within the image was analysed and coded into left, 
centre and right. Finally, the alignment of figures to the vertical axis or a diagonal axis 
was noted. 
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 4.4.1 Findings on the compositional metafunction by company 
 
As can be seen in Table 22, the most popular positioning for a narrative image was in 
the midst of other content on the website with a combined share of 53.7 % of all the 
images analysed in this study. The top of the page is also a popular position with a share 
of 37.7 %. The difference between the two positions may be explained by the potential 
for visual content in them. Whereas the middle part of a web page can be organised in 
various ways, the top part is often restricted by the site hierarchy. All of the narrative 
images placed on top of the page were banners, and although in many cases they 
included several different images that changed as a slide show, the coherence and 
design of the web page would have suffered if their number had been too great. 
 The greatest notable discrepancy within the positioning of the images is 
Orion, whose shares of the different positions are not as divided as the other 
companies’. Furthermore, Orion’s websites had the most images as the top banners of 
the web pages, whereas the other companies favoured the middle of the page. This 
would imply that images are placed along the commonly accepted F-shaped website 
viewing pattern that indicates that website visitors scan the top, middle and left-hand 
side of the page (Shrestha & Owens, 2008). The F-shaped pattern has, however, been 
established on websites with textual content, for which reason its applicability into 
viewing multimodal websites including several semiotic resources is not guaranteed. 
Awareness of images on websites has been widely researched in the context of 
advertising, where Drèze and Hussherr (2003) found out that only 50 % of website 
visitors consciously look at banner adverts on top of a web page. The researchers 
suggest that website visitors deliberately avoid looking at banner adverts (2003, p. 8). 
There is, however, no previous research on the relationship between online 
advertisements and visual communication through images online, and consequently 
these results cannot be accepted into the field of visual communication without further 
research.  
 On top of a trend towards short social distances, the companies show a 
tendency towards the use of fewer figures in the narrative images. A total of 61.5 % of 
the analysed images included either one or two figures in them. In accordance with the 
popularity of the public distance, the use of four and five or more figures in images also 
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 gained notable combined share. Not all the images containing four figures were, 
however, depicting a public distance. This is because they did not fill the requirement of 
far personal distance or further. 15 of the images analysed contained just a member of a 
figure, which explains the discrepancy in the total cell of the table. 
 
 Table 22: Results on the compositional elements at the rank of work by company 
Positioning  Novartis Orion Pfizer Sanofi Total 
Top 36 22 23 16 97 34.0% 43.1% 42.6% 34.8% 37.7% 
Middle 65 17 28 28 138 61.3% 33.3% 51.9% 60.9% 53.7% 
Bottom 5 12 3 2 22 4.7% 23.5% 5.6% 4.3% 8.6% 
Total 106 51 54 46 257 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Number of 
figures Novartis Orion Pfizer Sanofi Total 
1.00 26 17 16 19 78 26.0% 37.0% 31.4% 42.2% 32.2% 
2.00 28 15 16 12 71 28.0% 32.6% 31.4% 26.7% 29.3% 
3.00 8 6 7 2 23 8.0% 13.0% 13.7% 4.4% 9.5% 
4.00 6 4 4 2 16 6.0% 8.7% 7.8% 4.4% 6.6% 
5 or more 32 4 8 10 54 32.0% 8.7% 15.7% 22.2% 22.3% 
Total 100 46 51 45 242 100.0% 100.0% 100.0% 100.0% 100.0% 
 
The division of figures within the narrative images was fairly even in all 
companies, as seen in Table 23, with Novartis and Sanofi having similar shares for each 
position, and Orion and Pfizer favouring the centre of the image just over the left- and 
right-hand sides. 
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 Table 23: Results on the compositional elements at the rank of figure by company 
Positioning of 
figures Novartis Orion Pfizer Sanofi Total 
Left 69 22 27 39 157 34.5% 21.4% 29.0% 36.4% 31.2% 
Centre 68 51 39 38 196 34.0% 49.5% 41.9% 35.5% 39.0% 
Right 63 30 27 30 150 31.5% 29.1% 29.0% 28.0% 29.8% 
Total 200 103 93 107 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Alignment Novartis Orion Pfizer Sanofi Total 
Straight 145 83 57 64 349 72.5% 80.6% 61.3% 61.5% 69.8% 
Diagonally 55 20 36 40 151 27.5% 19.4% 38.7% 38.5% 30.2% 
Total 200 103 93 104 500 100.0% 100.0% 100.0% 100.0% 100.0% 
 
All companies preferred to align figures to the vertical axis on the 
narrative images portraying them as standing or sitting straight. The difference was not 
as great with Pfizer and Sanofi, as the companies used figures aligned to a diagonal axis 
in 38.7 % and 38.5 % of the figures respectively. 
 
4.4.2 Findings on the compositional metafunction by website 
 
Looking at the results by website, as presented in Table 24, slight differences are 
visible. Whereas the home country and Chinese localised websites follow along the 
same lines with differences of only up to four percentage points, the global websites 
show greater variation in the positioning of narrative images. The most common 
position used on the global website is the top of the page (47.1 %), whereas the home 
country and Chinese website favour the middle (59.5 % and 59.1 % respectively). The 
global websites also utilise the bottom of the page for visual messages more than the 
other two types of websites examined, however the differences are far smaller in this 
case. One might have expected there to be differences between the Chinese website and 
the other two types of websites considering the different reading paths in Western and 
Chinese cultures. This was, however, not supported by the results, which could imply 
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 that there are little or no differences between the reading paths online, or that these are 
not considered in the process of visual communication on websites.   
 The results on the number of figures in narrative images showed 
resemblance to the results on social distance. The closer social distances were preferred 
on the global and Chinese localised websites, which on Table 24 translate to a 
preference of less figures in images. In fact, the Chinese websites has as high percentage 
as 50.0 % of figures in the images on their own. On the global websites the most 
common number of figures in an image is two (35.0 %) followed by one (30.0 %). On 
the home country websites, however, equal shares of 27.9 % were gained by both one 
figure and five or more figures in images. Furthermore, two figures in an image gained 
only a slightly lower share of 27.1 %. 
 
 Table 24: Results on the compositional elements at the rank of work by website 
Positioning Global Home country China Total 
Top 72 48 16 136 47.1% 32.4% 36.4% 39.4% 
Middle 64 88 26 178 41.8% 59.5% 59.1% 51.6% 
Bottom 17 12 2 31 11.1% 8.1% 4.5% 9.0% 
Total 153 148 44 345 100.0% 100.0% 100.0% 100.0% 
     
Number of 
figures Global Home country China Total 
1.00 42 39 21 102 30.0% 27.9% 50.0% 31.7% 
2.00 49 38 9 96 35.0% 27.1% 21.4% 29.8% 
3.00 16 14 6 36 11.4% 10.0% 14.3% 11.2% 
4.00 10 10 2 22 7.1% 7.1% 4.8% 6.8% 
5 or more 23 39 4 66 16.4% 27.9% 9.5% 20.5% 
Total 140 140 42 322 100.0% 100.0% 100.0% 100.0% 
 
Only small differences were evident in the positioning of figures in narrative images 
between the different websites, as shown by Table 25. All websites preferred the centre 
of an image for figures with the left- and right-hand side gaining almost equal shares on 
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 each website type. The Chinese localised website, however, showed a more significant 
tendency towards the centre of the image with a share of 44.9 % compared to that of 
38.7 % on the global websites and 38.6 % on the home country ones.  
 On all websites the aligning of figures to the vertical axis was preferred to 
that of an alignment to a diagonal axis. Minor differences were visible but all websites 
still remained within five percentage points of each other.  
 
 Table 25: Results on the compositional elements at the rank of figure by website 
Positioning of 
figures Global Home country China Total 
Left 96 87 21 204 30.7% 31.4% 26.9% 30.5% 
Centre 121 107 35 263 38.7% 38.6% 44.9% 39.4% 
Right 96 83 22 201 30.7% 30.0% 28.2% 30.1% 
Total 313 277 78 668 100.0% 100.0% 100.0% 100.0% 
     
Alignment Global Home country China Total 
Straight 220 197 50 467 70.3% 71.1% 66.7% 70.2% 
Diagonally 93 80 25 198 29.7% 28.9% 33.3% 29.8% 
Total 313 277 75 665 100.0% 100.0% 100.0% 100.0% 
 
 
4.4.3 Findings on the compositional metafunction by section 
 
Looking at the compositional findings by section on Table 26 clear discrepancies are 
visible in terms of the positioning of images on web pages. On the homepages, the 
images were most often place at the top of the page as banners (87.5 %) with no 
narrative images having been placed below other content at the bottom of the page. On 
the About us- and Sustainability-sections the middle part of the page was preferred for 
narrative images. The Products & Services- and especially the Research & Development 
–sections showed greater variance in the placing of the images. Both sections still 
exhibited a preference towards the top of the page (46.0 % and 50.0 % respectively) but 
with a much smaller margin to the second most favoured position, the middle, compared 
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 to the other sections (34.0 % and 42.9 % respectively). Furthermore, 20.0 % of images 
on the Research & Development –section were placed below other content at the bottom 
of the page.  
 There were clear patterns visible in terms of the numbers of figures in the 
images as shown in Table 26. The homepages and Products & Services -section mostly 
showed just one figure in a narrative image (46.7 % and 53.8 % respectively). The 
Research & Development –section also had a prominent share of lone figures (51.1 %), 
although the use of two figures was also not uncommon (35.6 %). On the About us –
section three compilations were more popular than the rest: one (26.8 %), two (31.0 %) 
and five or more figures (25.4 %). The Sustainability-section included mostly images of 
five or more figures (35.3 %) or ones with two figures (30.6 %).  
 
 Table 26: Results on the compositional elements at the rank of work by section 
Positioning Homepage About us R&D 
Products & 
Services Sustainability Total 
Top 14 17 23 14 29 97 87.5% 22.7% 46.0% 50.0% 33.0% 37.7% 
Middle 2 54 17 12 53 138 12.5% 72.0% 34.0% 42.9% 60.2% 53.7% 
Bottom 0 4 10 2 6 22 0.0% 5.3% 20.0% 7.1% 6.8% 8.6% 
Total 16 75 50 28 88 257 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       
Number of 
figures Homepage About us R&D 
Products & 
Services Sustainability Total 
1.00 7 19 23 14 15 78 46.7% 26.8% 51.1% 53.8% 17.6% 32.2% 
2.00 2 22 16 5 26 71 13.3% 31.0% 35.6% 19.2% 30.6% 29.3% 
3.00 2 6 3 5 7 23 13.3% 8.5% 6.7% 19.2% 8.2% 9.5% 
4.00 2 6 0 1 7 16 13.3% 8.5% 0.0% 3.8% 8.2% 6.6% 
5 or more 2 18 3 1 30 54 13.3% 25.4% 6.7% 3.8% 35.3% 22.3% 
Total 15 71 45 26 85 242 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
 
 
At the rank of figure the results of the compositional function show that most of the 
sections preferred the placing of figures at the centre of images. One exception to this 
97
 rule, however, as seen in Table 27, is the Research & Development –section, which 
shows a very slight tendency towards figures on the right-hand side of images (38.0 % 
compared to 36.7 % at the centre).  As the Research & Development operations in a 
company aim at developing new innovative solutions and products, the placing of 
figures on the right-hand side of images can be seen as communicating this message 
visually. As discussed in Section 2.5 as well as noted by Hopearuoho and Ventola 
(2009, p. 188) and Kress and van Leeuwen (2006, p. 181) the right-hand side is 
comparable to a rheme in a clause: it presents something new that was not known 
beforehand.  
 The analysis of the alignment of figures to axes also produced an 
interesting result, as seen in Table 27. Whereas the majority of figures in all the sections 
studied were aligned to the vertical axis, the homepages of the websites featured a 
greater proportion of figures that were diagonally in the image. This suggests that the 
companies want to bring dynamism and energy into the homepages through visual 
means, perhaps to make it more inviting and fun. 
 
Table 27: Results on the compositional elements at the rank of figure by section 
Positioning of 
figures Homepage About us R&D 
Products & 
Services Sustainability Total 
Left 10 39 20 15 73 157 31.3% 32.2% 25.3% 32.6% 32.4% 31.2% 
Centre 15 43 29 16 93 196 46.9% 35.5% 36.7% 34.8% 41.3% 39.0% 
Right 7 39 30 15 59 150 21.9% 32.2% 38.0% 32.6% 26.2% 29.8% 
Total 32 121 79 46 225 503 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
       
Alignment Homepage About us R&D 
Products & 
Services Sustainability Total 
Straight 19 81 55 31 163 349 59.4% 66.9% 69.6% 72.1% 72.4% 69.8% 
Diagonally 13 40 24 12 62 151 40.6% 33.1% 30.4% 27.9% 27.6% 30.2% 
Total 32 121 79 43 225 500 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
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 4.4.4 Findings on the compositional metafunction by spokesperson group 
 
As seen in Table 28 presenting the results on the compositional function by 
spokesperson, the majority of figures were placed in the middle of the web page. An 
exception to this is the group of experts, which were more commonly placed at the top 
banner (47.4 %) although by a small margin to the middle of the page (42.1 %). 
Relating this back to research by Kress and van Leeuwen (2006) discussed in 
Subsection 2.5.3 it would seem that companies consider narrative images with experts 
in them less subservient to text compared to images with other spokespersons. The 
informational value of images containing experts would therefore be considered higher 
compared to that of images containing other spokespersons. More research should, 
however, be conducted to prove this assumption in a larger context. 
 Table 28 also shows the results of the analysis in terms of how many 
figures were presented in narrative images by spokesperson groups. Some trends are 
visible from the results. First of all, employees tend to be depicted in images either by 
themselves (37.6 %) or with one other figure (25.8 %). Consumers and business 
professionals, however, are rarely depicted by themselves but are mostly in groups of 
five or more figures (40.4 % and 39.4 % respectively). Experts, on the other hand, seem 
to provide a compromise between the other spokespersons. The biggest share of experts 
are shown in images with one other figure (36.8 %) followed by a group of 5 or more 
figures (23.7 %) and no other figures at all (21.1 %). 
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 Table 28: Results on the compositional elements at the rank of work by 
spokesperson group 
Positioning Consumer Employee Expert 
Business 
professional Total 
Top 112 38 18 29 197 41.8% 40.9% 47.4% 27.9% 39.2% 
Middle 136 47 16 71 270 50.7% 50.5% 42.1% 68.3% 53.7% 
Bottom 20 8 4 4 36 7.5% 8.6% 10.5% 3.8% 7.2% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Number of 
figures Consumer Employee Expert 
Business 
professional Total 
1.00 21 35 8 9 73 7.9% 37.6% 21.1% 8.7% 14.5% 
2.00 83 24 14 15 136 31.1% 25.8% 36.8% 14.4% 27.1% 
3.00 34 14 6 9 63 12.7% 15.1% 15.8% 8.7% 12.5% 
4.00 21 8 1 30 60 7.9% 8.6% 2.6% 28.8% 12.0% 
5 or more 108 12 9 41 170 40.4% 12.9% 23.7% 39.4% 33.9% 
Total 267 93 38 104 502 100.0% 100.0% 100.0% 100.0% 100.0% 
 
Examining the results on the compositional function at the rank of figure shown in 
Table 29 there is no clear evidence of the theme and rheme in terms of the spokesperson 
groups. No major discrepancies arose through the analysis, which implies that all the 
spokespersons are considered as either familiar or unfamiliar to the viewer depending 
on the image. 
 In terms of the alignment of figures it is clear that all spokespersons are 
aligned to the vertical axis in the majority of cases. This suggests that the case 
companies want to rather depict visual spokespersons as stable and calm than as 
energetic and dynamic.  
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 Table 29: Results on the compositional elements at the rank of figure by 
spokesperson group 
Positioning of 
the figures Consumer Employee Expert 
Business 
professional Total 
Left 86 25 13 33 157 32.1% 26.9% 34.2% 31.7% 31.2% 
Centre 99 44 13 40 196 36.9% 47.3% 34.2% 38.5% 39.0% 
Right 83 24 12 31 150 31.0% 25.8% 31.6% 29.8% 29.8% 
Total 268 93 38 104 503 100.0% 100.0% 100.0% 100.0% 100.0% 
      
Alignment Consumer Employee Expert 
Business 
professional   
Straight 181 67 27 74 349 67.8% 73.6% 71.1% 71.2% 69.8% 
Diagonally 86 24 11 30 151 32.2% 26.4% 28.9% 28.8% 30.2% 
Total 267 91 38 104 500 100.0% 100.0% 100.0% 100.0% 100.0% 
 
Chapter 4 has presented the findings of the study and thus provided a basis 
for the discussion on their implications in terms of the research questions of the study, 
as outlined in Section 1.2. Chapter 5 will view the findings in the light of the research 
objectives providing insights into the topic of visual communication through narrative 
images in the pharmaceutical industry.  
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 5. Discussion 
 
 
This chapter will discuss the research findings in reflection to previous research 
presented in the literature review in Chapter 2. The chapter is divided into four sections 
according to the research questions of the study presented in Section 1.2. Section 5.1 
will provide answers to how the pharmaceutical industry is presented in the images 
studied. Section 5.2 discusses the groups of spokespersons identified in the images and 
provides details on their visual signifiers. Section 5.3 addresses the concept of source 
credibility effect and reflects on how the spokespersons discussed in Section 5.2 enable 
the source credibility effect to take place according to prior research. Finally, Section 
5.4 discusses visual elements in the images that were localised to different audiences 
and those that were globally standardised. 
 
 
5.1 The representation of the pharmaceutical industry in the narrative 
images 
 
The first research question concerned the way in which the pharmaceutical industry is 
presented in images on the websites of multinational pharmaceutical companies. The 
images were analysed based on a framework composed of the visual grammars of Kress 
and van Leeuwen (2006) and O’Toole (1994), as is outlined in Table 3. 
 High modality, which refers to unaltered images, was favoured to altered 
low modality images. However, only the Sustainability- and Research & Development -
sections featured more high than low modality images. Research shows that the 
modality refers to the credibility of the image as it relates to the extent of realism that 
consumers apply to images (Kress & van Leeuwen, 2006, p. 155). The case companies 
thus seem to use highly credible and realistic images in sections, which are often the 
subject of greater scrutiny by different stakeholders. The reasons behind the use of low 
modality images on the homepages as well as About us- and Products & Services –
sections are, however, unclear.  
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  The two most popular settings in the images were informal-non-
pharmaceutical (38.5 %) and formal-pharmaceutical (37.0 %). The prominence of the 
informal-non-pharmaceutical setting in narrative images acts as evidence to show that 
pharmaceutical companies want to relate their operations into the lives of the 
consumers, and not only communicate about the company internal processes. The 
informal-non-pharmaceutical settings contain regular people living their lives normally, 
implying examples of the effects of the pharmaceutical products by the company. 
Interestingly, a total of 60.5 % of the images studied featured a traditionally non-
pharmaceutical setting suggesting that communicating about the outcomes of medicinal 
products and good healthcare is more important to pharmaceutical companies than 
communicating about their day-to-day operations. The informal-pharmaceutical setting 
was the least favoured setting with only 2.3 % of the images. 
 The companies prefer the use of intimate (16.3 %), close personal (17.9 
%), far personal (30.4 %) and public distances (25.3 %) in images on their websites. 
The close distances imply that the images are being used to form relationships as 
viewers are invited into the images as though they were already familiar with the 
figures. The public distance was preferred on the Sustainability and About us –sections, 
where it was used to create a communal atmosphere showing the pharmaceutical 
company as a good corporate citizen. 
 An impressive 95.9 % of narrative images that could be categorised on the 
feelings portrayed showed positive emotional appeals, mostly of people smiling and 
looking happy. The focus seems to therefore be on the results of effective healthcare. 
The use of negative emotional appeals has, however, been shown to have better results 
in terms of attitude change and action in advertising. Currently these have not been 
utilised by the case companies on their websites apart from in two images out of the 257 
studied. It would therefore seem that pharmaceutical companies are more inclined to 
create positive experiences rather than changing unfavourable attitudes.  
 In line with the lack of negative emotional appeals, illness is also only 
rarely present in the images. Some patients are pictured being treated but even in such 
cases positive emotional appeals are employed to create a happy and direct atmosphere. 
Images also feature significantly low numbers of elderly figures (3.8 %) suggesting that 
the inevitable worsening of health through old age is also being neglected as a topic.  
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  Gaze was most commonly at another figure (35.7 %), an inanimate object 
(33.0 %) or into the distance (27.6 %). Gaze directly towards the camera was rare (2.7 
%), however, this form of engagement with the viewer was utilised on the website in 
portrayals, which were, however, not included in the present study. The images with 
narrative themes therefore aim to offer information to rather than demand attention from 
the viewer. This together with the close social distances suggests that the viewer is 
invited into the images as a quiet observer of the situations, one that is already 
acquainted to the figures. 
 The images studied present the pharmaceutical industry as a male 
dominated field (57.5 %), which holds true in all the spokesperson groups perceived. 
Men are therefore not only presented as the healthcare professionals but also as the 
consumers of healthcare. Relating this to prior research (Whittler & Spira, 2002), the 
most favourable attitude towards the visual messages would thus be witnessed among 
male website visitors. This can be seen as a risky strategy, as healthcare concerns both 
genders equally, which suggests that pharmaceutical websites are visited by both 
genders relatively equally. The impact of the male domination in the images on 
pharmaceutical websites would provide another interesting and important topic for 
further research. 
 The representation of the pharmaceutical industry through the images 
studied from the websites of the case companies can be summarised into four statements 
as follows: 
 
1. In narrative images high modality is used to enhance the credibility of visual 
messages in such sections, which come under greater scrutiny by stakeholder 
groups 
2. Narrative images depict the whole lifecycle of pharmaceutical products from 
development to consumption and resulting health with notable absence of the 
illnesses, which are being treated 
3. Narrative images show healthcare-related situations with a happy, healthy, direct 
and inviting atmosphere, in which the figures are already familiar to the viewer 
4. Narrative images present the pharmaceutical industry as a male-dominated field 
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 These four statements conclude the answer to the first research question on how the 
pharmaceutical industry is presented in images on the websites of the case companies. 
The following Section will focus on the groups of spokespersons found in the images 
providing signifiers for each group, thus answering the second research question.  
 
 
5.2 The visual spokespersons used in the narrative images 
 
The second research question addressed the visual spokespersons that multinational 
pharmaceutical companies use in images on their websites. The literature review 
outlined six groups of spokespersons that are commonly discussed in the field of 
academic research: celebrities, chief executive officers (CEOs), consumers, employees, 
experts and spokescharacters (e.g. Limbu et al. 2012, p. 25; Fill, 2009, p. 509; Stafford 
et al., 2002, p. 18; Friedman & Friedman, 1979, p. 63). Spokescharacters were excluded 
from the list to start with, as the focus of the study was on human characters in images.  
 Four distinct groups of spokespersons emerged through the study: 
consumers, employees, experts and a group, which has not been discussed in marketing 
communication literature, business professionals. From the spokespersons found in the 
literature two groups were not represented in the images: celebrities and CEOs. The 
absence of celebrities as visual spokespersons in images may be down to their relative 
expensiveness, which drives pharmaceutical companies to use them in messages 
through channels, which approach the consumers, instead of using them on corporate 
websites, which require proactivity from the consumer’s part. For CEOs to stand out 
from the other spokespersons this would necessitate an almost celebrity-like status for 
them. As spokespersons in images are dependent on visual cues, the viewers would 
need to be able to recognise the CEO by facial features, hair or posture to be able to 
distinguish him/her from the other groups of spokespersons. If this is not the case, then 
the website visitor would require a combination of image and text to be able to 
recognise a CEO spokesperson. As this study focused on pure images without textual 
information, no figures could therefore be categorised as CEO spokespersons. Next the 
spokespersons found in the images will be discussed individually in more detail with an 
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 emphasis on their signifiers and their semiotic meaning. These results are also presented 
in Table 30. 
 
Table 30: Visual spokespersons and their signifiers 
GROUP CONSUMER EMPLOYEE EXPERT BUSINESS 
PROFESSIONAL 
Signifiers • Casual clothing 
• Non-
pharmaceutical 
setting 
• Adult/child 
• Public/ far 
personal distance 
• In a group of five 
or more figures 
• Gaze into 
distance or at a 
figure 
• Not a focal point 
• Goal 
• Work clothing 
• Formal-
pharmaceutical 
setting 
• Adult 
• Far personal 
distance 
• Alone 
• Gaze at an object 
• Focal point 
• Actor 
• Work clothing 
• Formal-
pharmaceutical 
setting 
• Adult 
• Far personal 
distance 
• With one other 
figure 
• Gaze at an 
object 
• Focal point 
• Actor 
• Smart clothing 
• Formal-non-
pharmaceutical 
setting 
• Adult 
• Public distance 
• In a group of four 
or more figures 
• Gaze at a figure 
• Not a focal point 
• Actor 
 
 
 Consumers formed the largest group of visual spokespersons found in the 
images investigated covering 53.3 % of all figures. The group was signified by casual 
clothing (77.9 %) but appeared in all four settings, although most commonly in non-
pharmaceutical ones (86.9 %). The most common combination of settings for 
consumers was informal-non-pharmaceutical settings (67.5 %). The most of the 
consumers were either depicted as adults (48.1 %) or children (35.1 %) and were 
commonly seen either in groups of five or more figures (40.4 %) or together with one 
other figure (31.1 %). The social distance used in images portraying consumer 
spokespersons was most commonly either public (38.8 %) or far personal (30.6 %). In 
the images presenting consumer spokespersons, gaze was often used to create 
engagement between figures in the image (36.2 %) or it was directed towards the 
distance (36.5 %). Consumer spokespersons were more often not the focal point of 
images (63.4 %) and were mostly depicted as the goals of actions (57.3 %). 
 Business professionals were the second largest group of visual 
spokespersons with a share of 20.7 % of the figures in images studied. The signifiers of 
this group of spokespersons were smart clothing (98.1 %) and formal-non-
pharmaceutical setting (90.4 %). The vast majority of business professionals depicted 
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 were adults (83.7 %) while the rest were young adults (16.3 %). Business professionals 
were most often shown in groups of four or more figures (with a combined total of 68.3 
%) and as a result were mostly depicted at a public distance (64.4 %). Gaze was most 
often directed at other figures (42.0 %) creating engagement between the figures. 
Business professionals were more often not presented as the focal point of images (62.5 
%) but were more often actors (53.2 %) rather than goals. Business professionals were 
more often compared to the other groups of spokespersons represented by male figures 
(65.4 %). The use of business professionals in images was also more focused on 
particular sections on the websites compared to the other groups of spokespersons. The 
vast majority of business professionals were found on two sections examined: 
Sustainability (44.2 %) and About us (40.4 %). The use of business professionals in 
images also varied between the case companies with Novartis and Pfizer’s images 
featuring 29.5 % and 29.0 % of business professionals respectively but Orion and 
Sanofi’s only 10.7 % and 6.5 % respectively. 
 Employees formed the third largest group of visual spokespersons in the 
images studied with a share of 18.5 %. Employees were signified by work clothing 
(87.1 %) and a formal-pharmaceutical setting (76.3 %). Employees were most often 
adult figures (84.3 %) but some young adults were also present (15.7 %). Employee 
spokespersons were most often shown at a far personal distance (41.9 %) and were 
often alone (37.6 %) or with one other figure in the images (25.8 %). The gaze of 
employees was mostly fixed at an inanimate object in an image (62.5 %). The majority 
of employees were depicted as the focal point (59.1 %) and as an actor in the image 
(84.0 %).  
 Experts were the smallest group of visual spokespersons in the images 
with a share of 7.6 %. Experts were only depicted in formal settings and in the vast 
majority of cases it was a formal-pharmaceutical setting (92.1 %). The group was also 
signified by work clothing (92.1 %). Almost all experts were depicted as adults (97.4 
%) and shown at a far personal distance (42.1 %). Expert spokespersons were most 
often shown in an image with one other figure (36.8 %) directing their gaze either at the 
figure (41.2 %) or at an inanimate object in the image (58.8 %). Experts were most 
often shown as the focal point (55.3 %) and as the actor in an image (87.5 %). Unlike 
the other groups of visual spokespersons images containing expert figures were most 
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 often placed at the top of a web page (47.4 %) suggesting that the informational value of 
such images is considered higher by companies than that of images containing other 
visual spokespersons. 
The existence and proportion of different spokespersons in images on the 
websites may be a reference to the target audience of the companies’ websites. 
Consumers were the largest group of visual spokespersons across the companies, 
websites and sections, with the exception of Orion, whose images featured employees 
just more than consumers (41.7 % and 39.8 % respectively). The use of the other 
spokesperson groups, however, varied significantly between these variables. Novartis 
and Pfizer showed tendency towards the use of business professionals (29.5 % and 29.0 
% respectively), whereas Sanofi had the greatest share of experts, which although was 
still relatively small (13.1 %). The home country websites had the greatest share of 
business professionals (27.4 %), whereas the Chinese localised website utilised 
employees to the greatest extent (29.5 %). Employees were the most represented on the 
homepages (28.1 %) and the Research & Development –section (30.4 %), experts on the 
Products & Services –section (21.7 %) and business professionals on the About us –
section (34.7 %). These differences would suggest that different visual spokespersons 
are used to communicate different types of messages, and potentially to different groups 
of target audiences.  
 The use of narrative images of consumers can be seen as justified across 
the various companies, websites and sections because consumers are the end users of 
pharmaceutical products. Following on from the conclusion by Whittler and Spira 
(2002) that the perceived similarity between spokespersons and the viewer is a 
significant factor in ad effectiveness, the spread of images of consumers would suggest 
that all case companies see it as a relevant target audience for their websites across the 
five sections investigated in this research. Furthermore, the images of satisfied end users 
is likely to have a positive impact on other target audiences as well.  
 The use of employees in narrative images is also reasonable as they 
communicate about the operations of the company. The homepage and the Research & 
Development –section could, therefore, be seen as logical choices for such images, as 
the homepage introduces the visitor to the website and the employees are in a key role 
in the research and development processes of pharmaceutical companies. Two 
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 interesting discrepancies can be noted from the findings in terms of the use of 
employees in images. First of these is the relatively small shares of employees on 
Novartis and Sanofi’s websites (10.5 % and 9.3 % respectively). The reasons for the 
small shares of employees in images on these websites is not as clear as it could, for 
example, be an implication of different communicative targets or a result of cultural 
differences. With the two highest shares of consumers in images in the reference group 
of the four case companies (Novartis 55.5 % and Sanofi 71.0 %) it would seem that the 
companies want their images to communicate the outcome of their products, namely 
better health, rather than the process of achieving it. The second notable discrepancy 
would, however, suggest that some element of cultural differences might be inherent. 
This is the high share of employees used on the Chinese localised websites compared to 
the global and home country websites (29.5 %, 19.8 % and 18.8 % respectively). To 
find better evidence of the reasons behind these variations further research into the 
matter would therefore be necessary. 
 The use of expert figures in narrative images was relatively low yet stable 
across the companies, websites and sections. A visible peak in their use, however, could 
be seen in the context of the Products & Services –section, where 21.7 % of all figures 
were categorised as experts. As experts, in the case of this study doctors and 
pharmacists, represent the pharmaceutical professionals, who have the opportunity to 
deal with the end users directly, this peak can be deemed reasonable. Pharmaceutical 
companies themselves are unable to provide their products and services to consumers 
directly because of legal restrictions and regulations, which is why the existence of 
images where these groups of middlemen are visible is justified. 
 The use of business professionals in the images would suggest that the 
pharmaceutical companies want to remind the website visitors that despite their aim for 
greater purposes, such as improving health, they are still viable businesses at heart. If 
this were the case, it would then be reasonable to assume that the business professional 
spokespersons are placed in images targeted towards financial and business audiences, 
such as current and potential investors or business partners. The placing of these images 
across the websites shows some support for this assumption, as the greatest shares of 
images with business professionals can be found in the About us- (34.7 %) and 
Sustainability-sections (20.4 %), which tend to be of particular interest to investors and 
109
 business partners. Interestingly, however, the use of business professionals in images is 
the most prominent on the home country localised websites of the case companies (27.4 
% compared to 17.9 % on the global and 19.2 % on the Chinese localised website). If 
business professionals were only used in images to communicate to investors and 
business partners, this would suggest that the companies considered their home country 
website as the channel of choice to communicate to them, something that is highly 
unlikely in the case of multinational companies with global investors and partners. 
Furthermore, there are major discrepancies between the companies in terms of the use 
of business professionals in images with the spokespersons taking up a share of 29.5 % 
and 29.0 % of figures in images on Novartis and Pfizer’s websites respectively, whereas 
Orion and Sanofi are far behind with shares of 10.7 % and 6.5 % respectively. The 
communicative purpose and meaning of business professionals as visual spokespersons 
would, therefore, require further research. 
This section presented the spokesperson groups found in the images 
studied thus providing an answer to research question 2. The section also highlighted 
the signifiers and notable differences between the spokespersons. Section 5.3 will 
follow in line of this theme and address the third research question on the transfer of 
credibility through the different visual spokesperson. In addition, the Section will 
further investigate the reasoning behind the use of the various groups of spokespersons 
in images on websites of multinational pharmaceutical companies.  
 
 
5.3 Source credibility effect in the narrative images 
 
This section discusses the findings of the study in view of the second research question 
presented in Section 1.2 addressing the concept of source credibility and considers how 
well the visual spokespersons used in the images studied enable the transfer of 
credibility to the visual messages. The section will be divided into the four groups of 
visual spokespersons discussed in the previous section: consumers, business 
professionals, employees and experts. These groups will be reflected on the dimensions 
of source credibility found in the literature: expertise, trustworthiness and attractiveness 
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 (Clow et al., 2006; Lefferty et al., 2002; Ohanian, 1991). Furthermore, the personal 
motives, as suggested by Fill (2009, p. 507) will be discussed. 
 Consumers spokespersons represent typical users of the product and may 
be viewed as highly attractive to actual consumers due to their perceived similarity to 
them. Consumer spokespersons have no expert knowledge of the products they are 
endorsing but speak from their own experience as an actual consumer might do to their 
friend or family member. The actual consumers can therefore relate to consumer 
spokespersons, which may increase their trustworthiness. For this reason the personal 
motives of consumer spokespersons may also be deemed as low. Due to their lack of 
expertise, however, it could be argued that consumer spokespersons are more successful 
in communicating about the less risky over-the-counter products than prescription-based 
medicinal products, which may often cause more severe side effects and be more 
expensive as well.  
 Employees are likely to be considered high on expertise, as through their 
education and experience they possess better knowledge of the pharmaceutical products 
compared to consumers. Their trustworthiness, however, may be seen as compromised 
by their personal motives to support their employer. Employee spokespersons still 
remain a crucial part in communicating about the operations of the pharmaceutical 
company and tend to be effective when communicating about the employer brand. For 
these reasons employee spokespersons could be deemed as especially effective in 
Careers-sections of websites, which mainly target potential job applicants. Employees 
may, however, be deemed as attractive on other sections of websites as well, as their 
work in creating cures and preventive measures for illnesses is commonly considered 
valuable.   
 It remains unclear whether or not images with business professionals are 
used to communicate to consumers or to other potential target audiences of the websites 
such as current and potential investors or business partners. In order to evaluate the 
source credibility of business professionals as visual spokespersons it is, however, 
necessary to distinguish a target group for them to use as a reference point for the 
analysis.  
 An investor or a business partner could relate a business professional 
spokesperson to an employee spokesperson, as the business professionals could be seen 
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 as company employees, who are responsible for the day-to-day running of the 
pharmaceutical business rather than the development, testing and analysis of drugs. A 
business professional could therefore be seen as a highly educated corporate 
professional, thus possessing a high level of expertise. As a company employee, 
however, the personal motives of endorsing one’s employer could be seen to undermine 
the visual spokesperson’s trustworthiness. However, the perceived similar background 
of the investor or business partner and the business professional spokesperson could 
lead to high perceived levels of attractiveness. 
 For a consumer, the business professional spokesperson could represent an 
upper-class consumer. In such a case the expertise of the spokesperson would be 
deemed as low, as the business professional would possess no greater knowledge than 
the consumer him/herself of the products. The trustworthiness of the business 
professional might, however, be perceived as high if the spokesperson was considered 
to lack any personal motives for communicating about the pharmaceutical company. 
The attractiveness of the business professional as an upper-class consumer can, 
however, be seen as two-folded. According to Whittler and Spira (2002) the perceived 
similarity of the spokesperson and the viewer has a positive impact on the perception of 
an advert. If the viewer considers him/herself to belong to the same class, they are likely 
to consider the spokesperson as attractive. However, if the viewer sees him/herself as a 
member of a lower class, it may result in unfavourable opinions on the visual message.  
 The low share of expert spokespersons in the narrative images (7.6 %) 
could be deemed as somewhat of a surprise, as they after all represent the people who 
prescribe medicinal products to consumers or the people who the consumers buy the 
products from. As their name suggests, expert spokespersons are logically high the 
expertise dimension. This stems from superior knowledge compared to the website 
visitor that is gained through experience, study or training (Limbu et al., 2012, p. 25; 
Fill, 2009, p. 509; Friedman & Friedman, 1979, p. 63). The perception of expertise is 
often linked to the trustworthiness of a spokesperson because of the perception of 
superior knowledge. In the context of this study, in which the group of experts consists 
of doctors and pharmacists, the professional ethics of the depicted spokespersons are 
also likely to result in a high level of trustworthiness perceived by the website visitors. 
The attractiveness of expert spokespersons is case specific, and has been shown to be 
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 subservient to the level of trustworthiness possessed by a spokesperson (Fill, 2009, p. 
509). It could therefore be argued that the source credibility of expert spokespersons is 
not dependent on the physical attractiveness of the expert. These factors would support 
the transfer of credibility from the expert spokesperson into the visual message 
communicated by a pharmaceutical company. Furthermore, it has been suggested in the 
literature that expert spokespersons are the most suitable to be used in adverts for such 
products that could cause financial or physical risk to the consumer (Friedman & 
Friedman, 1979, p. 71). As the price of medicinal products can be high and the use of 
them is linked to an element of risk in the form of side effects, medicinal products can 
be seen to qualify both of these statements. Their use in images on the websites of 
pharmaceutical companies could therefore be seen as justified.  
 The notion of personal motives is, however, ambiguous for expert 
spokespersons. Whereas pharmaceutical experts are often trusted without question in 
real-life situations, the fact that the image is found on a website of a pharmaceutical 
company may undermine this trust. The efforts that pharmaceutical companies go 
through to get doctors to prescribe their products have been discussed in the media to a 
great extent, which could translate to a high level of perceived personal motives. It is 
therefore possible that website visitors utilise a high level of criticality when decoding 
visual messages by doctors on websites of pharmaceutical companies, which could limit 
the effectiveness of using expert spokespersons in visual messages. 
  
Table 31: An analysis of the spokespersons’ source credibility  
DIMENSION CONSUMER EMPLOYEE EXPERT 
BUSINESS 
PROFESSIONAL 
Consumer/Employee 
Expertise Low High High Low/ High 
Trustworthiness High Low Either High/ Low 
Attractiveness High High High Either/ High 
Lack of personal 
motives 
High Low Either High/ Low 
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 As seen in Table 31, which summarises the analysis of the source 
credibility of the four spokesperson groups found through the study, each visual 
spokesperson contains personal strengths as well as weaknesses. As suggested by Tom 
et al. (1992, p. 48) it is crucial to match the spokesperson to the message that is to be 
communicated and take into account the different target audiences of the website and 
their differing views on the credibility of the various visual spokespersons.    
 
 
5.4 Localised vs. globalised elements in the narrative images 
 
The fourth research question concerned the extent to which visual elements were 
globalised or localised in the images on websites of pharmaceutical companies. The aim 
amongst multinational companies tends to be towards the saving of resources and the 
use of standard globalised communication whenever deemed suitable. Localisation and 
adaption of communication efforts into the target market has, however, been shown to 
result in increased rates of visitor satisfaction and higher potential for visitors to remain 
longer on the website (Luna et al., 2002; Cyr et al., 2009). An (2007) notes that many 
global brands have opted for a so-called glocalisation strategy, which refers to localised 
content with globalised access. This Section will discuss the research findings in terms 
of their localisation or globalisation across the global corporate websites as well as the 
localised home country and Chinese websites of the case companies. The discussion is 
divided into three parts: first any general notions regarding the images will be presented 
followed by the discussion on visual elements at the rank of work according to the 
analytical framework. Finally, the globalised and localised elements at the rank of figure 
will be discussed.  
 Looking at the research results by website presented in Tables 5, 7 and 8 
there are interesting observations to be made. Firstly, looking at the numbers of images 
on the three categories of websites it is clear that the Chinese localised website features 
much less images (12.8 %) compared to the almost equal shares of the global and the 
home country localised website (44.3 % and 42.9 % respectively). It would therefore 
seem that the Chinese localised websites are indeed localised in terms of the means of 
communication. Although it may hold valid that pharmaceutical companies deem visual 
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 communication through images less important in the Chinese market, it is also possible 
that the companies merely feel less confident to communicate through images to the 
Chinese audience. Either way, it would seem justified to say that pharmaceutical 
companies feel the need to localise their visual communication through images to the 
Chinese market, as they judge the images used on the global and home country localised 
websites unsuitable for this market. This is also evident when examining the reuse rates 
of the images found on the three types of websites. As stated in Section 4.1 presenting 
the general findings of the study, none of the images used on the global or the home 
country websites were duplicated on the Chinese websites. 
 From Table 7 it is evident that the four case companies distribute varying 
levels of importance to the three websites. Whereas Orion (54.0 %) and Sanofi (47.8 %) 
have placed the greatest number of images on their global websites, Novartis opted for 
their home country website (50.9 %). The Pfizer.com-website included 78.9 % of all 
images on the Pfizer websites examined. For all but one company (Sanofi: 32.6 %), the 
Chinese localised website features the smallest share of images (Novartis: 13.6 %, 
Orion: 2.3 %, Pfizer: 21.1 %). This shows that visual communication in the 
pharmaceutical industry has variation not only in terms of the target markets but also by 
company. One should therefore take greater care when applying the findings of this 
study to other pharmaceutical companies. 
 Table 8 presented the frequency of narrative images on the global, home 
country and Chinese websites by website section. The extent of deviation between the 
three categories of websites varies. For example, each category features a relatively 
similar share of narrative images on their About us –section (Global: 26.8 %, Home 
country: 35.8 % and Chinese: 31.8 %) whereas the Products & Services- (Global: 7.8 %, 
Home country: 6.1 % and Chinese: 25.0 %) and Sustainability-sections (Global: 36.6 %, 
Home country: 40.5 % and Chinese: 11.4 %) display greater variance. It would 
therefore seem that the need for visual communication is perceived differently within 
different target markets by pharmaceutical companies resulting in a visual emphasis of 
certain sections. Judging by the figures in Table 8, this need seems to be perceived as 
relatively similar in the global and home country websites, which both exhibit similar 
visual penetration of images in the sections. Sustainability- and About us –sections hold 
the largest shares of images for both categories of websites with shares of 36.6 % and 
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 26.8 % respectively on the global websites and shares of 40.5 % and 35.8 % 
respectively on the home country websites. The Chinese localised websites, however, 
has the most images on its About us- and Products & Services –sections (31.8 % and 
25.0 % respectively). 
 Moving onto the findings at the rank of work by the interpersonal 
metafunction presented in Table 12, it is interesting to see that the use of the different 
levels of modality vary between the three categories of websites. The home country 
websites are the only ones presenting more high than low modality images (58.1 % and 
41.9 % respectively). The global websites depict almost equal shares of 49.7 % of high 
and 50.3 % of low modality images, whereas the Chinese website has a more prominent 
tendency towards low modality images (54.5 %). It would therefore seem that 
pharmaceutical companies opt for a greater level of credibility on the home country 
website compared to the other two website categories. 
 In terms of the image settings both the global and the home country 
websites show a tendency towards informal-non-pharmaceutical images (41.2 % and 
42.6 % respectively), whereas the Chinese website contains the greatest share of formal-
pharmaceutical images (54.5 %). This may be seen to provide further evidence to the 
assumption that pharmaceutical companies are unsure of how to use images for 
communication within the Chinese market, which results in a greater use of images 
featuring settings, which are traditionally related to the pharmaceutical industry.  
 The findings for the social distance used in the narrative images shown in 
Table 12 suggests that the pharmaceutical companies want to display familiarity on the 
global and Chinese websites, whereas they opt for displaying their membership of the 
community on the home country websites. This assumption can be drawn from the 
preference for the far personal distance on the global and Chinese websites (35.3 % and 
40.9 % respectively) and that for the public distance on the home country website (33.8 
%). 
 All of the three categories of websites feature a majority of positive affect 
emotional appeals (Global: 61.2 %, Home country: 79.3 % and Chinese: 85.7 %). This 
visual element seems to therefore be standardised globally. The number of narrative 
images without clear appraisal or emotional appeals, however, was high in all three 
categories (Global: 68.0 %, Home country: 80.3 % and Chinese: 68.2 %). It would 
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 therefore seem that images without clearly defined feeling are preferred by 
pharmaceutical companies, but in images, which depict feelings, the positive affect 
appeal is favoured. Maughan et al. (2007) found in their eye tracking study of outdoor 
poster advertising that posters depicting images were looked at for longer by research 
participants. This could suggest that emotional appeals in images in other channels 
would gain more exposure to viewer’s attention as well, and therefore the greater use of 
emotional appeals in images could be recommended within the pharmaceutical industry 
as well.  
 Looking at the research findings on the compositional metafunction at the 
rank of work as seen in Table 24, it is clear that the two localised websites seem to have 
been standardised in terms of the positioning of the images on the web pages. On both 
categories of websites the middle of the page is preferred as it features a share of 59.5 % 
of images on the home country website and a share of 59.1 % on the Chinese localised 
websites. The top of the page is, however, preferred on the global websites with a share 
of 47.1 %. As the proportions for the top of the page for the home country websites and 
the Chinese websites equal 32.4 % and 36.4 % respectively, this may be seen as an 
adapted element for the global website. 
 The number of figures presented in the narrative images follows in line 
with findings on social distances already discussed in this section. The global websites 
as well as the Chinese localised websites show a clear tendency towards fewer figures in 
images with one figure being the most popular alternative on the Chinese websites (50.0 
%) and two figures on the global websites (35.0 %). The home country websites’ 
preference for the public distance is visible in the share of five or more figures in 
images (27.9 %), however, having one or two figures had also the same or similar share 
with 27.9 % and 27.1 % respectively. 
 Moving onto the analysis of the results by figure the gaze of the figures 
was examined at the interpersonal visual element of the framework. From the results 
presented in Table 13 a common trend is clearly visible across the three categories of 
websites: gazes at another figure, into the distance or at an inanimate object each gained 
a significantly larger share compared to the other gazes in all three categories. This 
suggests that gaze is to some extent globalised among pharmaceutical websites targeting 
different audiences. Minor variation does, however, occur. Whereas the global websites 
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 and the Chinese localised websites feature most commonly figures gazing at an object 
(36.8 % and 39.4 % respectively), the home country websites feature mostly figures 
gazing at other figures (38.4 %). 
   The results on the representational metafunction by figure are presented 
in Table 19. As is visible in the table, male figures were preferred on all categories of 
websites. However, whereas the global and home country websites share almost equal 
proportions of 54.4 % and 55.1 % of male figures, the Chinese localised website 
contains a much higher share of 73.8 %. Despite the other websites also featuring a 
majority of male figures, the much higher percentage on the Chinese website suggests 
that there is some element of localisation in the element. This is also evident in the 
comparison by company, as Orion is the only company to have a majority of female 
figures (55.7 %). 
 Adult figures are preferred on all three categories of websites with the age 
group achieving a share of 62.8 % of figures on the global websites, 65.0 % of those on 
the home country websites and as high as 73.3 % of those on the Chinese websites. The 
websites are also unanimous in the lack of elderly figures on their web pages (Global: 
3.8 %, Home country: 3.6 % and Chinese: 4.0 %). It would therefore seem that the age 
groups used in the images are to a large extent standardised across websites to different 
target audiences. Small discrepancies do, however, exist in terms of the other age 
groups with global websites featuring more children (24.4 %) compared to the localised 
websites (Home country: 16.6 % and Chinese: 16.0 %), whereas the home country 
websites depicting more young adult figures (14.8 % compared to 9.0 % on global 
websites and 6.7 % on Chinese websites). 
 The four groups of visual spokespersons identified through the study were 
all found across the three categories of websites. Consumers were the biggest group on 
all three categories even though the difference between the highest share (Global: 54.0 
%) and the lowest share (Chinese: 39.7 %) is notable. The low share of consumers on 
the Chinese website enabled a more balanced division of figures into the spokesperson 
groups, whereas the global and home country websites were heavily tilted towards the 
consumer spokesperson groups. For this reason, the Chinese websites featured the 
greatest share of employees (29.5 %) and experts (11.5 %), however the home country 
websites had the greatest preference towards business professionals (27.4 %). It is 
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 therefore fair to say that the overall spokesperson roles that are featured in images on 
the websites of multinational pharmaceutical companies are highly globalised, whereas 
the extent of their use is localised to the needs of the target market. 
 As discussed in Section 5.2 on the signifiers of the visual spokespersons, 
clothing emerged as a key indicator of a figure’s role in an image. The results on 
clothing, therefore, follow in line with those of the results on the visual spokesperson 
groups. Featuring the greatest shares of employees and experts, the Chinese websites 
also have the highest proportion of work clothing (37.2 %). The home country websites 
feature the greatest share of smart-clothed figures (35.9 %), which is a result of the high 
share of business professionals on the websites. The greatest share of casual clothing 
can be found on the global websites (48.4 %), which also had the highest share of 
consumer spokespersons. Components, which appear to be standard across the websites 
are the share of figures, whose clothes have been cropped out of the image (Global: 5.4 
%, Home country: 7.2 % and Chinese: 6.4 %) and that of those, who appear in the 
images as naked (Global: 0.3 %, Home country: 0.0 % and Chinese 0.0 %).  
 In terms of the compositional function at the rank of figure the visual 
elements seem to be highly globalised across the various websites, as is seen on table 
25. Each category of websites features the greatest share of figures at the centre of an 
image (Global: 38.7 %, Home country: 38.6 % and Chinese 44.9 %) and also has an 
evident preference for figures aligned along the vertical axis (Global: 70.3 %, Home 
country: 71.1 % and Chinese 66.7 %).  
 To conclude, this section has discussed the visual elements outlined in the 
analytical framework for this study in relation to their globalisation or localisation 
across the global websites as well as the home country and Chinese localised websites 
of the four case companies. The discussion of this Section is summarised in Table 32, 
which provides a coherent response to research question four, which it set out to answer. 
The visual elements are organised in the table according to the websites, if not all, 
which share the same feature.  
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 Table 32: Globalised and localised visual elements in the narrative images 
 GLOBALISED LOCALISED 
General • Global & Home country: the number 
of images 
• Global & Home country: the images 
to some extent (re-use) 
• Chinese: the number of 
images 
• All: Emphasis on different 
sections of the websites 
Work • Global & Home country: informal-
non-pharmaceutical setting 
• Global & Chinese: far personal 
distance 
• All: lack of emotional appeals 
(positive affect in those that feature 
emotion) 
• Home country & Chinese: middle of 
the web page 
 
• Home country: high modality 
• Chinese: low modality 
• Chinese: formal-
pharmaceutical setting 
• Home country: public 
distance 
• Global: top of the web page 
• All: number of figures 
Figure • Global & Chinese: gaze at an object 
• All: male figures 
• All: adult figures, lack of elderly 
figures 
• All: emphasis on consumers 
• All: lack of figures with cropped-out 
or no clothing 
• All: positioning of figures in an 
image 
• All: alignment to the vertical axis 
• Home country: gaze at a 
figure  
• Chinese: the greater 
proportion of male figures 
• Chinese: employees and 
experts 
• Home country: business 
professionals 
 
As is evident from the table both localised and globalised visual elements 
were found through the analysis. The visual elements at the rank of figure were more 
likely to be globally standardised compared to general elements or those at the rank of 
work. This suggests that the persons involved in health-care related situations are 
considered universally adaptable by multinational pharmaceutical companies. The 
findings on the global websites were almost without exception in line with one of the 
localised websites. The only adapted element on the global websites was the tendency 
towards placing images at the top of web pages. The two localised websites, home 
country and Chinese, included greater extent of adaptation suggesting that 
pharmaceutical companies feel the need to localise their online visual communication. 
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 6. Conclusion 
 
 
This chapter concludes the thesis by summarizing the study and its findings in terms of 
the research questions. The practical implications of the study will be considered both 
for academics and practitioners dealing with visual communication issues. A section is 
also provided for the critical analysis of the study in terms of its limitations. Finally, the 
chapter will provide suggestions for further research following on from the research 
conducted for this study. 
 
6.1 Research summary 
 
The aim of the present study was to examine the visual communication of four 
multinational pharmaceutical companies, Novartis, Orion, Pfizer and Sanofi, through 
images on their global corporate website as well as two localised websites: their home 
country and China. The main emphasis of the study was on human roles depicted in the 
images and whether or not these roles could enable the source credibility effect 
commonly researched in marketing communication. The study also investigated 
whether pharmaceutical companies globalised visual elements across the three websites 
or whether the elements were localised to the target markets. The research questions 
presented for the study were as follows: 
 
1. How is the pharmaceutical industry presented in images on the websites of 
multinational pharmaceutical companies? 
2. What kinds of visual spokespersons do multinational pharmaceutical companies 
use in images on their websites? 
3. How do the visual spokespersons used on the websites of multinational 
pharmaceutical companies enable the source credibility effect to take place? 
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 4. Which visual elements are globalised and which ones localised in the images of 
multinational pharmaceutical companies found on their corporate, home country 
and Chinese localised website? 
 
The study utilised the methods of semiotic analysis and content analysis to analyse the 
meaning created in the images found on the websites and to quantify these findings for 
quantitative analysis. The analytical framework used for the study combined elements 
of two well-known frameworks of visual language, one by Kress and van Leeuwen 
(2006) and one by O’Toole (1994). The main findings of the analysis will next be 
summarised in terms of the research questions of the study. 
 
1. How is the pharmaceutical industry presented in images on the websites of 
multinational pharmaceutical companies? 
 
Four statements were made about the pharmaceutical industry, based on the analysis of 
the images:  
 
1. In narrative images high modality is used to enhance the credibility of visual 
messages in such sections, which come under greater scrutiny by stakeholder 
groups 
 
2. Narrative images depict the whole lifecycle of pharmaceutical products from 
development to consumption and resulting health with notable absence of the 
illnesses, which are being treated 
 
3. Narrative images show healthcare-related situations with a happy, healthy, direct 
and inviting atmosphere, in which the figures are already familiar to the viewer 
 
4. Narrative images present the pharmaceutical industry as a male-dominated field 
 
It could therefore be concluded that the representation of the pharmaceutical industry in 
narrative images on the websites of multinational pharmaceutical companies is not an 
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 entirely comprehensive. Relating these findings back to the fair balance view exposed 
by the FDA for the US pharmaceutical market, the risks of medicinal products are far 
less represented in the images on the websites compared to the health benefits of the 
products. 
 
 
2. What kinds of visual spokespersons do multinational pharmaceutical companies 
use in images on their websites? 
 
Four distinct groups of visual spokespersons were found through the analysis: 
consumers, employees, experts and business professionals. The clothing of the figures 
as well as the setting, in which the figures are depicted, proved to be the key signifiers 
of the different groups of visual spokespersons. The way in which these key signifiers 
were established among the visual spokesperson groups will next be outlined as well as 
other individual signifiers identified for the groups. 
 Consumers were signified by casual clothing and appeared most often in 
non-pharmaceutical settings. The consumer spokespersons were either adults or children 
pictured from a public or far personal distance. Consumers were most often shown in 
groups of five or more figures and gazing at another figure in the image. Consumers 
were more often not the focal point of images and were more often depicted as goals of 
action rather than as actors themselves.  
 Employee spokespersons appeared in formal-pharmaceutical settings 
wearing appropriate work clothing. Employees were depicted as adults from a far 
personal distance. Employee spokespersons were often depicted on their own gazing at 
an object in the image. The spokespersons were more often than not the focal point of 
images and were portrayed as actors. 
 Experts shared multiple signifiers with the employee spokespersons. 
Experts were also most often found wearing work clothing in formal-pharmaceutical 
settings. The spokespersons were depicted as adults at a far personal distance gazing at 
an object in the image. Like employee spokespersons, experts were also often actors and 
focal points of images. Unlike employees, however, expert spokespersons were most 
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 commonly pictured with one other figure. Experts were also signified by other elements 
in an image, such as a medical object (for example a stethoscope).  
 Business professionals were shown in formal-non-pharmaceutical settings. 
The group was also signified by smart clothing appropriate for an office-worker. 
Business professionals were adults shown at a public distance. As a result the 
spokespersons were most commonly shown in groups of four or more figures. Their 
gaze was often directed towards another figure, and even though the business 
professionals were more often not the focal point of images, they were still more often 
depicted as the actors in them. 
 
  
3. How do the visual spokespersons used on the websites of multinational 
pharmaceutical companies enable the source credibility effect to take place? 
 
Source credibility has been commonly divided into three dimensions: expertise, 
trustworthiness and attractiveness (e.g. Clow et al., 2006; Lefferty et al., 2002; Ohanian, 
1991). These three dimensions were considered in the present study to examine the 
potential for the source credibility effect to take place and the visual spokesperson to 
transfer credibility into the visual message by the pharmaceutical company. 
Furthermore, the personal motives of the visual spokespersons were also analysed, 
especially in relation to the trustworthiness dimension.  
 All four groups of visual spokespersons could be deemed to enable the 
source credibility effect, although with different credentials. The consumer 
spokespersons are commonly deemed low on expertise but high on trustworthiness and 
attractiveness due to their similarity to consumers visiting the websites. The lack of 
personal motives also contributed to the high trustworthiness of the consumer 
spokespersons.  
 The employee spokespersons have better knowledge on the 
pharmaceutical industry and its products than consumers visiting the websites. They can 
therefore be argued to have high expertise. Their trustworthiness may, however, be 
compromised by their perceived personal motives to support their employer. Due to the 
124
 valuable nature of their work as curers of illnesses, employee spokespersons may still be 
considered as attractive to website visitors.  
 Similarly to the employee spokespersons, the expert spokespersons are 
also high on expertise and on attractiveness. A crucial difference, however, is that as an 
external party to the pharmaceutical companies, the expert spokespersons are often 
considered as highly trustworthy. This argument may, however, be compromised by 
perceived personal motives arising from the high media attention that has been given to 
the ways pharmaceutical companies aim to influence doctors and pharmacists to 
prescribe and sell their products. If the personal motives of an expert spokesperson are 
considered as high, the trustworthiness achieved through their position may erode.  
 The business professional spokespersons can take the form of two 
characters depending on the status of the website visitor. For a consumer visiting the 
website, the business professionals may represent an upper class consumer. The source 
credibility of the business professional would then follow in line with that of a 
consumer spokesperson (low expertise, high trustworthiness, lack of personal motives) 
with the exception of the attractiveness dimension. If the consumer perceives 
him/herself as upper class as well, the perceived similarity to the business professional 
could result in high spokesperson attractiveness. However, if the visitor considers 
him/herself to belong to another class, the attractiveness of the business professional is 
likely to be lower. 
 The second scenario is posed by a current or potential investor or business 
partner visiting the website. In this case the visitor could reflect the business 
professional spokesperson to an employee working in the offices of the pharmaceutical 
company. As a result, the business professional spokesperson would follow in line with 
the credibility of the employee in that it is high on expertise and attractiveness, but low 
on trustworthiness due to high levels of personal motives. 
 
4. Which visual elements are globalised and which ones localised in the images of 
multinational pharmaceutical companies found on their corporate, home country 
and Chinese localised website? 
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 Both globalised and localised visual elements were found among those investigated 
through this study. The majority of the elements at the rank of figure, such as gender, 
age, spokespersons and alignment, were globalised across the global websites as well as 
the localised home country and Chinese websites. In addition, the appraisal of images 
was also globally standardised at the rank of work, with all categories showing a lack of 
emotional appeals and a tendency for positive affect in images containing feelings. 
 What is noteworthy from the findings on the globalised and localised 
visual elements is the tendency towards globalisation on the global websites. Only one 
visual element could be identified as localised for the global audiences. This would 
suggest that the global website is used as a visual reference point when creating 
localised websites, or vice versa that the changes to the localised websites are copied 
and pasted onto the global website as well. The localised websites featured a higher 
level of localisation suggesting that the pharmaceutical companies recognise the 
importance for adapting visual elements to target audiences to some extent.  
 
 
6.2 Practical implications 
 
The present study showcases implications both to academics interested in visual 
communication and the pharmaceutical industry as well as to practitioners operating 
within the industry in question. In academic terms, the study added to the pool of 
academic research on the pharmaceutical industry with a novel angle by investigating 
visual communication through images, and it has also provided valuable knowledge on 
how the industry is represented in the images as well as how the companies utilise 
images for online visual communication. Furthermore, the study adopted the concept of 
source credibility effect from marketing communication to visual communication 
providing evidence on the argument that visual spokespersons can transfer credibility to 
a message without the inclusion of textual elements.  
 For the pharmaceutical industry the study presented valid arguments why 
companies should pay attention to how and what they communicate through images on 
their websites. In addition recommendations and insights were also provided to 
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 practitioners on how to improve online visual communication to better engage and 
inform website visitors.  
 
 
6.3 Limitations of the study 
 
As any research project would, the present study also included limitations. As the 
limitations are inherent in the research methods chosen for the study they were known 
by the researcher already in the beginning of the research project and thus their impact 
could be limited to the absolute minimum whenever possible.  
 As semiotic analysis relies on the informed knowledge and training of the 
coder, it is commonly conducted with several coders verifying the findings of the 
others. As the present study was coded by a sole researcher, this may have led to 
shortcomings. To minimise these the coding sheets were included in the thesis as well 
as detailed descriptions of the basis of the coding to enable future verification of the 
coding. 
 The study examined the visual elements in images on the websites of four 
multinational pharmaceutical companies. A total of 257 images and 503 figures were 
analysed from the 11 websites chosen for this study. Despite the large numbers of 
images, figures and websites analysed, the findings cannot be fully generalised into the 
entire pharmaceutical industry due to the small number of companies examined. The 
findings do, however, give some indication of how visual communication is used within 
the pharmaceutical industry. 
 Next section will give suggestions for further research from the basis of 
this study. Suggestions have also been made on how the limitations of this study could 
be prevented in future research projects.  
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 6.4 Suggestions for further research 
 
The present study has highlighted several topics and objectives how the visual 
communication through images on the websites of multinational pharmaceutical 
companies could be further researched. A logical next step following on from the 
present study would be to incorporate members of the target audiences into the research 
project by investigating the decoding of visual messages and the impact of the visual 
elements within them. To further the adoption of the source credibility effect into the 
field of visual communication one could also investigate the impact of visual 
spokespersons on website visitors within a relevant target group. For a holistic view, a 
study on what multinational pharmaceutical companies themselves intend to 
communicate through images on their website would also broaden our knowledge on 
the topic. Furthermore, to combat some of the limitations of the present study, it could 
be reiterated with a higher number of case companies, a higher number of different 
localised websites or with more researchers. New variables, such as the size of the case 
company, could then be added into the study. 
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Appendix 1: The analysis of the narrative images in terms of the website and 
 
 
 
 
Appendix 2: The analysis of the narrative images at the rank of work 
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Appendix 3: The analysis of the narrative images at the rank of figure
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